Sommaire

• • ·Scientific program

    Page :440-517

    
• • ·Author index

    Page :519-550

    
• • ·Subject index

    Page :551-576

    

• Abstract Saturday, March 16, 1996

  • ·1 PEFR as a measure of airway obstruction in pediatric asthmatic patients

    Page :183

    C.B. Arant, R.R. Baker, N.T. Rupp

    
  • ·2 Questionnaire, BHR, and total IgE variability over time and their interrelationships

    Page :183

    D.A. Drury, L. Daniels

    
  • ·3 The role of a peripatetic allergy nurse practitioner in the care of the allergy patient within primary care

    Page :183

    M.J. Brydon

    
  • ·4 Office nurses' perceptions of competencies for the patient teaching role

    Page :183

    C.W. Wagner

    
  • ·5 Starting a database in clinical practice: benefits of even simple electronic records in the organization of an immunization clinic

    Page :184

    N. Veltri, J. Brooks, S. Bell, J. George, A. Rios-Rodriguez, R.J.M. Engler

    
  • ·6 Interrelationship of an asthma respiratory questionnaire, Isaac video questionnaire, and bronchial hyperresponsiveness/reversibility

    Page :184

    M. Stockton, L. Freidhoff, K. Barnes, A. Togias, R. Rosenthal, F. Malveaux, D. Marsh

    
  • ·7 Comparison of the efficiency of two nebulizer systems using battery power

    Page :184

    D.T. Loffert

    
  • ·8 Ethnic differences in biologic factors related to childhood asthma

    Page :184

    C.L.M. Joseph, D.R. Ownby, B.C. Tilley

    
  • ·9 Awareness of potential adverse reactions to triatoma bite and appropriate treatment

    Page :185

    S.F. Johnson, R.S. Zeiger, N.A. Marshall

    
  • ·10 An intervention program prolongs duration of breast feeding of newborns at high risk for development of asthma and allergies

    Page :185

    M.K. Lilley, S.E. Harrison

    
  • ·11 Community-based asthma education project for Latino children

    Page :185

    N.F. Gorham, D. Santoyo, R.S. Gruchalla

    
  • ·12 A comparison study of candida albicans & dermatophyton “O” skin test antigens

    Page :185

    A.M. Gerard, R.M. Roth

    
  • ·13 Evaluation of low allergenic latex gloves in latex sensitive patients

    Page :186

    L.L. Gehring, J.N. Pink, K.J. Kelly

    
  • ·14 Monitoring of indoor temperature and relative humidity in the summertime in homes in the Southeastern US

    Page :186

    J.L. Ford, N.T. Rupp

    
  • ·15 Value of peak flow readings in the safe administration of immunotherapy in asthmatics

    Page :186

    I.M. Dunn, J.M. Demasi

    
  • ·16 Success rate in changing patients on intravenous lin (IVG) to a solvent detergent treated product (SDTP)

    Page :186

    C. Dirato, M.R. Stein, D. Amran

    
  • ·17 The high risk asthma program

    Page :187

    K.A. Conboy, L.C. Schneider

    
  • ·18 Immunotherapy vial preparation using a computer spreadsheet

    Page :187

    C. Coleman, H. Windom

    
  • ·19 Comparison of performance of four skin test devices

    Page :187

    K.M. Caruso, S. Witkowski, S.M. Slattern, A.L. Melton, W.O. Wagner, L.C. Pien

    
  • ·20 Relationship between bronchodilator reversibility (REV), bronchial reactivity (BR), and baseline pulmonary function in asthma

    Page :187

    F. Brennan, E. Horowitz, A. Togias

    
  • ·21 Computerization of extract information in the allergy office

    Page :188

    L. Brazener, S.L. Roth

    
  • ·22 Patient education in a managed care environment

    Page :188

    L. Brabyn, M. Nisam, A. Margolin

    
  • ·23 Reliability of instruments in a pediatric asthmatic population

    Page :188

    K. Bagstad, L. Lacey-Haun, T. Buford

    
  • ·24 Effects of advertisement methods on success of subject recruitment for clinical research trials

    Page :188

    B.L. Angelini, K.M. Cordoro, P. Fireman, D.P. Skoner

    
  • ·25 Clinical implications of sinus imaging in pediatrics

    Page :189

    D.D. Kalman, G.W. Gross, S.J. McGea

    
  • ·26 Total IgE levels (IgE) correlate with the severity of sinusitis on computerized tomography (CT) scans

    Page :189

    S.H. Suh, F.M. Baroody, R.M. Naclerio

    
  • ·27 Chronic sinusitis in an allergy office

    Page :189

    P.A. McNally, M.V. White, M.A. Kaliner

    
  • ·28 Determination of the duration of antibiotic therapy in chronic sinusitis

    Page :189

    M. Serwonska, D. German, M. Strub

    
  • ·29 Treatment of chronic sinusitis in an allergy office

    Page :190

    M.A. Kaliner, P.A. McNally, M.V. White

    
  • ·30 CT sinus studies in allergic rhinitis

    Page :190

    J.R. Leipzig, D.S. Martin, R.G. Slavin

    
  • ·31 Clinical and immunologic characteristics of patients with allergic fungal sinusitis

    Page :190

    R.R. Chrzanowski, N.T. Runn, F.A. Kuhn, W.K. Dolen

    
  • ·32 Immunologic changes in patients with “allergic mucin”

    Page :190

    M.C. Ouintal, M.G. Ostro, S. Bornschein, S. Salman, K.J. Bloch

    
  • ·33 A subtype of allergic fungal sinusitis(AFS) with laboratory findings similar to allergic bronchopulmonary aspergillosis (ABPA)

    Page :191

    Steven Rubinstein

    
  • ·34 Concomitant sinus mycetoma and allergic fungal sinusitis

    Page :191

    M. Soto-Aguilar, R. deShazo, M. O'Brien, K. Chapin, C. Blunck, M. Lyons, R. Swain

    
  • ·35 Endothelial VCAM-1 expression is increased in nonallergic chronic hyperplastic sinusitis with nasal polyposis (CHS/NP)

    Page :191

    D.L. Hamilos, D.Y.M. Leung, R. Wood, L. Cunningham, D.K. Bean, Y.L. Song, E. Schotman, O. Hamid

    
  • ·36 Fluticasone aqueous nasal spray in the treatment of nasal polyposis

    Page :191

    S. Juliusson, K. Holmberg, B. Balder, D.L. Smith, G. Karlsson

    
  • ·37 Development and validation of a nasal polyposis quality of life questionnaire

    Page :192

    P.K. Keith, M. Conway, J. Dolovich

    
  • ·38 Cytokine gene expression in nasal polyp

    Page :192

    C.H. Lee, C.S. Rhee, Y.G. Min

    
  • ·39 Messenger RNA expression of RANTES, interleukins 6 and 12 in nasal polyps in relation to allergy

    Page :192

    Å. Davidsson, H.E. Helllquist, A. Danielsen, G. Viale

    
  • ·40 IL-5 Dominates in nasal polyps

    Page :192

    C. Rudack, H.C. Reeker, M. Wagenmann, C. Bachert

    
  • ·41 Peptide absorption across the airway mucosa in seasonal and perennial allergic rhinitis

    Page :193

    L. Greiff, M. Andersson, C. Svensson, P. Wollmer, S. Lundin, C.G.A. Persson

    
  • ·42 Correlation between eosinophil caionic protein (ECP) and eosinophil peroxidase (EPO) in rhinitis

    Page :193

    P. Ostertag, G. Raso, I. Enander

    
  • ·43 Increases in RANTES mRNA and protein in the nasal mucosa and nasal secretions in hay fever patients after allergen challenge

    Page :193

    K. Rajakulasingam, Q. Hamidmid, F. O'Brien, E. Schotman, P.J. Jose, T.J. Williams, M. Jacobson, J. Barkans, S.R. Durham

    
  • ·44 Nasal provocation with cockroach (CR) extract

    Page :193

    L.S. Hernandez, E. Fernández-Caldas, R.F. Lockey

    
  • ·45 Recruitment of FcεRI positive cells in the nasal mucosa in atopic rhinitic subjects following allergen challenge

    Page :194

    F. O'Brien, K. Rajakulasingam, S.R. Durham, M. Humbert, L. Taborda-Barata, A.B. Kay, J.A. Grant

    
  • ·46 Expression of IL-13 in allergen-induced late nasal reaction and in response to topical steroids

    Page :194

    O. Ghaffar, S. Durham, S. Laberge, M. Jacobson, S. Rak, O. Lowhagen, O. Hamid

    
  • ·47 Nasal airway changes assessed by acoustic rhinometry and mediator release during immediate and late reactions to allergen challenge

    Page :194

    J. Getsy, B. Zweiman, A. Lane, M. Kalenian, R. Doty, D. Lanza

    
  • ·48 Repeated nasal challenges with allergen produce exudative hyperresponsiveness and local eosinophilia

    Page :194

    M. Andersson, C. Svensson, L. Greiff, M. Linden, C.G.A. Persson

    
  • ·49 Tryptase release after nasal provocation tests in Parietaria allergy

    Page :195

    M.L. Palma Carlos, M.C. Santos, E. Pedro, A. Spinola, F. Ferreira, A.G. Palma Carlos

    
  • ·50 Effects of exogenous neuropeptide Y on nasal response to allergen challenge in atopic patients

    Page :195

    Bernard L. Mosimann, J. Sylvain Lacroix

    
  • ·51 Children with allergic rhinitis have low mucosal IgA, a longitudinal cohort study

    Page :195

    B.R. Ludviksson, O. Thorarensen, B. Ardal, H. Valdimarsson

    
  • ·52 Differences in mite-specific immune responses in atopic patients with asthma or rhinitis

    Page :195

    M.B. Shennan, K. Chen, D. Fogelman, Z. Liao, Y. Chen, D.L. Rosenstreich

    
  • ·53 Development of a dose-response protocol for localized nasal provocation with capsaicin (CAP)

    Page :196

    A. Togias, G. Lai

    
  • ·54 Reproducibility of a nasal allergen challenge model in evaluating the efficacy of intranasal beclomethasone (BEC)

    Page :196

    D. Proud, E.C. King, D.K. Riker, A. Togias

    
  • ·55 The effect of prior exposure for 6 hours to 400ppb NO₂ on allergen-induced inflammatory changes in nasal airways of allergic rhinitics and the influence of fluticasone propionate aqueous nasal spray (FP)

    Page :196

    J.H. Wane, J.L. Devalia, C. Rusznak, A. Bagnall, R.J. Davies

    
  • ·56 Effects of nedocromil sodium (NDS) on the late nasal response to allergen challenge [LNR] and the accompanying cellular changes in the nasal secretions (NS)

    Page :196

    B.S.V. Stegt, Z. Pelikan, M. Pelikan-Filivek

    
  • ·57 The protective effects of intranasal nedocromil sodium (NDS) on the immediate [INR] and the late nasal response [LNR] to allergen challenge

    Page :197

    M. Pelikan-Filipek, J.H. Oostenbrink, Z. Pelikan

    
  • ·58 Improved protection from topical levocabastine over nedocromil sodium in conjunctival provocation test with allergen: A double-blind, cross-over study

    Page :197

    C. Hammann, R. Kämmerer, M. Gerber, F. Spertini

    
  • ·59 Pharmacoeconomic benefits of fluticasone propionate aqueous nasal spray 200μg once daily in perennial allergic rhinitis

    Page :197

    J.E. Adams, N.J.M. Blackman, D.B. Tesarowski, N. Stepner

    
  • ·60 Efficacy and safety of once-daily triamcinolone acetonide aqueous nasal spray in pediatric patients with spring grass seasonal allergic rhinitis

    Page :197

    J.A. Smith, E.J. Schenkel, G. Gross, K. Jacobson, R. Kobayashi, G. Settipane, G. Feiss, J.A. Furst, B. Simpson

    
  • ·61 Triamcinolone acetonide aqueous nasal spray does not alter adrenocortical function in children with allergic rhinitis

    Page :198

    E.J. Schenkel, M.H. Ellis, G. Gross, B. Lanier, L. Mendelson, A. Nayak, G. Feiss, J.A. Furst, B. Simpson, J.A. Smith

    
  • ·62 Lack of systemic activity with intranasal mometasone furoate

    Page :198

    M.D. Brannan, M. Seiberling, D.L. Cutler, F.M. Cuss, M.B. Affrime

    
  • ·63 Intranasal fluticasone propionate (FP) is more effective than loratadine (LOR) for treatment of seasonal allergic rhinitis symptoms

    Page :198

    A.S. Nayak, D. Shulan, D.I. Bernstein, M. Livezey, G. Settipane, P. Chervinsky, J. Melamed, J. Selcow, K.D. Reed, G. Anschuetz, C.K. Cook, P.R. Rogenes

    
  • ·64 Once daily mometasone furoate aqueous nasal spray is as active as twice daily beclomethasone dipropionate for perennial allergic rhinitis

    Page :198

    M. Drouin, K. Nolop, B. Lutsky, I92-293 Study Group

    
  • ·65 Pseudoephedrine (PDE) pharmacokinetics and pharmacodynamics in children with allergic rhinitis

    Page :199

    X. Gu, K.J. Simons, J.C.M. St. Vincent, W.T.A. Watson, J.D. Reggin, F.E.R. Simons

    
  • ·66 Phenylpropanolamine (PPA) pharmacokinetics and pharmacodynamics in children with allergic rhinitis

    Page :199

    J.C.M. St. Vincent, K.J. Simons, X. Gu, W.T.A. Watson, J.D. Reggin, F.E.R. Simons

    
  • ·67 Recombinant human monoclonal anti-IgE therapy in allergic rhinitis

    Page :199

    T.B. Casale, I.L. Bernstein, W.W. Busse, C.F. LaForce, D.G. Tinkelman, R.R. Stoltz, R.J. Dockhorn, D.C. Adelman

    
  • ·68 N-acetyl-aspartyl-glutamic acid inhibits late antigen-induced reaction in the nose

    Page :199

    A. Miadonna, M. Cottini, M. Lorini, C. Candiani, A. Tedeschi, N. Milazzo

    
  • ·69 The effects of salmeterol on the early and late sequelae of allergen challenge in the nose

    Page :200

    R. Gerth van Wijk, C. de Graaf-in 't Veld, C.J.A.M. Tak, I.M. Garrelds, A.W. van Toorenenbergen

    
  • ·70 Immediate and short-term effects of benzalkonium chloride on nasal mucosa

    Page :200

    C. McMahon, R. Ryan, Y.C. Darby, G.K. Scadding

    
  • ·71 Occupational asthma caused by roasted coffee: Immunological evidence that roasted coffee contains the same antigens as green cofee, but fewer

    Page :200

    J. L'Archevêque, C. Lemière, J.-L. Malo, M. McCants, S. Lehrer

    
  • ·72 Closed-circuit apparatus for specific inhalation challenges with occupational agents in vapour form: application to formaldehyde

    Page :200

    Y. Cloutier, G. Perrault, D. Drolet, A. Cartier, C. Lemière, J.-L. Malo

    
  • ·73 Isolated late asthmatic reaction after exposure to a high-molecular-weight occupational agent

    Page :201

    A. Cartier, C. Lemière, J.-L. Malo

    
  • ·74 Occupational asthma to lobster and shrimp

    Page :201

    J. Vallée, A. Desjardins, C. Lemière, S. Lehrer, J.-L. Malo

    
  • ·75 Allergen cross-reactivity between α-amylase (aspergillus oryzae), hemicellulase (A. niger) and amyloglycosidase (A. niger)

    Page :201

    R. Wiewrodt, K. Spix, U. Biller, K. Viel, J. Bargon, W. Caspary, R. Buhl

    
  • ·76 Inhalative and ingestive occupational allergy to Boletus edulis

    Page :201

    R. Torricelli, B. Wüthrich

    
  • ·77 Comparative study to low persistent vs high short exposition to TDI in two different populations

    Page :202

    J.R. Gagliardi, C.C. Castro, L. Soriano, O. Vila, D. Lerda, M. Romero, J.C. Muiño, H. Misericordia

    
  • ·78 Diesel exhaust particles and phenanthrene enhance IgE production by human B cells in vitro

    Page :202

    A. Tsien, D. Diaz-Sanchez, I. Ma, A. Saxon

    
  • ·79 Identification of prolamin allergens involved in cereal hypersensitivity

    Page :202

    C.P. Sandiford, A. Tatham, M.G. Jones, R. Fido, R.D. Tee, P.R. Shewry, A.J. Newman Taylor

    
  • ·80 Long-term treatment of occupational asthma: a follow-up study

    Page :202

    A. Siracusa, A. Marabini, A. Ripandelli, S. Truppe

    
  • ·81 Alveolar macrophage heterogeneity in hypersensitivity pneumonitis

    Page :203

    L. Delgado, J.C. Winck, J. Rodrigues, J.P. Ramos, J.A. Fleming Torrinha

    
  • ·82 Bronchial hyperreactivity among cotton textile workers

    Page :203

    J. Torres da Costav, J.P. Silva, H. Barros, Marianela Azevedo, H.S. João

    
  • ·83 Underutilization of respiratory measurements in evaluations of suspected occupational asthma

    Page :203

    M.S. Dykewicz

    
  • ·84 Formaldehyde and phenol exposure during the anatomy dissecting course: A possible source for IgE-mediated sensitization?

    Page :203

    M. Tschabitscher, F. Wantke, M. Focke, W. Hemmer, M. Gann, P. Tappler, R. Bracun, S. Wolf, M. Götz, R. Jarisch

    
  • ·85 In vivo and in vitro activities of purified allergens from rye flour

    Page :204

    A. Armentia, G. García-Casado, R. Sánchez-Monge, G. Salcedo

    
  • ·86 Documentation of nasal irritant sensitivity utilizing pulsed carbon dioxide stimuli

    Page :204

    D. Shusterman, J. Balmes

    
  • ·87 Occupational asthma to aromatic herbs

    Page :204

    N. Patry, J.L. Malo, C. Lemière, A. Cartier

    
  • ·88 Chloramine-T induced asthma in a female cleaner

    Page :204

    V.M. Kujala, K.E. Reijula

    
  • ·89 Following-up of 91 patients with occupational asthma (OA)

    Page :205

    S. Echechipía, B.E. García, M.J. Alvarez, S. Acero, J.M. Olaguibel, A. Rodriguez, M.T. Lizaso, A.I. Tabar

    
  • ·90 The lung B lymphocyte (B cell) antibody response to trimellitic anhydride (TMA) inhalation

    Page :205

    C.R. Zeiss, F.S. Siddiqui, S. Garthwaite, J. Henderson, D. Levitz, N.S. Hatoum

    
  • ·91 Immune system function in the offspring of methyl mercury exposed rats

    Page :205

    L. Wild, H. Ortega, J. Salvaggio, M. Lopez

    
  • ·92 Specific immunoglobulins to soybean hull allergens in soybean asthma

    Page :205

    R. Codina, R.F. Lockey, E. Fernandez-Caldas

    
  • ·93 Indoor exposure to formaldehyde at concentrations below 50 μg/m³ does not contribute to asthma development

    Page :206

    P. Górski, C. Paczyński, J. Stankiewicz, B. Koacińska, U. Ruta, J. Gruchaa, A. Krakowiak, B. Szulc, J. Jakubowski, W. Hanke

    
  • ·94 In utero exposure to tobacco smoke

    Page :206

    E. Hossny, A. Hosni, R. Mabrouk

    
  • ·95 Formaldehyde and respirable suspended particles levels in Louisiana homes

    Page :206

    R. Lemus-Olalde, T.G. Akers, A. Abdelghani

    
  • ·96 Mechanism of persistent inflammation in RADS and RUDS

    Page :206

    W.J. Meggs, T. Elsheikh, W.J. Metzger, M. Albernaz, R. Bloch

    
  • ·97 Respiratory function in workers exposed to pesticides

    Page :207

    S.M. Jones, A.W. Burks, P.K. Roberson, R.M. Helm

    
  • ·98 Total serum IgE in trimellitic anhydride induced asthma

    Page :207

    K.S. Backman, M.A. Shaughnessy, K.E. Harris, L.C. Grammer

    
  • ·99 Factors affecting the inhibition ELISA for determining potency of Dermatophagoides mite extracts

    Page :207

    G.A. Plunkett, F.A. Dailey, L.D. Baldwin

    
  • ·100 Cross-reactivity of new grass extracts in percutaneous testing

    Page :207

    J.J. Condemi, P.H. Smith

    
  • ·101 Manufacture and analysis of 100,000 BAU/mL and 10,000 BAU/mL standardized grass pollen extracts

    Page :208

    P. Lally, L. Featherstone, B. Tompkins, J. King, L. Weitz, L. Baldwin, G. Plunkett

    
  • ·102 Computer-assisted measurement of skin test wheals

    Page :208

    P.H. Smith, J.J. Condemi, J. Baum, R.N. Rosier

    
  • ·103 Skin testing strategies in the diagnosis of cat allergy

    Page :208

    R.E. Luka, A. Wolff, L. Bielory

    
  • ·104 Pharmacia CAP system vs. intradermal skin test — one year experience on asthmatic children

    Page :208

    Chen-Kuang Niu, Chien-Chung Lee, Song-Chei Hunag

    
  • ·105 Fel d I levels in cat anal glands

    Page :209

    D. Vervloet, A. Dornelas De Andrade, C. Magalon, J.P. Magnol, A. Lanteaume, D. Charpin, J. Birnbaum

    
  • ·106 Purification and characterization of the plantain (Plantago lanceolata) allergen Pla l 1

    Page :209

    B. Weber, H. Kahlert, A. Petersen, H. Fiebig, O. Cromwell

    
  • ·107 The roles of Mannan (Mn) and secreted enzyme, acid protease (AP), as allergens of Candida albicans (C. alb)

    Page :209

    K. Akiyama, T. Shida, H. Yasueda, H. Mita, Y. Yanagihara, A. Saito, M. Hasegawa, Y. Maeda, H. Yamaguchi, K. Takesako

    
  • ·108 Expression of the recombinant Lepidoglyphus destructor major allergen Lep d 2

    Page :209

    M. Schmidt, E. Johansson, S. Olsson, M. van Hage-Hamsten

    
  • ·109 Partial characterization of the silk allergens in mulberry silk extract

    Page :210

    W. Zaoming, R. Codina, E. Fernandez-Caldas, R.F. Lockey, S.C. Bukanz

    
  • ·110 Partial characterization of Fraxinus chinensis (Urapan) allergens and cross-reactivity among different Fraxinus species and Olea europea (OLIVE)

    Page :210

    A. Rodriguez, R. Codina, E. Fernandez-Caldas, F.C. Leal, R.F. Lockey

    
  • ·111 Allergens of horse dander. Comparison between breeds and individual animals using immunoblotting

    Page :210

    S. Dreborg, K. Felix, R. Ferrándiz, R. Einarsson

    
  • ·112 Study of bermuda pollen IgE-binding protein, BG60: Characterization of its physicochemical property

    Page :210

    S.N. Su, S.W. Huang, Y.C. Lee

    
  • ·113 Allergenic components in three different species of pencillium: Cross-reactivity among major allergens

    Page :211

    H.D. Shen, W.L. Lin, J.J. Tsai, S.S. Han

    
  • ·114 Cross-allergenicity of the house dust mites Euroglyphus maynei and Blomia tropicalis

    Page :211

    L.G. Arlian, M.S. Morgan, E. Fernandez-Caldas

    
  • ·115 Autologous Western blotting with house dust in atopic subjects

    Page :211

    D.J. Pearson, M. Lees

    
  • ·116 Cross-reactivity studies of Lepidoglyphus destructor and Blomia tropicalis

    Page :211

    E. Johansson, L. Machado, S.G.O. Johansson, M. van Hage-Hamsten

    
  • ·117 Bovine dander allergen BDA20 is a lipocalin identical or closely related to Bos d 2

    Page :212

    R.A. Mantyjarvi, M. Rytkonen, J. Pentikainen, J. Rautiainen, T. Virtanen, H. Santa, R. Laatikainen

    
  • ·118 Quantification of the major allergen Pla l 1 from plantain extracts using monoclonal antibodies

    Page :212

    H. Kahlert, B. Weber, O. Cromwell, H. Fiebig

    
  • ·119 Characterization of the saltmarsh fungi Phaeosphaeria spartinicola

    Page :212

    M.C. Janowski, S.Y. Newell, A.E. Phillips, L. Smith, B.B. Wray, R.R. Chrzanowski, W.K. Dolen

    
  • ·120 PCR identification of multiple alter-naria (ALT) cDNA segments containing ALT A1 sequence

    Page :212

    F. Hu, F. Pacheco, J. Landuyt, C. Barnes, J. Portnoy

    
  • ·121 Analysis of IgE antibody responses to D. pteronyssinus and Blomia tropicalis using recombinant Group 5 allergens

    Page :213

    L.D. Vailes, M.C. Rizzo, C.K. Naspitz, F. Montealegre, E. Fernandez-Caldas, T.A.E. Platts-Mills, M.D. Chapman, L.K. Arruda

    
  • ·122 Allergic rhinoconjunctivitis by lilac flowers

    Page :213

    T. Sainza, M. Barrio de, A. Montoro, E. Ordoqui, M.L. Baeza

    
  • ·123 Immunologic responses to chironomus flaviplumus in atopic children

    Page :213

    Hye Young Kang, Ki Young Lee, Dong Soo Kim, Kyu Earn Kim, Byung Ju Jeong

    
  • ·124 Characterization of oilseed rape allergens

    Page :213

    M. Focke, W. Hemmer, R. Bracun, S. Wolf, F. Wantke, M. Götz, R. Jarisch

    
  • ·125 Evaluation of in vitro cross-reactivity between allergens from birch and ash pollen

    Page :214

    M. Wekkeli, M. Focke, W. Hemmer, R. Bracun, S. Wolf-Abdolvahab, M. Götz, R. Jarisch

    
  • ·126 Helminth secretory proteins are related to wasp antigen 5 by both sequence and immunologic cross-reactivity

    Page :214

    D.R. Hoffman, J.M. Hawdon, B.F. Jones, P.J. Hotez

    
  • ·127 Cross-reactivity of major antigens and allergens in the saliva of different mosquito species

    Page :214

    H. Brummer-Korvenkontio, K. Palosuo, T. Palosuo, T. Reunala

    
  • ·128 Threshold values for IgE sensitization by indoor major cow hair allergen Bos d 2

    Page :214

    S. Hinze, K.C. Bergmann, H. Løwenstein, G.N. Hansen

    
  • ·129 Cat major allergen (Fel d 1): Correlation between dust and airborne exposure using a portable air sampler

    Page :215

    M. Ott, F. de Blay, P. Gries, G. Pauli

    
  • ·130 Indoor air quality in special daycare centres for atopic children

    Page :215

    G. Emenius, A.-C. Egmar, P.H. Larsson, Bengt Christenson, M. Wickman

    
  • ·131 Comparison of two Fel d 1 assays in house dust samples

    Page :215

    A. Hoppe, A. Hoffmann auR. Wahl, H. Müsken, K.-Ch. Bergmann

    
  • ·132 Measurement of ficus benjamina antigen using polyclonal antibody sandwich ELISA

    Page :215

    M. Faller, F. de Blay, E. Lett, A. Vérot, J.C. Bessot, G. Pauli

    
  • ·133 Comparative study of air samplers measuring airborne Fel d 1

    Page :216

    C. Ohmes, A. Vérot, G. Pauli, F. de Blay

    
  • ·134 A new continuous volumetric recording indoor air sampler

    Page :216

    M.A. Stern, U. Allitt, J.M. Corden, W.M. Millington

    
  • ·135 Documenting variability in indoor allergen ELISAs

    Page :216

    K. Higgins, G. Chew, M. Davidian, D. Milton, H.A. Burge

    
  • ·136 Automation of a spreadsheet model for selection of geographically relevant allergens for skin testing

    Page :216

    J. McGerity, J. Jorgensen, A. Rosen

    
  • ·137 Comparison of allergic sensitivity to perennial and seasonal allergens in patients presenting for initial allergy evaluations

    Page :217

    H.J. Wedner, A. Dixit, W.H. Lewis, W. Crozier

    
  • ·138 Skin prick test (SPT) reactivity in East- and West Germany is changing

    Page :217

    T. Schäfer, U. Krämer, H. Behrendt, D. Vieluf, J. Ring

    
  • ·139 Aero-allergen allergy in a population of four year olds

    Page :217

    S. Ridout, S. Tariq, S. Matthews, D. Hide

    
  • ·140 Aerobiology: Grass pollen forecasting models

    Page :217

    S.L. Kagen, R. Muthiah, R. Knoll, G. Graphos, B. DeStasio

    
  • ·141 Daily variation of airborne ragweed (RW) allergen concentration

    Page :218

    C. Barnes, J. Landuyt, F. Pacheco, F. Hu, J. Portnoy

    
  • ·142 Allergic and immunologic profile of symptomatic Persian gulf war veterans

    Page :218

    K.G. Lee, G.K. Kraske, W.B. Klaustermeyer

    
  • ·143 Influence of gaseous pollutants on pollen viability (PV), germination (PG) and protein release (PR)

    Page :218

    P. Thomas, P. Deutinger, G. Heubl, D. Strube, B. Przybilla

    
  • ·144 Determination of humulus scandens pollen specific IgE by two in vitro assay: ELISA and phamacia CAP system (CAP)

    Page :218

    Jia Yin, Lianglu Wang, Haijuan He, Shital Ye

    
  • ·145 Consistency of season aerobiological peak pollen counts 1992–1995

    Page :219

    L. Ford, R. Loker, R. Hartel

    
  • ·146 Analysis of geographic and demographic patterns of aeroallergen sensitivity using a spreadsheet model

    Page :219

    P.C. Avila, J.L. McGerity, J. Jorgensen, N.H. Gershman, D.C. Adelman, J.L. Kishiyama

    
  • ·147 Evaluation of allergen levels and air quality in central Wisconsin grade schools

    Page :219

    J.T. Twiggs, J.J. Marx, B.J. Ault, R.L. Gray

    
  • ·148 Seasonal variation of airborne allergen concentration

    Page :219

    J. Landuyt, C. Barnes, F. Pacheco, F. Hu, J. Portnoy

    
  • ·149 Distribution of mold spores in indoor and outdoor air during summer season

    Page :220

    Yong Kwan Kim, Young Jin Lee, Kyu-Earn Kim, Ki Young Lee

    
  • ·150 Stachybotrys atra-induced lung injury in mice

    Page :220

    K.E. Reijula, M. Nikulin, B.B. Jarvis, E.-L. Hintikka

    
  • ·151 Immunoreactive alternaria allergen in house dust: Presence in prairie homes in the absence of environmental mold spores

    Page :220

    A.B. Becker, G. Muradia, H.M. Vijay, W.T.A. Watson, Z. Peng, F.E.R. Simons

    
  • ·152 Population assessment of airborne molds utilizing two volumetric air samplers in a study of five Central Florida buildings

    Page :220

    P. Cruz-Perez, R.N. Gennaro, S.D. Klotz, R.S. White, M.J. Sweeney

    
  • ·153 Indoor allergen loads in homes in South Louisiana

    Page :221

    W.E. Horner, D. Pinero, G. Reese, S.B. Lehrer

    
  • ·154 Health risk assessment of fungi in homes

    Page :221

    A.P. Verhoeff, H.A. Burge

    
  • ·155 A comparison of post-flooding fungal contamination and related health effects in reoccupied buildings in Western and Eastern Missouri

    Page :221

    A. Dixit, S. Clardy, W.H. Lewis, H.J. Wedner

    
  • ·156 Relationship between intradomiciliar bacteria and fungi exposure and asthma

    Page :221

    M.C. Rizzo, C.K. Naspitz, E. Fernandez-Caldas, I. Mimiça, R.F. Lockey, D. Solé

    
  • ·157 Relationship between levels of fungi in house dust and occupant's responses to home characteristics questions

    Page :222

    M.L. Muilenberg, H.A. Burge, G.L. Chew, D. Gold

    
  • ·158 Time series analysis of mold aeroallergens in relation to meterologic parameters

    Page :222

    R.K. Katial, Y. Zhang, R.H. Jones, P.D. Dyer

    
  • ·159 A case study of airborne fungi: Why viable sampling is not enough

    Page :222

    E. Levetin, R. Shaughnessy, L. Stetzenbach

    
  • ·160 Intranasal provocation with Euroglyphus maynei extract

    Page :222

    R.F. Lockey, S.F. Kemp, E. Fernández-Caldas

    
  • ·161 House dust mite allergens in mattresses. A cross sectional analysis in a temperate costal area

    Page :223

    H. Mosbech, M. Steensen, C. Veggerby, L. Poulsen, J.H. Heinig, C. Johnsen

    
  • ·162 Impact of an individual teaching program on environmental control in moderate to severe asthmatics

    Page :223

    J. Côte, P. Robichaud, H. Boutin, A. Filion, M. Lavallée, M. Krausky, M. Rouleau, J.L. Malo, A. Cartier, L.P. Boulet

    
  • ·163 Clinical study of bedding covers in mite-allergic asthmatic patients

    Page :223

    J. Birnbaum, F. de Blay, E. Paty, J. Just, G. Pauli, D. Vervloet, D. Charpin

    
  • ·164 Allergen transfer chamber: A new method for testing allergen barriers

    Page :223

    J.H. Ransom, J.F. Halsey

    
  • ·165 Mite cultures on delicate garments and mite control by low temperature washing (LTW) with commercial detergents and a benzyl benzoate containing additive

    Page :224

    E.R.C. Bischoff, F.M. Kniest

    
  • ·166 Dust mites' survival at high temperatures

    Page :224

    J.S. Dippold, L.G. Arlian, C.M. Rapp, J.S. Chang

    
  • ·167 Effect of dst mite allergen avoidance in homes of children hospitalized with acute asthma

    Page :224

    M. Hayden, M. Perzanowski, R. Call, L. Matheson, J. Scott, T. Platts-Mills

    
  • ·168 Correlation between airborne and dust exposure to mite group 1 allergens using Petri dish method

    Page :224

    F. de Blay, S. Mahler, P. Gries, M. Ott, G. Pauli

    
  • ·169 A comparison of monoclonal antibody (mAb)-capture and Der f I-capture ELISAs for measurement of Dermatophagoides farinae (Der f) I-specific IgE

    Page :225

    W. Xu, F.E.R. Simons, Z. Peng

    
  • ·170 Comparison of guanine levels and mite allergen content in house dust samples

    Page :225

    R.R. Baker, C.B. Arant, N.T. Rupp

    
  • ·171 Peak expiratory flow (PEF) variability and exposure to Dermatophagoides farinae

    Page :225

    M.K. O'Rourke, Shan Jin, A. Atmowidjojo

    
  • ·172 Euroglyphus maynei (Em) skin test reactivity in patients with asthma and or rhinitis in Rio de Janeiro

    Page :225

    M. Geller, R.E. Esch, E. Fernandez-Caldas

    
  • ·173 Prevalence of Blomia tropicalis sensitization in Singapore

    Page :226

    B.W. Lee, F.T. Chew, D.Y.T. Goh, G.W. Wong

    
  • ·174 Prevalence of storage mite sensitisation in urban patients

    Page :226

    S.T. Röseler, M. Wagenmann, C. Bachert

    
  • ·175 Sensitization to Dermatophagoides siboney, Blomia tropicalis and other domestic mites in asthmatic patients as measured by SPT and specific IgE

    Page :226

    R. Ferrándiz, R. Casas, S. Dreborg

    
  • ·176 Respiratory allergy in Library workers. Are mites implicated?

    Page :226

    M. Sánchez-Medina, I. Zarante, M.N. Rodríguez, M.R. Ramírez

    
  • ·177 Allergen avoidance measures reduce the risk of the development of house dust mite allergy in atopic infants

    Page :227

    H.D. Oei, R. de Haas, S.B. Tjiook

    
  • ·178 Weekly variation of dust mite and alternaria in house dust

    Page :227

    J. Guss, C. Barnes, J. Landuyt, F. Pacheco, F. Hu, J. Portnoy

    
  • ·179 Sensitization to house dust mites in asthmatic children in Argentina and cross-reactivity studies

    Page :227

    C. Baena-Cagnani, E. Fernandez-Caldas, L.G. Arlian, R. Codina, M. Cuello, C. Patino, R.F. Lockey

    
  • ·180 Prevalence of the house dust mite (Dermatophagoides farinae and D. pteronyssinus) in a Southern United States tertiary care hospital

    Page :227

    K.S. Babe, L.G. Arlian, J. Dippold, S.R. Marney

    
  • ·181 Respiratory allergies due to the basiodiomycete Hemileia vastatrix

    Page :228

    J. Croce, M. Croce, E. CostaManso, L. Takayama, W. Gambale

    
  • ·182 Angioedema following dust mite exposure presenting as suspected food allergy

    Page :228

    S. Skoda-Smith, G.R. Mullen, F. Oi, T.P. Atkinson

    
  • ·183 Chemokine production by peripheral blood mononuclear cells during rush venom immunotherapy

    Page :228

    H. Akoum, A. Tsicopoulos, H. Vorng, B. Wallaert, A.B. Tonnel

    
  • ·184 Inactivation of skin and pulmonary mast cells and basophils in sensitized rats and dogs by non-allergenic conjugates of allergen and mPEG

    Page :228

    A.H. Sehon, G.M. Lang, R.D. Wakefield, M.M. Kozak, A.B. Becker

    
  • ·185 Immunomodulating activity of the extract from high mycelium fungus polyporus squamosus

    Page :229

    A.A. Babakhin, N.Y. Logina, H. Nolte, L.M. DuBuske

    
  • ·186 Blood basophils are influenced by ultra-rush bee venom immunotherapy: Changes in histamine release and leukotriene secretion

    Page :229

    M. Jutel, U.R. Müller, S. Rihs, M. Fricker, W.J. Pichler, C. Dahinden

    
  • ·187 Site-directed mutagenesis of recombinant Der p 2 decreases in vitro and in vivo reactivity with IgE Ab

    Page :229

    A. Smith, L. Wheatley, M. Chapman

    
  • ·188 Analysis of T-cell epitopes of group 5 grass pollen allergens

    Page :229

    W.-D. Müller, T. Karamfilov, B. Fahlbusch, H.-T. Stüwe, H. Fiebig

    
  • ·189 Allergenic components of the Russian thistle (S. Kali) pollen

    Page :230

    B. de la Hoz, J. Martínez, M.A. Tejedor, C. Pérez, A. Martínez, J. Sastre

    
  • ·190 Fel d 1 peptides (Allervax* cat) in cat-allergic subjects

    Page :230

    F.E.R. Simons, W.T.A. Watson, D.J. Dilay, C.A. Gillespie, M. Imada, K.T. HayGlass

    
  • ·191 Kinetics of radiolabelled allergen administered by sublingual and oral route

    Page :230

    G.W. Canonica, M. Bagnasco, G. Passalacqua, C. Motta, M. Bartolomei, G. Mariani

    
  • ·192 Assessment of expresion and allergenicity of recombinant mouse major urinary protein produced in a Baculovirus system

    Page :230

    J. Stacks, A.J. Cavaggione, L.J. Rosenwasser

    
  • ·193 Isolation and partial purification of allergenic components of the pollens Paspalum notatum and Melaleuca leucadendron

    Page :231

    Susan Lee Hunter, R.N. Gennaro, S.D. Klotz, M.J. Sweeney, R.S. White

    
  • ·194 Variations in the administration of allergy immunotherapy (AI) in Kansas

    Page :231

    L.A. Wiens, L.A. Soeken, K.A. Fischer, D. Walker

    
  • ·195 Deaths associated with skin testing and immunotherapy

    Page :231

    Michael Reid, Gary Gurka

    
  • ·196 Molecular changes following vaccination and immunotherapy with a multi-epitopic recombinant allergen

    Page :231

    S.S. Mohapatra, Y. Cao, Z. Luo

    
  • ·197 Reduction of oral corticotherapy by sublingual immunotherapy (IT): Double-blind placebo-controlled study in grass pollen allergy

    Page :232

    R. Clavel, C. André, J. Bousquet, study group Rhône Moyen

    
  • ·198 Immunotherapy as preventive allergy treatment (PAT)

    Page :232

    L. Jacobsen, S. Dreborg, C. Møller, E. Valovirta, U. Wahn, B. Niggemann, D. Koller, R. Urbanek, S. Halken, A. Høst, H. Løwenstein

    
  • ·199 Serum IgG4: Monovalent or possibly hetero-bivalent antibodies?

    Page :232

    J. Schuurman, G.J. Perdok, R.C. Aalberse

    
  • ·200 Nasal immunotherapy (NIT) to parietaria: Follow-up of a double blind study

    Page :232

    G. Passalacqua, M. Albano, A. Riccio, C. Pronzato, P. Falagiani, A. Scordamaglia, G.W. Canonica

    
  • ·201 Tolerance of an Olea europaea pollen extract in asthmatic patients from a high exposure area

    Page :233

    P. González, F. Florido, B. Saéz, F. de la Torre

    
  • ·202 Duration of efficacy of specific immunotherapy (SIT) with Dermatophagoides pteronussinus (Der p) extract after its cessation is related to skin test reactivity

    Page :233

    A. Des Roches, L. Paradis, J. Knani, A. Hejjaoui, H. Dhivert, F.B. Michel, J. Bousquet

    
  • ·203 Incidence of false positive reactions in allergy testing using extract mixes

    Page :233

    David Weldon

    
  • ·204 High prevalence of sensitization to Anisakis simplex (AK) in patients with increased levels of total IgE

    Page :233

    C. Pascual, J.F. Crespo, N. Ortega, N. Ornia, M.S. San-Martin, M. Martin-Esteban

    
  • ·205 Analysis of mild systemic side effects of specific immunotherapy

    Page :234

    M. Götz, F. Wantke, W. Hemmer, M. Focke, R. Jarisch

    
  • ·206 Effect of oral immunotherapy (O-IT) on short ragweed (SR) pollen allergy

    Page :234

    B.A. Seiler, B.L. Angelini, M. Van Deusen, K.M. Cordoro, L. Wood, D. Skoner

    
  • ·207 Rapid and simultaneous quantitation of specific IgE against 20 purified allergens in allergic patients sera by Checkerboard immunoblotting (CBIB)

    Page :234

    J. Rabillon, T. Musu, B. David, J.P. Dandeu

    
  • ·208 Clinical efficiency of UniCAP™ specific IgE

    Page :234

    L. Yman, P. Ewan, H. de Groot, C. Lange, N. Lindholm, R. Paganelli, M. Roovers, J. Sastre

    
  • ·209 Total IgE normal ranges for pediatric sera

    Page :235

    S. Lau, U. Wahn

    
  • ·210 Specificity of rabbit sera immunized with either ammoniated (AL) or nonammoniated (NAL) latex extracts

    Page :235

    Vesna J. Tomazic

    
  • ·211 An indirect bioassay to detect spontaneous production of nitric oxide in asthma

    Page :235

    L. Jaimez, S.F. Wang, A. Matin, M. Frieri

    
  • ·212 Serological diagnosis of chagas disease: A confirmatory assay by western blot using preserved protein antigens of Trypanosoma cruzi

    Page :235

    R.P. Mendes, S. Hoshino-Shimizu, A.M. Moura da Silva, I. Mota, A. O Luquetti, R.A.G. Heredia, P.G. Leser

    
  • ·213 Specific tear prealbumin an adjunct to lysozyme's activity in the human

    Page :236

    H. Drew, A.S. Josephson

    
  • ·214 Immortalization of an epithelial cell line derived from a nasal polyp

    Page :236

    A. Campbell, B. Lebel, L. Crampette, B. Mainprice, J. Bousquet

    
  • ·215 HLA-DR2 is associated with increased risk of renal allograft failure in Alport's syndrome

    Page :236

    A. Karadsheh, P. Rao, D. Das, P. Kissinger, P. Kumar

    
  • ·216 The dose relationship of specific IgE to severity of food hypersensitivity

    Page :236

    J.F. Crespo, C. Pascual, P. Daroca, E. Fernandez-Caldas, J. Rodriguez, M. Martin-Esteban

    
  • ·217 Loratadine improves intestinal hyperpermeability in children with atopic dermatitis (AD) related to food allergy (FA)

    Page :237

    P. Molkhou, F. Rocchiccioli, F. Wessel, C. Antoine, J. Cougnard, W. Czarlewski

    
  • ·218 Allergenicity of individual cow milk proteins in DBPCFC-positive milk allergic adults

    Page :237

    A. Norgaard, H. Bernard, J.-M. Wal, G. Peltre, I.P.S. Skov, L.K. Poulsen, C. Bindslev-Jensen

    
  • ·219 IgE-mediated cow's milk allergy (IgE-CMA) in adults

    Page :237

    R.H. Schwartz, L.B. Peers

    
  • ·220 Oral hyposensitization in a patient with IgE-mediated hypersensitivity to milk

    Page :237

    I. Vieluf, D. Vieluf

    
  • ·221 Allergen in the steam of cooking foods

    Page :238

    S. Figueroa, J. McCullough, D.R. Ownby

    
  • ·222 Histamine in wine: Bronchoconstriction after a double blind placebo controlled red wine provocation test

    Page :238

    F. Wantke, W. Hemmer, T. Haglmüller, M. Götz, R. Jarisch

    
  • ·223 Allergenicity of gourmet nut oils processed by different methods

    Page :238

    R.L. Brown, L.A.D. Haapanen, S.S. Teuber

    
  • ·224 Investigation of the familial nature of peanut allergy and its association with tree nut and legume allergy

    Page :238

    J.O. Warner, J.O.'B. Hourihane, C.M. Bicknell, T.P. Dean

    
  • ·225 Identification of peanut allergens by FPLC & immunoblotting using sera from 50 peanut allergic patients

    Page :239

    M.C.A. Clarke, K.R. Dean, J.O'B. Hourihane, J.O. Warner, T.P. Dean

    
  • ·226 Age of onset and reported symptoms in 500 peanut allergics

    Page :239

    C.M. Bicknell, J.O'B. Hourihane, T.P. Dean, J.O. Warner

    
  • ·227 Allergic reaction to measles-mumps-rubella (MMR) vaccine in a girl tolerant to egg-protein

    Page :239

    Y. Levy, B. Kornbrot, Y.L. Danon

    
  • ·228 Safe administration of influenza vaccine to egg-allergic patients

    Page :239

    J.M. James, R.S. Zeiger, M.R. Lester, L.E. Mansfield, M.B. Fasano, J.E. Gern, H. Windom, H.A. Sampson

    
  • ·229 Effect of early feeding of soy (SF), extensively-hydrolyzed casein (EHCF), and partially-hydrolyzed whey (PHWF) formula on the development of allergic manifestations in children during the second year of life

    Page :240

    M.C. Porch, A. Shahane, R.C. Elston, L. Leiva, R.U. Sorensen

    
  • ·230 Influence of maternal dietary restriction during lactation on infants T-cell responses and IgE levels

    Page :240

    T. Dean, C. Pollard, S. Bevin, J. Hourihane, S. Little, M. Clarke, J.O. Warner

    
  • ·231 Influence of maternal diet during lactation upon allergic manifestation in infants - tolerisation or sensitisation?

    Page :240

    C. Pollard, S. Bevin, S.A. Little, J.O'B. Hourihane, J.O. Warner, T.P. Dean

    
  • ·232 Comparison of taste preference development between breastfed infants and infants receiving standard, soy or hydrolysate formulae

    Page :240

    S. Still, S.A. Little, C. Pollard, S. Bevin, J.O'B. Hourihane, G. Harris, J.O. Warner, T.P. Dean

    
  • ·233 Maternal food antigen avoidance during lactation and allergy during the first 10 years of age

    Page :241

    Gunar Hattevig, Nele Sigurs, Bengt Kjellman

    
  • ·234 Food allergens are stable to digestion in a simple model of the gastrointestinal tract

    Page :241

    J.D. Astwood, R.L. Fuchs

    
  • ·235 Cloning and sequencing of a Walnut (Juglans regia) food allergen and its sequence similarity with other seed storage proteins

    Page :241

    S.S. Teuber, A.M. Dandekar, W.R. Peterson, S.L. Uratsu

    
  • ·236 Assessments of eosinophil cationic protein (ECP) in nasal washes from wheezing infants

    Page :241

    J.B. LaRussa, G.P. Rakes, D.D. Murphy, T.A.E. Platts-Mills, P.W. Heymann

    
  • ·237 Effects of dexamethasone administered during acute viral bronchiolitis in Brown Norway (BN) rats

    Page :242

    A. Kumar, R.L. Sorkness, M.R. Kaplan, W.L. Castleman, R.F. Lemanske

    
  • ·238 IL-8 and soluble ICAM-1 (sICAM-1) concentration in bronchoalveolar lavage (BAL) of asthmatic children and infantile wheezers

    Page :242

    T.P. Dean, C. Marguet, E. Mailet, J.O. Warner

    
  • ·239 IL-2 & IL-4 mediates allergen induced glucocorticoid (GC) receptor (R) binding abnormalities

    Page :242

    S.R. Nimmagadda, S.J. Szefler, J.D. Spahn, W. Surs, D.Y.M. Leung

    
  • ·240 Inhibition of the allergen-induced late phase asthmatic reaction by oral cyclosporin A (CsA)

    Page :242

    B.S. Sihra, S.M. Walker, O.M. Kon, N.C. Barnes, A.B. Kay

    
  • ·241 Attenuation of the airways response to AMP by inhaled heparin in asthmatics: study of the time-course

    Page :243

    R. Polosa, N. Crimi, S. Magrì, C. Vancheri, C. Mastruzzo, G. Paolino, A. Mistretta

    
  • ·242 Human eosinophils (Eos) express RANTES mRNA and store and release biologically active RANTES protein

    Page :243

    Sun Ying, Q. Meng, L. Taborda-Barata, C.J. Corrigan, J. Barkans, B. Assoufi, R. Moqbel, S.R. Durham, A.B. Kay

    
  • ·243 The association of total IgE, indoor and outdoor allergen specific IgE and asthma — The 3 schools study

    Page :243

    R.B. Sporik, S.P. Squillace, J.M. Ingram, W. Price, G. Rose, R. Honsinger, T.A.E. Platts-Mills

    
  • ·244 Superantigens alter glucocorticoid receptor binding (GCR) affinity in vitro

    Page :243

    S.S. Prager, D.Y.M. Leung, S.R. Nimmagadda, W. Surs, J.D. Spahn, S.J. Szefler

    
  • ·245 Inflammatory constituents of bronchoalveolar lavage (BALF) and lung interstitium in cockroach sensitized and sham sensitized guinea pigs

    Page :244

    B.M. Miller, B.C. Kang, H. Grinding, K. Sajadi, J.S. Thompson

    
  • ·246 Intra- and interindividually restricted TCR-Vβ usage of allergen-specific T cell lines

    Page :244

    A. Daser, P. Parronchi, L. Giannarini, S. Sampognaro, E. Maggi, G. Rombola, U. Wahn, S. Romagnani, H. Renz

    
  • ·247 Specificity and functional characteristics of Bet v 1-specific T lymphocytes derived from atopic patients

    Page :244

    R.J.J. van Neerven, S.H. Sparholt, J.N. Larsen, H. Ipsen, C. Schou

    
  • ·248 MHC class II restriction and TCR beta usage in patients with allergic bronchopulmonary aspergillosis (ABPA)

    Page :244

    B. Chauhan, R.G. Slavin, P.S. Hutcheson, C.J. Bellone

    
  • ·249 Antigen-specific T cells are activated at early times following antigen inhalation

    Page :245

    J. Lou, M.N. Blumenthal, Z.M. Chen, M.K. Jenkins

    
  • ·250 Grass pollen induced IL-5 production by peripheral blood mononuclear cells (PBMC) is increased in allergic rhinitis and inhibited by immunotherapy (IT)

    Page :245

    S.J. Till, C. Corrigan, D. Huston, R. Dickason, S. Walker, J. Lamb, A.B. Kay, S.R. Durham

    
  • ·251 Phase I study of anti-IgE recombinant humanized monoclonal antibody rhuMAB-E25 (E25) in adults with moderate to severe asthma

    Page :245

    Jonathan Corren, Juergen Froehlich, Monika Schoenhoff, Sheldon Spector, Gary Rachelefsky, Howard Schanker, M. Patnaik, Sheldon Siegel

    
  • ·252 Development of a pulmonary inflammatory-type reaction in humanized SCID mice after sensitization by allergen aerosols

    Page :245

    C. Duez, A. Tsicopoulos, A. Janin, B. Wallaert, I. Tillie-Leblond, C. Andre, O. Hamid, A.-B. Tonnel, J. Pestel

    
  • ·253 Allergen confirmation-dependent T cell cytokine and antibody isotype patterns in bee sting sensitized subjects

    Page :246

    A.C. Akdis, T. Blesken, D. Wymann, M. Akdis, A. Faith, K. Blaser

    
  • ·254 Trans-splicing of Ig heavy chain RNA transcripts in human B cells

    Page :246

    S. Fujieda, K. Zhang, Y.Q. Lin, A. Saxon

    
  • ·255 Isotype switch to the murine IgE Cε locus in B cells with intact Iε and Sε sequences but deletion of the Cε exons

    Page :246

    Alison Goldberg, Hans C. Oettgen

    
  • ·256 Daily asthma severity relates to personal ozone exposure and outdoor fungal spores

    Page :246

    R.S. Zeiger, R.J. Delfino, B.D. Coate, J.M. Seltzer, D.H. Street, P. Koutrakis

    
  • ·257 Diesel exhaust particles and ragweed allergen in vivo induce TH2 cytokine production in the nasal mucosa of ragweed-sensitive subjects

    Page :247

    D. Diaz-Sanchez, A.Y. Tsien, A. Saxon

    
  • ·258 Diesel exhaust particles downregulate IL-10 and enhance CD23 in PBMC's from allergic and non-allergic individuals

    Page :247

    K. Pacheco, J. Negri, L.J. Rosenwasser, L. Borish

    
  • ·259 Histopathological features of RADS at various intervals

    Page :247

    J.L. Malo, C. Lemière, M. Boutet, L. Garbe-Galanti

    
  • ·260 Synthetic oligopeptides from A. fumigatus ribotoxin react with IgE antibody in the sera of ABPA patients

    Page :247

    V.P. Kurup, V. Hari, P.A. Greenberger, L. Castillo, J.N. Fink

    
  • ·261 Monoclonal antibody based purification of a major allergen of A. fumigatus reacting significantly with IgE antibodies in ABPA sera

    Page :248

    B. Banerjee, D. Nair, V.P. Kurup, P.A. Greenberger, D.R. Hoffman, J.N. Fink

    
  • ·262 Prognostic factors for the isocyanate-induced occupational asthma(OA)

    Page :248

    H.S. Park, D.H. Nahm

    
  • ·263 In vitro production of MCP-1 in workers with diisocyanate-induced occupatioal asthma

    Page :248

    Z.L. Lummus, R. Alam, J.A. Bernstein, D.I. Bernstein

    
  • ·264 Outcome of specific bronchial responsiveness to occupational agents after removal from exposure

    Page :248

    C. Lemière, A. Cartier, J. Dolovich, M. Chan-Yeung, L. Grammer, H. Ghezzo, J. L'Archevêque, J.-L. Malo

    

• Abstract Sunday, March 17, 1996

  • ·265 Study of employees with anhydride-induced respiratory disease after removal from exposure

    Page :249

    L.C. Grammer, M.A. Shaughnessy

    
  • ·266 Patient satisfaction with a multi-purpose powder inhaler (MDPI) device in treatment of asthma

    Page :249

    P. Mahajan, L. Okamoto, J. Schaumberg, M. Goldstein

    
  • ·267 A comparison of fluticasone propionate via Diskus™(Accuhaler™) inhaler and budesonide via Turbuhaler™ inhaler in adult asthmatics

    Page :249

    R. Backman, C.A.C. Pickering, C. Baumgarten, S.C. Huskisson

    
  • ·268 Comparison trial of pirbuterol acetate administered via a breath-actuated inhaler with albuterol administered by a MDI with a spacing device

    Page :249

    J. Grossman, D.G. Tinkelman, I. Ziment

    
  • ·269 Zileuton inhibits interleukin-4 (IL-4) production by peripheral blood mononuclear cells (PBMC)

    Page :250

    R.H. Fisher, L.J. Lu

    
  • ·270 Effect of treatment with zafirlukast (ACCOLATE™) on brobchial hyperresponsiveness in patients with mild-to-moderate asthma

    Page :250

    B.J. O'Connor, P. Godard, L.M. Dubé, L.J. Swanson, R. Maki, European Zileuton Study Group

    
  • ·271 The comparative effect of Zileuton, a 5-lipoxygenase inhibitori, plus low dose inhaled beclomethasone vs higher dose beclomethasone for asthma

    Page :250

    B.J. O'Connor, P. Goddard, L.M. Dubé, L.J. Swanson, R. Maki, European Zileuton Study Group

    
  • ·272 Effect of fluticasone propionate (FP) on ozone(O₃)-induced inflammatory cell changes, following segmental allergen challenge, in mild asthmatics

    Page :250

    C. Rusznak, J.H. Wang, O.A. Khair, J.L. Devalia, R.J. Davies

    
  • ·273 Low doses of inhaled fluticasone propionate (FP) reduce bronchial hyperresponsiveness (BHR)

    Page :251

    M.J. Noonan, Z.M. Munk, P. Chervinsky, R.J. Dockhorn, J. Pinnas, J. Wolfe, K.L. Crescenzi, D.J. Kellerman

    
  • ·274 Comparison of three different doses of budesonide and placebo on the allergen-induced early asthmatic response (EAR)

    Page :251

    V.A. Swystun, R. Bhagat, S. Kalra, B. Jennings, D.W. Cockroft

    
  • ·275 Inhaled budesonide activity over eosinophilic cationic protein (ECP) serum concentrations, bronchial hyperresponsiveness to cold air (BHR) and spirographic evolution in asthmatic patients

    Page :251

    D. Josviack, P. Moreno

    
  • ·276 Chronotherapeutic effect of inhaled steroids on asthma at 8AM or 5:30 PM versus QID dosing

    Page :251

    D.J. Pincus, E.E. Weeks, R.J. Martin

    
  • ·277 Linear growth of asthmatic children on inhaled and systemic steroids

    Page :252

    L.C. Kovalhuk, N.A. Rosario, L. Lacerda, J. Gabardo, A. Schmidt, F. Ferrari

    
  • ·278 Osteoporosis in corticosteroid treated children

    Page :252

    P. Patel, S.J. McGeady

    
  • ·279 Effects of prednisolone on bone turnover in patients with corticosteroid resistant asthma

    Page :252

    T.H. Lee, S.J. Lane, V. Sashi, R. Swaminathan

    
  • ·280 Individual variations in endogenous cortisoltonus in normal population has no influence on metabolism in subcutaneous adipose tissue

    Page :252

    U. Knutsson, U. Ekström, M. Brönnegard, U. Ungerstedt, S. Werner, P. Stierna, C. Marcus

    
  • ·281 Delayed asthmatic response [DYAR] and the protective effects of disodium cromoglycate [DSCG], nedocromil sodium [NDS] and beclomethasone dipropionate [BDA]

    Page :253

    S.-A. Johansson, W.M.A.J. Miesen, D.M.V. Pelikan, Z. Pelikan

    
  • ·282 Nebulized nedocromil in the treatment of asthma in young children

    Page :253

    S. Mehra

    
  • ·283 Cost efficacy of nedocromil sodium (NED) aerosol for asthma

    Page :253

    P. Korenblat, J. Farrar

    
  • ·284 Steroid enhancing effects of clarithromycin

    Page :253

    S. Raschal, J. Moy, G.W. Richmond

    
  • ·285 Immunomodulation of roxithromycin for Dermatophagoides farinae(Df)-induced IL4, IFN-γ production in PBMCs from patients with bronchial asthma (BA)

    Page :254

    T. Noma, I. Yoshizawa, T. Nakajima, M. Hayashi, Y. Kawano, K. Kou

    
  • ·286 Effect of scheduled albuterol inhalation on spirometry, lung volumes and bronchial hyperreactivity

    Page :254

    B. Balson, K. Ziemke, S.J. McGeady

    
  • ·287 Albuterol MDI cumulative dose-response in asthmatic children

    Page :254

    F.P. Ferrari, N.A. Rosário, O. Kantor, L.S. Kovalhuk, L.G. Caleffe

    
  • ·288 Long term effect of fenoterol (F) and fenoterol + ipratropium bromide (F+IB) in asthmatic children

    Page :254

    W. Rocha, E. Rocha, C. Wurtz, R. Duarte, S.N. Senna

    
  • ·289 The effects of IVIG in severe steroid-dependent asthmic adults and adolescents

    Page :255

    L.P. Landwehr, J.D. Jeppson, M.G. Katlan, B. Estrel, D.L. Hamilos, E.W. Gelfand

    
  • ·290 Theophylline blocks the spontaneous release of nitric oxide in vitro in mononuclear cells from asthmatic patients

    Page :255

    G. Sansone, A. Matin, S.F. Wang, D. Bouboulis, M. Frieri

    
  • ·291 The use of the internet as a recruitment tool for asthma drug development studies

    Page :255

    M.B. Wiener, S. Carr, A. Blagg

    
  • ·292 A site evaluation of a national Ad recruitment campaign

    Page :255

    J.S. Kelloway, S.A. Peterson, W.F. Schoenwetter

    
  • ·293 Asthma-specific quality of life in patients treated with salmeterol or albuterol

    Page :256

    F. Cox, B. Goodwin, S. Wenzel, K. Rickard, C. Kalberg, A. Emmett

    
  • ·294 Quality of life and serum eosinophil cationic protein (ECP) in asthmatics

    Page :256

    C. Colás, A. Lezaun, J. Fraj, M.A. Domínguez, F. Duce

    
  • ·295 The impact of salmeterol versus albuterol on disease specific quality of life in mild to moderate asthmatics

    Page :256

    Goodwin B., F. Cox, W. Lumry, K. Rickard, C. Kalberg, A. Emmett

    
  • ·296 General health status in rhinitis and asthma patients

    Page :256

    W.F. Schoenwetter, J.S. Kelloway, M. Ireland

    
  • ·297 Outcomes analysis of a summer asthma camp

    Page :257

    C. Szelc Kelly

    
  • ·298 Validation of a pediatric asthma diary

    Page :257

    N.C. Santanello, B.L. Barber, B.A. Knorr

    
  • ·299 Psychologic comorbidity in asthma

    Page :257

    D.M. Lang, M.S. Sherman, J.S. Jaffe, S. Verdecchia, P.J. Rutigliano, L.R. Derogatis

    
  • ·300 Pulmonary effects of acute and chronic stress during allergen exposure

    Page :257

    B.L. Laube, B.A. Curbow, S.T. Fitzgerald, K. Spratt

    
  • ·301 Home bound asthma education for children in medium sized cities: Effectiveness analysis

    Page :258

    H.S. Prabhakara, J.W. Georgitis, A.J. Althaus

    
  • ·302 Correct use of metered dose inhalers/spacers in 8 pediatric allergy clinic

    Page :258

    J. Brauckmann, J. Pongracic

    
  • ·303 Effects of an asthma educational videocassette for adults

    Page :258

    G. Moscato, G. Bertolotti, C.F. Donner, L.M. Fabbri, M. Neri, C. Rampulla, P. Zanon

    
  • ·304 Compliance to peak expiratory flow (PEF) measurements in long-term follow-up of asthma

    Page :258

    A. Cartier, J. Côté, P. Robichaud, H. Boutin, M. Lavallee, A. Filion, M. Rouleau, M. Krausky, J.L. Malo, L.P. Boulet

    
  • ·305 Interventions lead to drop in asthma hospitalization for children in three Kaiser HMOs

    Page :259

    T.F. Plaut, M.A. Stevens, A. Weiss-Harrison, C.B. Gascoigne, M.L. Tochen

    
  • ·306 Relationship of PEFR to FEV1, FVC, and FEF 25–75 in adults

    Page :259

    R.C. Lavy

    
  • ·307 Improving reading and language skills in inner city youth is the key to asthma self management

    Page :259

    L.D. Robinson, D. Broussard-Perry, J. Berger, E. Nero

    
  • ·308 Characteristics, clinical outcomes and influence of education on asthma patients with a poor compliance to asthma treatment

    Page :259

    L.P. Boulet, J. Côté, P. Robichaud, H. Boutin, A. Filion, M. Lavallee, M. Rouleau, M. Krausky, J.L. Malo, A. Cartier

    
  • ·309 Asthma video review

    Page :260

    A.R. Bergstrom, K.L. Jensen, J.T. Li

    
  • ·310 Floating characteristics of metered-dose inhalers

    Page :260

    B.L. Wolf, K.R. Cochran, J.M. Anchor

    
  • ·311 Aerosols: How to improve inhalation technique in children

    Page :260

    D.E. Larenas, J.G. Huerta

    
  • ·312 Drug delivery from a metered dose inhaler (MDI) used with an inspiratory flow control device (IFCD), compared to a spacer device (SD)

    Page :260

    Lewis J. Kanter, Richard E. Kanter

    
  • ·313 Expression of MHC class II molecules on HMC-1 cells is upregulated by IFN-γ but not IL-4

    Page :261

    K.S. Love, R.R. Lakshmann, J.H. Butterfield, C.C. Fox

    
  • ·314 Mast cells and T-lymphocytes in rheumatoid and non-rheumatoid synovium

    Page :261

    A.M. Nafie, E. Fouda, B. Gruber, A.M. Irani, L.B. Schwartz

    
  • ·315 Histamine release from human skin mast cells by monocyte chemoattractant factor — 1, RANTES, macrophage inflammatory protein — 1α, and stem cell factor using microdialysis technique

    Page :261

    L.J. Petersen, K. Brasso, M. Pryds, P.S. Skov

    
  • ·316 Expression of Fas antigen on a human and on murine mast cell lines: Antibody to Fas antigen induces mast cell apoptosis

    Page :261

    K. Hartmann, A.S. Worobec, P.J. Bianchine, Y.A. Mckori, D.D. Metcalfe

    
  • ·317 Immobilized serum amyloid A (SAA) induces mast cell (MC) adhesion to extracellular matrix (ECM)

    Page :262

    R. Hershkoviz, M. Rashkovsky, O. Lider, M. Fridkin, Y.A. Mekori

    
  • ·318 A method for purification of human conjunctival mast cells

    Page :262

    E. Cook, J. Stahl, F.M. Graziano

    
  • ·319 Role of ABC transporter proteins in the release of leukotriene C4 (LTC₄) by normal murine mast cell line

    Page :262

    T. Nguyen, S. Gupta

    
  • ·320 IgE-induced PGD2 release from cultured human mast cells

    Page :262

    T. Nagakura, T. Obata, K. Yamashita, M. Kurosawa, T. Masaki, K. Maekawa

    
  • ·321 Induction of mast cell degranulation by heterotypic aggregation with T cells

    Page :263

    Y.A. Mekori, N. Inamura, D.D. Metcalfe

    
  • ·322 Identification of genes through a mast cell subtraction library

    Page :263

    H. Vliagoftis, D.D. Metcalfe, C.K. Oh

    
  • ·323 Importance of G_q protein function in mast cell adenosine receptor mediated calcium mobilization

    Page :263

    H.M. Hoffman, D.L. Marquardt

    
  • ·324 Type-II PLA₂ supplies arachidonic acid to PGHS-2 in the delayed phase of PGD₂ generation by mouse mast cells

    Page :263

    J.P. Arm, M. Murakami, C.O. Bingham, K.F. Austen

    
  • ·325 Integrin-dependent histamine release in human basophils: Relationship with disease status

    Page :264

    K. Goldring, K. Hurst, R. Djukanovic, J.A. Warner

    
  • ·326 Potentiation of basophil function by antibodies of ICAM-3

    Page :264

    S. Saini, J. White, W.M. Gallatin, P.A. Hoffman, W.M. Lichtenstein, B.S. Bochner

    
  • ·327 Expression of calcium-dependent and independent PKC isozymes in human basophils (HB)

    Page :264

    K. Miura, D.W. MacGlashan

    
  • ·328 FcεR1 β-subunit expression is enhanced by in vivo administration of IgE in rats

    Page :264

    J.S. Marshall, J. Rivera, B. Hewlett, R. Stead, N. Shaikh

    
  • ·329 Interleukin-4 enhances and soluble interleukin-4 receptor inhibits histamine release from peripheral blood basophils and mast cells in vitro and in vivo

    Page :265

    H. Renz, B. Niggemann, T. Zuberbier, U. Herz, K. Enssle, U. Wahn

    
  • ·330 Expression of cytokine genes by human mast cells: Profile, kinetics and modulation by anti-inflammatory steroids

    Page :265

    T. Lakshman, K. Hall, J.K. Smith, S.K. Huang, G. Krishnaswamy

    
  • ·331 Naive human mast cells (MC) transcribe IL-3, IL-5 and GM-CSF mRNA and secrete IL-5 and GM-CSF protein following FcεRI ligation

    Page :265

    R.B. Bressler, J. Lesko, M. Jones, M. Wasserman, R.R. Dickason, S. Cook, M.M. Huston, D.P. Huston

    
  • ·332 Epithelial inhibition of mast cell activity

    Page :265

    D. Peden, I. Wortman, L. Dailey

    
  • ·333 Lower enhancing effect of IL-3 on basophil histamine release in atopic than in nonatopic subjects

    Page :266

    C. Salmaso, A. Tedeschi, N. Milazzo, M. Cottini, A. Miadonna

    
  • ·334 Influence of the growth factors NGF and GM-CSF on the expression of mast cell characteristics

    Page :266

    P. Welker, J. Grabbe, A. Grützkau, B.M. Henz

    
  • ·335 Investigation of Thymus-derived factors as modulators of basophil functional activity

    Page :266

    T.Yu. Gots

    
  • ·Index

    Page :266

    M. Gurish, D.S. Friend, K.F. Austen, J.P. Arm

    
  • ·337 Human recombinant IgE-dependent histamine releasing factor (HrHRF) primes basophils for histamine release

    Page :267

    S.M. MacDonald, J.T. Schroeder, J.M. Langdon, K.M. Jenkens, D.W. MacGlashan, L.M. Lichtenstein

    
  • ·338 The production of MIP-1α by basophils and its comparison to the production by other leukocytes

    Page :267

    H. Li, T. Sim, J.A. Grant, R. Alam

    
  • ·339 Serum secretory phospholipase A2 levels in patients with mastocytosis

    Page :267

    E. Bernton, J. Hershey, R. Franson, R. Engler, L. Schwartz, D. Metcalfe, A. Worobec

    
  • ·340 Altered mast cell phenotype in synovial tissues of patients with osteoarthritis

    Page :267

    M.G. Buckley, P.J. Gallagher, A.F. Walls

    
  • ·341 Mast cells MC_C expressing chymase and not tryptase are induced from umbilical cord blood progenitors by conditioned media from a mastocytosis cell strain, with kit ligand

    Page :268

    L. Li, S.A. Krilis

    
  • ·342 Csk associates directly with GAP-associated protein p60 upon FcεRI stimulation

    Page :268

    T. Rafnar, R.S. Peebles, D.W. MacGlashan, M.E. Brummet, D.G. Marsh

    
  • ·343 Mast cell activation in allergic rhinitis can be measured by nasal fluid tryptase

    Page :268

    G. Rasp, L.B. Schwartz, I. Enander

    
  • ·344 Characterization of the two principal isoforms of chymase from human skin and heart

    Page :268

    A.R. McEuen, M. Gaça, M.G. Buckley, M.J. Davies, E.F. Hounsell, M.G. Gore, A.F. Walls

    
  • ·345 Serum α-tryptase, an update on its use to screen for systemic mastocytosis

    Page :269

    K. Carias, C. Abernathy, L.B. Schwartz

    
  • ·346 Expression and isolation of non-glycosylated recombinant human (rh)β-tryptase

    Page :269

    F.R. Sheikh, S. Ren, L.B. Schwartz

    
  • ·347 Mast cell tryptase stimulates the synthesis of type I collagen by human fibroblasts

    Page :269

    J.A. Cairns, A.F. Walls

    
  • ·348 Mast cell tryptase is a growth factor for human airway smooth muscle cells

    Page :269

    H. Thabrew, J.A. Cairns, A.F. Walls

    
  • ·349 Serum tryptase levels in ICU patients with unexplained acute hypotension

    Page :270

    G.D. Marshall, D.M. Calabrese, L.B. Schwartz

    
  • ·350 Cyclic AMP-elevating agents prolong the survival of human eosinophils in culture

    Page :270

    M.P. Hallsworth, M.A. Giembycz, Peter J. Barnes, Tak H. Lee

    
  • ·351 Heterogeniety of human eosinophils in response to platelet activity factor and interleukin-5

    Page :270

    Jaw-Ji Tsai, Ting-Fang Wang, Paul-H Chen

    
  • ·352 TNF-α prolongs eosinophil survival, partly through expression of ICAM-1

    Page :270

    T. Fujisawa, J. Atsuta, A. Terada, K. Iguchi, H. Kamiya, M. Sakurai

    
  • ·353 Spontaneous survival of eosinophils and IL-5 levels in patients with idiopathic hypereosinophilic syndrome (HES)

    Page :271

    H. Kita, D.A. Weiler, K.R. Bartemes, J.S. Abrams, G.J. Gleich

    
  • ·354 Mast cell sonicates enhance eosinophil survival: A GM-CSF mediated effect

    Page :271

    F. Levi-Schaffer, V. Temkin, V.B. Weg, Y. Zilberman

    
  • ·355 Effects of protein kinase inhibitors on eosinophil degranulation induced by secretory IgA (sIgA) conjugated sepharose beads

    Page :271

    H. Ohashi, M. Ishikawa, H. Kita, G.J. Gleich, H. Kawai, T. Osawa

    
  • ·356 CD9 — An activity marker on eosinophils in platelet containing blood?

    Page :271

    E. Fernvik, J. Lundahl, R. Grönneberg, G. Halldén

    
  • ·357 The expression of FcγRIII (CD16) on peripheral blood eosinophils

    Page :272

    G. Halldén, L. Whelin, E. Fernvik, J. Lundahl

    
  • ·358 Cross-linking of CD9 induces degranulation, GM-CSF production and survival of human eosinophils

    Page :272

    J.-T. Kim, G.J. Gleich, H. Kita

    
  • ·359 Platelet-activating factor (PAF) activates three isoforms of microtubule-associated protein (MAP) kinase in human eosinophils

    Page :272

    S. Milke, M. Hiraguri, I. Iwamoto

    
  • ·360 Mast cell sonicates activate eosinophils for cytokine release: Effect of dexamethasone

    Page :272

    V.B. Weg, V. Temkin, F. Levi-Schaffer

    
  • ·361 Eosinophils bind to bronchial epithelial cells

    Page :273

    A. Fitzpatrick, I.C. Crocker, M. McGovern, R.G. Townley, R.A. Robbins

    
  • ·362 Eotaxin is an eosinophil chemokine produced by endothelial and epithelial cells and during IL-4 tumor suppression

    Page :273

    M.E. Rothenberg, E. Garcia, P. Leder, A.D. Luster

    
  • ·363 Eosinophil (EOS) interaction with ICAM-1 promoted release of superoxide anion (O₂⁻), EOS-derived neurotoxin (EDN) and LTC₄

    Page :273

    M. Nagata, J.B. Sedgwick, H. Kita, W.W. Busse

    
  • ·364 Eosinophil adhesion and degranulation induced by PMA, GM-CSF and solid phase bound proteins

    Page :273

    C.M. Reimert, P.S. Skov, L.K. Poulsen

    
  • ·365 Heparin inhibits RANTES-induced chemotaxis of eosinophils

    Page :274

    P. Kuna, M. Antczak, G. Cieslewicz, J. Rozniecki

    
  • ·366 Injection of histamine with mast cell tryptase selectively stimulates eosinophil accumulation In vivo

    Page :274

    S. He, Q. Peng, A.F. Walls

    
  • ·367 The cell surface antigens CD44 and CD69 are activation markers for human eosinophils (EOS)

    Page :274

    K. Matsumoto, J. Appiah-Pippim, C. Bickel, R.P. Schleimer, B.S. Bochner

    
  • ·368 The differential expression of adhesion molecules on airway and circulating eosinophils

    Page :274

    D.A. Wong, P.M. O'Byrne, Asthma Research Group

    
  • ·369 GM-CSF regulation in human peripheral blood eosinophils

    Page :275

    R.J. Horwitz, W.W. Busse, J.S. Malter

    
  • ·370 Eosinophils (EOS) bind rhinovirus (RV) via ICAM-1 and present antigen to RV-specific T cells

    Page :275

    Z.T. Handzel, J.E. Gern, E.A.B. Kelly, R.R. Rodriguez, J.B. Sedgwick, W.W. Busse

    
  • ·371 Interleukin-5-mediated eosinophilia in Hodgkin's disease (HD)

    Page :275

    M. Sánchez-Borges, E. Di Biagio, J. Desenne, R. Suárez, R. Somoza, G. Acquatella

    
  • ·372 Mononuclear eosinophils developed in vitro from hybrid eosinophil/basophil granulocytes produce GM-CSF

    Page :275

    J.A. Boyce, D. Friend, M.F. Gurish, K.F. Austen, W.F. Owen

    
  • ·373 Eosinophils express B7-2 (CD86) and provide co-stimulatory signals to T cells for activation and proliferation

    Page :276

    J. Celestin, R.S. Geha

    
  • ·374 Nitric oxide (NO) production by human eosinophils

    Page :276

    V. del Pozo, E. de Arruda-Chavez, B. de Andrés, B. Cárdaba, S. Gallardo, A. Jurado, P. Palomino, C. Lahoz

    
  • ·375 Localization of interleukin-5 (IL-5) mRNA in eosinophils of nasal polyps by in situ hybridization

    Page :276

    I. Däter, C. Bachert

    
  • ·376 Interferon-γ (IFN-γ) suppresses GM-CSF release from human eosinophils (EOS)

    Page :276

    Y. Shikama, R. Rodriguez, J.B. Sedgwick, E.A.B. Kelly, W.W. Busse

    
  • ·377 Analysis of recombinant human tumor necrosis factor-α-induced CD4 expression on human eosinophils

    Page :277

    M. Hossain, Y. Okubo, S. Horie, M. Sekiguchi

    
  • ·378 Eosinophil-T lymphocyte interaction: Induction of T cell proliferation via CD40

    Page :277

    K. Lim, R. Geha, P.F. Weller

    
  • ·379 Effects of dexamethasone, cyclosporine A and rapamycin on eosinophil degranulation and survival

    Page :277

    Q. Meng, S. Ying, B. Assoufi, R. Moqbel, A.B. Kay

    
  • ·380 Increases in circulating CD34⁺ hemopoietic progenitors in allergen-induced late asthmatic responses

    Page :277

    R. Sehmi, L. Wood, R. Watson, M.D. Inman, P.M. O'Byrne, J.A. Denburg

    
  • ·381 Chemokine (Ck) levels in developing allergic skin late phase reactions (LPR)

    Page :278

    A. Moskovitz, S. Reddigari, B. Zweiman, A.P. Kaplan

    
  • ·382 Comparison of inflammatory events in skin sites with and without late phase allergic reactions (LPR)

    Page :278

    C. von Allmen, B. Zweiman, A. Moskovitz

    
  • ·383 Cytokine mRNA positive cells in developing late phase reactions (LPR)

    Page :278

    B. Zweiman, W. Anderson, A.R. Moskovitz, S. Sullivan, D.H. Broide

    
  • ·384 Sputum Eosinophils and IL-5 in late phase asthmatic reactions to antigen

    Page :278

    C. Swenson, R. Rodriguez, E.A.B. Kelly, W.W. Busse

    
  • ·385 Inhibitory activity of loratidine and descarboxyethoxyloratadine on histamine-induced activation of human endothelial cells

    Page :279

    S. Molci, P. Gosset, F. Vasseur, W. Czarlewski, A.B. Tonnel

    
  • ·386 Neuromedin B (NMB) induces guinea pig nasal gland secretion

    Page :279

    A. Gawin, M. Ali, J.N. Baraniuk

    
  • ·387 Adhesion protein expression does not parallel nasal eosinophil (EOS) influx during persistent pollen exposure in seasonal allergic rhinitis (SAR)

    Page :279

    E. Zoratti, L. Meyerson, M. Benninger, J. Carey, C. Swenson, T. Kelly, W. Busse

    
  • ·388 Soluble FcεRIα-subunit in serum from allergic and non-allergic patients with asthma: Immunopurification and correlation to disease activity

    Page :279

    T. Bjerke, M. Christensen, R. Dahl, J. Kochan, P. Jardieu, L.K. Poulsen

    
  • ·389 Soluble α-subunit (S-α)—A humoral form of the high affinity IgE receptor—Is present in serum and nasal lavages of allergic individuals

    Page :280

    L.K. Poulsen, H.H. Jacobi, J. Kochan, C.M. Reimert, P.S. Skov, N. Mygind, T. Bjerke

    
  • ·390 Interaction of allergenic pollens with C1q and its significance in allergic inflammation

    Page :280

    B.K. Thakur, M.R. Murali, B. Ghebrehiwet

    
  • ·391 Allergen-specific IgE and IL-5 are essential for the development of airway hyperresponsiveness (AHR) in a mouse model

    Page :280

    E. Hamelmann, A. Oshiba, J. Schwarze, K. Bradley, J. Loader, G. Larsen, E.W. Gelfand

    
  • ·392 Mast cell chemoattractive activity in nasal lavage from allergic patients

    Page :280

    Gunnar Nilsson, M. Hjertson, M. Andersson, K. Nilsson, A. Siegbahn

    
  • ·393 Comparison of basophil releasability in cord blood of newborns between healthy mothers and asthmatic mothers

    Page :281

    Y.P. Xu, L.J. Zhu, Y.Y. Zhu

    
  • ·394 Th1/Th2 type cytokine and major basic protein expression in lung explants following specific antigen challenge in vitro

    Page :281

    E. Minshall, R. Dandurand, C. Dolman, E. Schotman, D.H. Eidelman, Q.A. Hamid

    
  • ·395 Mast cells are not playing a role in eosinophil accumulation induced by allergen in vivo

    Page :281

    M. Kaneko, A.W. Schimming, K.R. Bartemes, G.J. Gleich, H. Kita

    
  • ·396 Regulation of production of stem cell factor (SCF) by fibroblasts: Role of serum factors

    Page :281

    S. Finotto, J. Horowitz, R. McLaren, P.J. Busse, D.D. Metcalfe

    
  • ·397 Immunolocalization of stem cell factor in inflamed human nasal tissues

    Page :282

    Y.K. Kim, N. Nakagawa, I. Sulakvelidze, J. Dolovich, J.A. Denburg

    
  • ·398 Evidence for functional in vivo interactions of human IgE with murine effector cells

    Page :282

    U. Herz, N. Schnoy, G. Kolde, T. Zuberbier, A. Daser, H. Renz

    
  • ·399 Granulocyte-macrophage colony-stimulating factor (GM-CSF) is essential for enhancing airway responsiveness in mice with the liquid transformation product (LTP) of NO₂

    Page :282

    K. Ohta, T. Miiyasaka, M. Nishizawa, S. Kubota, M. Kuwabara, R. Ito, A. Ishii, T. Horiuchi, K. Mano, T. Miyamoto, H. Miyashita

    
  • ·400 Interferon gamma (IFN-γ) inhibits neutrophil chemotacis (CTX) without affecting generation of superoxide anion (SO)

    Page :282

    M.L. Kowalski, B. Szkudlińska, R. Pawliczak, J. Iwaszkiewicz

    
  • ·401 The effect of rhinovirus (RV) 16 on mononuclear cell generation of α and γ interferon (INF)

    Page :283

    R.F. Vrtis, E.C. Dick, J.N. Gern, W.W. Busse

    
  • ·402 Upregulation of major histocompatibility complex (MHC) molecules and adhesion ligands on respiratory syncytial virus (RSV)-infected upper airway epithelial cells

    Page :283

    T. Saito, R.P. Garofalo, V.E. Reyes, P.L. Ogra

    
  • ·403 Respiratory syncytial virus (RSV)-infected airway epithelial cells induce transendothelial migration of human blood eosinophils

    Page :283

    B. Olszewska, F. Mei, P.L. Ogra, R.P. Garofalo

    
  • ·404 The lung inflammatory responses to CC chemokines — MCP-1, MCP-3, MIP-1α and RANTES in mice challenged in vivo

    Page :283

    Alnoor Malick, Susan Stafford, Huamin Li, Patricia Forsythe, Rafeul Alam

    
  • ·405 Relationship between urinary leucotriene E4, thromboxane B2 and lung function (FEV1)

    Page :284

    M.H. Chabane, S. Graba, N. Mounedji, O. Doudou, F. Leynadier

    
  • ·406 Sulphidoleukotriene releasability in pollinic patients

    Page :284

    M. Ferrer, M.L. Sanz, I. Prieto, A.L. de Weck, A. Oehling

    
  • ·407 The cellular antigen-stimulation-test (CAST) in the diagnosis of hymenoptera sting allergy

    Page :284

    B. Wüthrich, F.E. Maly

    
  • ·408 Allergen specific IgE determined by Sanofi-Diagnostic ACCESS® and pharmacia CAP

    Page :284

    B. Kravis, M. Olson, H.N. Nguyen, M.N. Blumenthal, A. Rosenberg

    
  • ·409 New methodologies to analyze IgG subclass distribution in specific IgG response and in IgG/IgE immune complexes

    Page :285

    S. Allauzen, A. Rosenberg, C. Larue, F. Blocki, M.N. Blumenthal

    
  • ·410 New methodology to measure average affinity of specific IgG response in response in patients with allergic disease

    Page :285

    L. Pierson, S. Allauzen, B. Kravis, L. Daniels, A. Rosenberg

    
  • ·411 Total serum IgD in atopic infants and children

    Page :285

    Y. El Gamal, Z. Awad, M. Zaghloul, A. Fouad

    
  • ·412 The effects of inhaled prostaglandin E₂ on allergen-induced airway responses

    Page :285

    G.M. Gauvreau, R.M. Watson, P.M. O'Byrne, Asthma Research Group

    
  • ·413 Urinary eosinophil protein X (EPX) in children with atopic asthma. A useful marker of antiinflammatory treatment

    Page :286

    S. Kristjánsson, I.-L. Strannegård, Ö. Strannegård, C. Peterson, I. Enander, G. Wennergren

    
  • ·414 Effect of manganese on inflammatory cell activity

    Page :286

    B. Lebel, C. Suck, J. Bousquet, A.M. Campbell

    
  • ·415 Critical evaluation of the histamine release assay

    Page :286

    K. Hermann, S. Donhauser, J. Ring

    
  • ·416 Effects of allergy/asthma drugs on IgE synthesis

    Page :286

    C.B. Broome, R.H. Buckley

    
  • ·417 Effect of the leumedin N-(fluorenyl-9-methoxycarbonyl)-L-leucine (FMOC-LEU) on eosinophil function

    Page :287

    K.F. Salata, J.N. Hershey, R.G. Alford

    
  • ·418 Inhibition of sodium, potassium adenosine triphosphatase (Na⁺, K⁺ ATPase) downregulates proliferation of peripheral blood mononuclear cells (PBMNC) and subsets

    Page :287

    A. Patel, D. Gentile, D. Skoner

    
  • ·419 In vivo and in vitro studies of leukotrienes in asthmatic children before and after different therapeutic modalities

    Page :287

    M. Zedan, Z. El-Morsy, Z. El-Shennawy, A. Shaltout

    
  • ·420 Effects of nedocromil sodium (NDS) on the immediate nasal response to allergen challenge [INR] and the accompanying cellular changes in the nasal secretions (NS)

    Page :287

    Z. Pelikan, Y.A. Trimbach, M. Pelikan-Filipek

    
  • ·421 Effects of drugs on expression of adhesion molecule on cytokine-stimulated human eosinophils

    Page :288

    T. Momose, Y. Okubo, M. Hossain, S. Horie, M. Sekiguchi

    
  • ·422 Effect of theophylline and procaterol on degranulation and surface antigen expression of human eosinophils

    Page :288

    Y. Okubo, S. Horie, M. Hossain, M. Sekiguchi

    
  • ·423 Effects of mometasone furoate and other glucocorticoids on cytokine production from cultured peripheral blood CD4⁺ T cells

    Page :288

    S.P. Umland, D.K. Nahrebne, S. Razac, M.M. Billah, R.W. Egan

    
  • ·424 Propranolol enhances histamine and interleukin-5 generation from anti-IgE challenged human lung fragments: evidence for inverse agonist effect

    Page :288

    F.J. Remy, J.S. Jaffe, D.G. Raible, T.J. Post, Y. Wang, M. Glaum, E.S. Schulman

    
  • ·425 Effect of the Lazaroid U-89843D on allergen-induced bronchial hyperresponsiveness and pulmonary eosinophilia in an allergic rabbit model of asthma

    Page :289

    M. Aktaruzzaman, L. Gregg, W.J. Metzger

    
  • ·426 The cysteinyl-leukotriene (CysLT) receptor antagonist, pranlukast, attenuates airway inflammation

    Page :289

    D.C. Underwood, S. Bochnowicz, R.R. Osborn, S.J. Newsholme, T.J. Torphy, D.W.P. Hay

    
  • ·427 Glucocorticoids inhibit leukotriene release by mixed leukocytes

    Page :289

    I.C. Crocker, C.-Y. Zhou, W. Kreutner, A.K. Bewtra, R.G. Townley

    
  • ·428 Fluticasone propionate (FP) attenuates the release of RANTES and sICAM-1 from human bronchial epithelial cells (HBEC) in vitro

    Page :289

    J.L. Devalia, J.H. Wang, R.J. Sapsford, R.J. Davies

    
  • ·429 Immunomodulatory efficacy of selective phosphodiesterase (PDE) inhibitors on antigen-specific T cell clones (TCC)

    Page :290

    D.M. Essayan, A. Kagey-Sobotka, L.M. Lichtenstein, S.-K. Huang

    
  • ·430 Suppression of eosinophil function by suplatast tosilate

    Page :290

    A. Terada, T. Fujisawa, J. Atsuta, K. Iguchi, H. Kamiya, M. Sakurai

    
  • ·431 Antiallergic activity of azelastine eye drops

    Page :290

    G. Ciprandi, S. Buscagli, A. Catrullo, G.P. Pesce, N. Fiorino, P. Montagna, M. Bagnasco, G.W. Canoica

    
  • ·432 A sodium, potassium adenosine triphosphatase inhibitor (Na⁺, K⁺ ATPaseINH) in bronchoalveolar lavages (BAL) of asthmatics following segmental allergen challenge (SAC)

    Page :290

    D. Gentile, C. Ollila, W. Calhoun, D. Skoner

    
  • ·433 Chimeric proteins expressed by recombinant DNA and a synthetic oligopeptide represent a dominant antigenic determinant of Par o 1 for human IgG and IgE antibodies

    Page :291

    G. Cassese, T. Menna, A. Chersi, F. di Modugno, A. Ruffilli

    
  • ·434 IgE-reactivity of recombinant grass pollen allergens expressed in the yeast Pichia pastoris

    Page :291

    C. Suphioglu, M.B. Singh, R.B. Knox

    
  • ·435 Adult onset hyper-IgE syndrome (HIES), eosinophilia and dermatitis, associated with lack of CD3 expression on CD4 lymphocytes

    Page :291

    A. Reshef, A. Shemer, I. Bank, F. Levi-Schaffer

    
  • ·436 Expression of trichophyton proteins in culture: Relevance to skin test extracts

    Page :291

    J.A. Woodfolk, J.B. Slunt, T.A.E. Platts-Mills

    
  • ·437 ICAM-1 expression and regulation on 3 epithelial cells: Relevance for allergic inflammation

    Page :292

    M. Bagnasco, F. Paolieri, G.P. Pesce, M. Battifora, A.M. Riccio, G. Ciprandi, G.W. Canonica

    
  • ·438 GM-CSF increases cytosolic free calcium ([Ca²⁺]i) and ciliary beat frequency (CBF) of cultured tracheal ciliated epithelial cells

    Page :292

    C.L. Park, T. Dong, H. Mao, L.B. Wong

    
  • ·439 Phenotyping and cytokine regulation of the human bronchial epithelial cell line BEAS-2B

    Page :292

    J. Atsuta, B.S. Bochner, S.A. Sterbinsky, R.P. Schleimer

    
  • ·440 Eosinophil peroxidase stimulates the release of granulocyte-macrophage colony-stimulating factor from respiratory epithelial cells

    Page :292

    S. Motojima, T. Adachi, M. Arima, K. Manaka, T. Fukuda, S. Makino

    
  • ·441 RANTES production in cultured human conjunctival epithelial cell line

    Page :293

    K. Fukagawa, H. Saito, H. Tachimoto, M. Kimata, Y. Oguchi, Y. Iikura

    
  • ·442 Patchy epithelial damage/restitution processes at allergen challenge-induced airway inflammation

    Page :293

    C.G.A. Persson, J.S. Erjefält, M. Korsgren, M. Nilsson, F. Sundler

    
  • ·443 The expression of lymphocyte chemoattractant factor (LCF) in human bronchial epithelial cells

    Page :293

    M. Arima, J.R. Plitt, C. Stellato, L.M. Schweibert, R.P. Schleimer

    
  • ·444 Whole body plethysmography (WBP) in mice detects airway sensitization through changes in lower airways function

    Page :293

    J. Schwarze, E. Hamelmann, G. Larsen, E.W. Gelfand

    
  • ·445 Antigen induced plasma protein leakage in the lungs of sensitized brown Norway rats

    Page :294

    B.M. Taylor, K.P. Kolbasa, J.E. Chin, I.M. Richards, F.F. Sun

    
  • ·446 Increased permeability of the respiratory membrane four hours after segmental allergen challenge

    Page :294

    R.E.T. Nocker, F.R. Weller, M.J. de Riemer, K.F. Traanberg, T.A. Out, H.M. Jansen, J.S. van der Zee

    
  • ·447 Asymptomatic lymphoma in a patient with extreme IgE elevation

    Page :294

    A. Koutsonikolis, N.K. Day, W. Chamizo, R.A. Good, S.J. Kornfeld

    
  • ·448 The relationship between CD23 and IgE in atopics and non-atopics

    Page :294

    M. Nejat, I. Haralabalos, D.S. Mazza, D.K. Meriney, M. Reddy, L. Cleveland, M.H. Grieco

    
  • ·449 Study of SCD23 and total IgE level in serum of atopic groups

    Page :295

    R. Farid, R. Sedaghatnia, A. Masood

    
  • ·450 Antigen stimulated cytokine synthesis, specific IgE and clinical sensitivity to cats are directly related

    Page :295

    S. Fitzpatrick-Wong, M. Imada, F.E.R. Simons, Z. Peng, K.J. Simons, K.T. HayGlass

    
  • ·451 IgE and IgG4 specific antibodies to dactylis glomerata allergens

    Page :295

    S. Correia, L.M. Martins, D.V. Peres, H. Costa, M.L. Meisel, F. Desvaux, G. Peltre, F. Inácio

    
  • ·452 Lack of specificity of B7 homologues in human Th1 and Th2 responses

    Page :295

    G.G. Bashian, C.M. Braun, A. Kagey-Sobotka, L.M. Lichtenstein, S.-K. Huang, D.M. Essayan

    
  • ·453 Effects of an antibody to interleukin-5 in a murine model of airway sensitization

    Page :296

    E.W. Gelfand, J. Schwarze, A. Oshiba, K. Bradley, J. Loader, G. Larsen, R. Coffman, E. Hamelmann

    
  • ·454 Dendritic cells and B cells in rDer p2 presentation to memory and naive T cells from atopic patients

    Page :296

    E.A. Taketomi, S.J. Sung, J.B. Slunt, A.M. Smith, T.A.E. Platts-Mills, S.M. Fu

    
  • ·455 T_γ,δ cells and parameters of allergic disease: Relationship to total IgE, atopy, and basophil histamine release

    Page :296

    David J. Volkman, Piotr Kuna, Ewa Kuna, Allen P. Kaplan

    
  • ·456 Depletion of neutrophils promotes T helper 2 cytokine pathway in murine allergic aspergillosis

    Page :296

    P.S. Murali, J. Guo, J.Q. Xia, R.L. Coffman, V.P. Kurup

    
  • ·457 IFN-γ treatment results in the functional alteration of antigen-specific CD4⁺ T cells

    Page :297

    G. Lack, A. Kupfer, A. Oshiba, E. Hamelmann, K.L. Bradley, H. Kupfer, J. Loader, G. Larsen, E.W. Gelfand

    
  • ·458 Increased bone marrow progenitor growth after allergen challenge in dogs depends on a serum factor

    Page :297

    M.D. Inman, R. Ellis, J. Wattie, C.G. Lane, M. Dählback, J.A. Denburg, P.M. O'Byrne

    
  • ·459 Effect of acellular pertussis vaccine (APV) on the development of allergic sensitization to environmental allergens

    Page :297

    A.H. Assa'ad, K. Sebastian, M.B. Lierl

    
  • ·460 Local control of ε-gene expression in B cells of the nasal mucosa in hay fever patients following allergen-challenge

    Page :297

    S.R. Durham, H.J. Gould, C.P. Thienes, M.R. Jacobson, K. Masuyama, S. Rak, O. Lowhagen, E. Schotman, Q. Hamid

    
  • ·461 Distribution of plasma cell markers and intracellular IgE in the cell line U266

    Page :298

    E. Lagging, M. van Hage-Hamsten, B. Härfast, G. Halldén

    
  • ·462 Cytokine production by peripheral blood mononuclear cells(PBMCs) and allergen-specific T cell clones in atopic individuals

    Page :298

    S.J. Hong, Y.J. Choi, S.H. Oh, J.Y. Shim, S.W. Choi, H.B. Moon

    
  • ·463 rhGM-CSF promotes an antigen-presenting phenotype in human macrophages

    Page :298

    J.J. Caulfield, D.M. Kemeny, T.H. Lee

    
  • ·464 CD4⁺ but not CD8⁺ T cells transfer allergic airway hyperresponsiveness (AHR) in BN-rats

    Page :298

    A. Haczku, P. MacAry, D. Huang, H. Tsukagoshi, P.J. Barnes, A.B. Kay, D.M. Kemeny, K.F. Chung, R. Moqbel

    
  • ·465 Modulation of antigen-dependent B and T cell responses by antigen-specific IgE antibody

    Page :299

    A. Oshiba, A. Haczku, E. Hamelmann, K. Takeda, K. Bradley, D. Conrad, H. Kikutani, E.W. Gelfand

    
  • ·466 Interleukin-2 is produced by both Th1 and Th2 cells

    Page :299

    C. Prussin, B. Foster, D.D. Metcalfe

    
  • ·467 Increased levels of interleukin-1, interleukin-6, interleukin-8, soluble intercellular adhesion molecule, and bradykinin are detected in nasal secretions of patients during naturally acquired rhinovirus colds

    Page :299

    K.L. Höpken, M.H. Hillebrandt, S.T. Röseler, C. Bachert

    
  • ·468 Natural history of Hay fever: A 23-year follow-up of college students

    Page :299

    W.A. Greisner, R.J. Settipane, G.A. Settipane

    
  • ·469 In utero sensitization of the human T-cell system to aeroallergens

    Page :300

    S.L. Prescott, P. Sly, B. Holt, R.K.S. Loh, P. Holt

    
  • ·470 Interleukin-5 protein and mRNA are increased in nasal polyps

    Page :300

    M. Wagenmann, I. Däter, C. Rudack, U. Ganzer, C. Bachert

    
  • ·471 Effect of a topical nasal steroid on GM-CSF, IL-6, IL-8 and HLA-D expression by nasal epithelial cells in seasonal allergic rhinitis (SAR)

    Page :300

    I. Sulakvelidze, K. Nakano, M. Conway, P. Edney, R. Brattsand, E. Duku, C. Goldsmith, J. Dolovich

    
  • ·472 Nasal γδ- T cells in perennial allergic rhinitics express the CD40L and induce IgE synthesis

    Page :300

    R. Pawankar, M. Okuda, N. Wada, M. Azuma, K. Okumura, C. Ra

    
  • ·473 Hypertonic saline bronchial challenge (HSC) in normal (N), allergic rhinitis (AR) and asthmatic (A) subjects. A comparison with methacholine challenge (MC). An update

    Page :301

    R.G. Townley, F.A. Romero, P. Williams, J. Pinnas, R. Rosenthal, L. Ford

    
  • ·474 Local nasal immunotherapy (LNIT) with aqueous weed extract is an effective therapy for weed induced rhinitis

    Page :301

    B. Gaglani, L. Borish, A. Buchmeier, L. Keller, H. Nelson

    
  • ·475 Absolute quantitation of mite allergen-specific IgE antibody levels by ELISA using a chimeric mouse Fab/human Fc epsilon antibody to Der p 2

    Page :301

    A.J. Elderfield, J. Schuurman, R. Aalberse, A. Smith, A. Woodcock, M.D. Chapman

    
  • ·476 Allergens in inner city homes

    Page :301

    P. Eggleston

    
  • ·477 Evaluation of cockroach allergens in low income housing: Bla g 1 & Bla g 2 only airborne during disturbance

    Page :302

    J. Mollet, M. Perzanowski, D. Avner, L.K. Arruda, M. Chapman, T.A.E. Platts-Mills

    
  • ·478 Major dog allergen can f 1: Distribution in homes, airborne levels and particle sizing

    Page :302

    A. Custovic, R. Green, C.A.C. Pickering, A. Smith, M.D. Chapman, A. Woodcock

    
  • ·479 Avoidance of dog allergen f 1 with the dog in situ: Washing the dog and use of A HEPA air filter

    Page :302

    R. Green, A. Custovic, A. Smith, M.D. Chaoman, A. Woodcock

    
  • ·480 “Drawing the line” — Rapid diagnostic tests (RDT) for detection of dust mite, cat and cockroach allergens

    Page :302

    M.D. Chapman, L. Williams, J. Chandler

    
  • ·481 Reduction of exposure to laboratory animal allergens

    Page :303

    S. Gordon, J. Wallace, J.A. Welch, A. Cook, M. Jones, R.D. Tee, A.J. Newman Taylor

    
  • ·482 Endotoxin levels in various house dust samples

    Page :303

    P. Brock Williams

    
  • ·483 GM-CSF regulates the functional adhesive state of VLA-4 expressed by eosinophils

    Page :303

    D.H. Broide, L. Yang, M. Elices, G. Jin, P. Sriramarao, K.-L. Sung

    
  • ·484 IL-13 but not IL-4 prolongs eosinophil survival and induces eosinophil chemotaxis

    Page :303

    S. Horie, Y. Okubo, M. Hossain, E. Sato, H. Nomura, S. Koyama, M. Sekiguchi

    
  • ·485 Induction of lymphotactin gene expression in mast cells following FcεRI aggregation: Modulation by TGF-β, IL-4 and dexamethasone

    Page :304

    V. Rumsaeng, H. Vliagoftis, C. Oh, J. Nagata, D.D. Metcalfe

    
  • ·486 Interleukin-5 induces activation of the phosphotyrosine phosphatase, SHPTP2 (Syp) in eosinophils

    Page :304

    K. Pazdrak, R. Alam

    
  • ·487 A novel C-C chemokine, CKβ10 is expressed in airway epithelial cells and is a potent eosinophil chemoattractant

    Page :304

    C. Stellato, L. Beck, L. Schwiebert, H. Li, J. White, R.P. Schleimer

    
  • ·488 Epithelial cells are the major cellular source of eotaxin mRNA in the Guinea pig lung

    Page :304

    J. Stahl, E. Cook, M. Rothenberg, F.M. Graziano

    

• Abstract Monday, March 18, 1996

  • ·489 Respiratory syncytial virus-induced release of RANTES and MIP-1α by bronchial epithelial and peripheral mononuclear cells

    Page :305

    A. Siddiqi, M. Peeples, A. Brees, J. Moy

    
  • ·490 The expression of CC chemokines in the lung in an allergic model of airway inflammation

    Page :305

    R. Alam, S. Stafford, Huamin Li, Rodrigo Bravo

    
  • ·491 Analysis of superoxide production by ovine alveolar cells before and after infection with RSV

    Page :305

    B.K. Bacot, S.L. Abramson, P.W. Hiatt, A.A. Piedra, W.T. Shearer

    
  • ·492 Association between nasal sIGA to chronic Chlamydia pneumoniae infection and asthma exacerbations in children

    Page :305

    A. Cunningham, S.L. Johnston, S.A. Julious, F.C. Lampe, M.E. Ward

    
  • ·493 Markers of inflammation in induced sputum in acute bronchitis caused by Chlamydia pneumoniae

    Page :306

    M.M.M. Pizzichini, A. Efthimiadis, L. Clelland, E. Pizzichini, S. Evans, J. Mahony, J. Dolovich, F.E. Hargreave

    
  • ·494 Airway pathology after viral antigen challenge in rats after antecedent viral illness

    Page :306

    M. Kaplan, R. Sorkness, J. Stokes, W.L. Castleman, J.E. Gern, R.F. Lemanske

    
  • ·495 Effect of experimental rhinovirus 39 (RV-39) infection on nasal bradykinin (BK) levels

    Page :306

    D. Skoner, Y. Shibayama, W. Doyle, J. Seroky, P. Fireman, S. Cohen, A.P. Kaplan

    
  • ·496 The role of Chlamydia pneumoniae in reversible obstructive airway disease

    Page :306

    F.T. Simon, H.S. Nelson, J.A. Noda, J.M. Routes

    
  • ·497 Effect of Hanks rhinovirus (RV-H) infection on the lower airways in allergic rhinitis (AR) and non-AR subjects

    Page :307

    M. Van Deusen, B. Angelini, W.J. Doyle, J. Seroky, S. Cohen, D.P. Skoner

    
  • ·498 Patterns of respiratory virus infections and its association with acute childhood asthma

    Page :307

    F.T. Chew, S. Doraisingham, D.Y.T. Goh, G. Kumaransinghe, B.C. Ooi, Y.L. Lim, S.Y. Soh, B.W. Lee

    
  • ·499 Cellular inflammation in the airways in asthma compared with bronchiectasis

    Page :307

    A.M. Bentley, M. Gaga, J. Barkans, M. Humbert, C.G. Wathen, A.B. Kay, S.R. Durham

    
  • ·500 Comparison of inflammatory cells in sputom, bronchoalveolar lavage (BAL) and bronchial biopsies in asthma and chronic bronchitis

    Page :307

    P. Maestrelli, A. DiStefano, P. Calcagni, G. Turato, C.E. Mapp, L.M. Fabbri

    
  • ·501 Expression of activation markers on alveolar macrophages (AM) in allergic asthmatics after endobronchial (EB) or whole lung (WL) allergen challenge

    Page :308

    M.Y. Viksman, B.S. Bochner, M.C. Liu, R.P. Schleimer

    
  • ·502 High affinity IgE receptor (FcεRI)-bearing cells in bronchial biopsies from atopic and non-atopic asthma

    Page :308

    J. Barkans, J.A. Grant, L. Taborda-Barata, S. Ying, G. Menz, R. Pfister, S.R. Durham, A.B. Kay, M. Humbert

    
  • ·503 A comparison between airway resistance and cellular responses in bronchoalveolar lavage fluid (BALF) and in lung interstitium (LUNG) in cockroach allergic guinea pigs

    Page :308

    D. Zhou, B. Miller, H. Gindling, R. Profitt, K. Sajadi, B.C. Kang

    
  • ·504 Safety of bronchoscopy in asthmatics and control subjects and effect on asthma control over two weeks

    Page :308

    D.S. Robinson, M. Humbert, B. Assoufi, A.B. Kay, S.R. Durham

    
  • ·505 Analysis of T cell receptor clonotypes in bronchoalvelar lavage fluids of nonatopic asthmatics

    Page :309

    T. Umibe, Y. Kita, A. Nakao, N. Nakagawa, T. Fukuda, S. Makino, I. Iwamoto

    
  • ·506 Release of GM-CSF from cultured epithelial cells stimulated with sputum from patients with asthma

    Page :309

    T. Adachi, S. Motojima, K. Manaka, M. Arima, T. Fukuda, N. Kihara, S. Makino

    
  • ·507 Secretory phospholipase A₂ is elevated in lung lavage fluid after antigen sensitization in asthmatic guinea pigs

    Page :309

    A.C. Sane, T. Mendenhall, D.A. Bass

    
  • ·508 Specific IgE antibodies in serum and in bronchoalveolar (BAL) fluid correlate with the magnitude of the antigen-induced late phase reaction

    Page :309

    R.S. Peebles, R.G. Hamilton, L.M. Lichtenstein, M. Schlosberg, M.C. Liu, A. Togias

    
  • ·509 Bronchoalveolar lavage (BAL) cellularity in asthmatic children and infantile wheezers: Role of neutrophils

    Page :310

    C. Marguet, F. Jouen, O. Lees, E. Mallet, T.P. Dean, J.O. Warner

    
  • ·510 Assay of ABO(H) erythrocyte antigen by hemagglutination inhibition of murine monoclonal antiA and antiB antibodies

    Page :310

    S.C. Bukantz, E. Calderon, R.F. Lockey

    
  • ·511 Use of eosinophil cationic protein as a predictive marker for exacerbations of asthma

    Page :310

    K.A. McGill, C.A. Sorkness, A. Lanner, C. Swenson, W.W. Busse

    
  • ·512 Bronchial mucosal gene expression of the CC chemokines RANTES and MCP-3 in symptomatic atopic and non-atopic asthma: Relationship to eosinophil-active cytokines IL-5, GM-CSF and IL-3

    Page :310

    M. Humbert, S. Ying, G. Menz, J. Barkans, R. Pfister, C. Corrigan, S.R. Durham, A.B. Kay

    
  • ·513 Sputum cellular and fluid phase components: Comparison of the effect of dithiothreitol vs. phosphate buffered saline

    Page :311

    A. Efthimiadis, M.M.M. Pizzichini, S. Weston, E. Pizzichini, S. Evans, J. Dolovich, F.E. Hargreave

    
  • ·514 Eosinophils (Eo) and ECP of induced sputum compared with peripheral blood (B)

    Page :311

    E. Pizzichini, M.M.M. Pizzichini, A. Efthimiadis, S. Evans, J. Dolovich, F.E. Hargreave

    
  • ·515 Eosinophil cationic protein (ECP) in cystic fibrosis (CF)

    Page :311

    I.M. Jacques, R. Selden, G.P. Rakes, D.P. Huston, T.A.E. Platts-Mills, P.W. Heymann

    
  • ·516 Platelet-activating factor (PAF)-induced eosinophil degranulation requires tyrosine phosphorylation

    Page :311

    D.K. Agrawal

    
  • ·517 Nasal eosinophil cationic protein and urinary protein X as markers of asthma

    Page :312

    N. Neuparth, T. Gamboa, I. Ribeiro da Silva, H. Carvalho, H. Trindade, J.E. Rosado Pinto, A.B. Rendas

    
  • ·518 Comparative studies of specific bronchial provocation tests with two differently standardized Dpt allergens

    Page :312

    Z. Siergiejko, Z. Ziętkowski, S. Chyrek-Borowska

    
  • ·519 Relationship between bronchial hiperresponsiveness to cold air (BHR), eosinophilic cationic protein (ECP) and IgE levels to dermatophagoides pteronyssinus in asthmatic patients

    Page :312

    L. Greiding, L.D. Cortigiani, D. Josviack, P. Moreno, D. Flores, P. Paulin, M. Grinstein

    
  • ·520 Sialyl Lewis X analog suppresses eosinophil accumulation and late asthmatic response in a guinea pig model of asthma

    Page :312

    Hironori Sagara, Chisei Ra, Takenori Okada, Akiko Ishikawa, Sakumi Sinohara, Takeshi Fukuda, Ko Okumura, Sohei Makino

    
  • ·521 A monoclonal antibody against PRF receptor inhibits allergic reaction

    Page :313

    Takenori Okada, Hironori Sagara, Akiko Ishikawa, Tomomi Nakada, Takeshi Fukuda, Ko Okumura, Chisei Ra

    
  • ·522 Both lymphocytes and monocytes contribute to the enhanced tumour necrosis factor-α (TNF-α) production by peripheral blood mononuclear cells (PBMC) of severe and mild atopic asthmatics

    Page :313

    S. Waserman, J. Dolovich, J. Bryk, J.S. Marshall

    
  • ·523 Relationship of bronchial mucosal IL-5 mRNA expression with disease severity and IL-4 mRNA expression with serum IgE concentrations in atopic and non-atopic asthmatics

    Page :313

    C. Corrigan, M. Humbert, S.R. Durham, P. Kimmitt, S. Ying, J. Barkans, D.S. Robinson, B. Asoufi, B. Pfister, G. Menz, A.B. Kay

    
  • ·524 Increase in interleukin-16 (IL-16) expression in baseline asthma

    Page :313

    S. Laberge, P. Ernst, O. Ghaffar, Y.L. Song, W.W. Cruikshank, D.M. Center, Q. Hamid

    
  • ·525 Endogenous kinins are formed in airways during plasma extravasation induced by leukotriene D4

    Page :314

    I. Kawikova, H. Arakawa, B.E. Skoogh, J. Lötvall

    
  • ·526 Bronchoconstriction induced by bradykinin: Attenuation by inhaled L-ASA in asthmatic subjects

    Page :314

    N. Crimi, R. Polosa, V.L. Milazzo, G. Santonocito, G. Prosperini, I. Ciamarra, A. Mistretta

    
  • ·527 Indoor and outdoor allergen-stimulated interleukin 8 production in asthma

    Page :314

    J. Therattil, M. Zitt, D. Bouboulis, S.F. Wang, G. Sansone, J. Castro, M. Frieri

    
  • ·528 Interleukin-4 and interferon-gamma mRNA expression in minor salivary glands in bronchial asthma

    Page :314

    A. Tsicopoulos, A. Janin, H. Vorng, A.B. Tonnel, B. Wallaert

    
  • ·529 Increased c-fos synthesis in mononuclear cells from patients with corticosteroid resistent asthma

    Page :315

    S.J. Lane, I.M. Adcock, P.J. Barnes, T.H. Lee

    
  • ·530 Bronchial hyperresponsiveness (BHR) in patients with symptoms of gastroesophageal reflux disease (GERD)

    Page :315

    S.G. Hinze, D. Rosemeyer

    
  • ·531 Nasal cold, dry air (CDA) challenge results in stronger nasal and pulmonary responses in asthmatics compared to patients with rhinitis

    Page :315

    L. Stephens, D. Proud, A. Togias

    
  • ·532 rhuMAb-E25 (E25), humanized murine monoclonal anti-IgE, inhibits the allerggen-induced early asthmatic response (EAR)

    Page :315

    D.W. Cockcroft, S. Kalra, R. Bhagat, V.A. Swystun, L.-P. Boulet, J. Cote, M. Laviolette, F. Deschesnes, K.R. Chapman, L.D. Cleland, R.B. Fick, J. Su, A. De Vault

    
  • ·533 Occasional wheezing in children is not always associated with bronchial hyperresponsiveness (BHR)

    Page :316

    H. Roizin, A. Reshef, S. Benzaray, R.J. Shiner

    
  • ·534 Dose-response of inhaled beclomethasone (B) for attenuating the airway responses to allergen

    Page :316

    P.L. Marshik, D. Thomas, R. Ahrens, H. Braver, L. Hendeles

    
  • ·535 Effect of cetirizine on bronchial hyperresponsiveness in patients with allergic rhinitis

    Page :316

    M. Aubier, C. Neukirch, M. Melac

    
  • ·536 A comparison of the effects of oral cetirizine and inhaled beclomethasone on early and late asthmatic responses to allergen and the associated increase in airway responsiveness

    Page :316

    S.M. Walker, A.M. Bentley, F. Hanotte, C. de Vos, S.R. Durham

    
  • ·537 Spontaneous recovery from methacholine (Mch) —Induced bronchoconstruction: A test to assess asthma severity

    Page :317

    I. Livas, R.S. Peebles, F. Brennan, A. Togias

    
  • ·538 Confluence determines the effect of hyperoxic injury on MDCK epithelial cells and antioxidant vitamin protection

    Page :317

    H. Jyonouchi, S. Sun, M. Mizokami, D.H. Ingbar

    
  • ·539 Bronchial hiperreactivity in patients with atopic dermatitis without asthma symptoms comparing with those atopic dermatitis patients and asthma symptoms, using methacoline challenger test

    Page :317

    A. Gazca-Aguilar, B. Del Rio-Navarro, J.J. Sienra-Monge

    
  • ·540 Aspirin desensitization/treatment of aspirin sensitive rhinosinusitic-asthmatic patients: Long term outcomes

    Page :317

    D.D. Stevenson, M.A. Hankammer, D.A. Mathison, S.C. Christiansen, R.A. Simon

    
  • ·541 RANTES levels and eosinophils increase in broncoalveolar lavage fluid (BALF) after indomethacin in aspirin-intolerant asthmatics (AIA)

    Page :318

    M.S. Warren, S.I. Sloan, J.B. Trudeau, N.E. Hoffman, J.Y. Westcott, S.E. Wenzel

    
  • ·542 Expression of COX1 and COX2 on aspirin-sensitive (ASA) and non-aspirin-sensitive (NASA) asthmatic and normal bronchial mucosa

    Page :318

    A.R. Sousa, R. Pfister, S.J. Lane, P.E. Christie, S.M. Nasser, M. Schmitz-Schumann, T.H. Lee

    
  • ·543 Effect of prednisone on serodiagnosis of ABPA in patients with CF

    Page :318

    P.A. Greenberger, M. Roberts

    
  • ·544 Ambiguity in diagnosing allergic bronchopulmonary aspergillosis

    Page :318

    P.S. Rihal, D. Jerome, H. Novey

    
  • ·545 Cough count (CC) as an objective outcome parameter for controlled clinical trials (CCT) of asthma therapy

    Page :319

    J. Henry, J. Seroky, W. Doyle, D. Skoner

    
  • ·546 Auto-immune syndromes masquerading as allergic disease: Implications for the practicing allergist

    Page :319

    B. Guha, D. Beals, J.K. Smith, G. Krishnaswamy

    
  • ·547 Spontaneous pneumothorax and asthma in a patient with intermediate alpha-1-antitrypsin deficiency

    Page :319

    S.I. Rosenfeld, P.H. Smith, R.H. Schwartz

    
  • ·548 Subglottic schwannoma in a child

    Page :319

    R.J. Holzhauer, D.W. Pulver, R.H. Schwartz, J.U. Coniglio, R. Pulli

    
  • ·549 Dysautonomia, sports and asthma

    Page :320

    L.M. Capão-Filipe, J.A. Capão-Filipe, L. Delgado, J. Rodrigues, L. Cunha, H. Barros, J. Castro-Correia, M. Vaz-Azevedo

    
  • ·550 Association between sensitization to natural rubber latex (NRL) and papain

    Page :320

    O. Vandenplas, L.M. Vandezande, J.P. Delwiche, J. Jamart, Y. Looze

    
  • ·551 Assessment by Hycor RAST and pharmacia CAP of cross sensitization to banana and avocado among latex sensitive hospital employees

    Page :320

    G. Anderson, T. Li, J. Malki, A. Patel, M. Alem, A.A. Babakhin, G. Cieslewicz, I. Zakirova, H. Nolte, J. Boyce, K. Pearson, A.L. Sheffer, L.M. Du Buske

    
  • ·552 Evaluation of the clinical significance of serological cross-reactivity between latex and ragweed allergens

    Page :320

    S.G. Rao, J.A. McCullough, D. Bishop, D.R. Ownby

    
  • ·553 Identification and characterization of avocado chitinase with cross-reactivity to a latex protein

    Page :321

    A. Akasawa, L. Hsieh, K. Tanaka, Y. Lin, Y. Iikura

    
  • ·554 Cross-reactivity between wheat germ agglutinin (WGA) and prohevein, a major latex allergen

    Page :321

    H. Alenius, N. Kalkkinen, K. Turjanmaa, A. Lauerma, T. Reunala, T. Palosuo

    
  • ·555 Immediate type hypersensitivity to condurango bark (CB) in patient allergic to natural rubber latex (NRL)

    Page :321

    W. Pfützner, P. Thomas, B. Przybilla

    
  • ·556 Natural rubber latex (NRL) allergy in food allergic children

    Page :321

    L. Ylitalo, K. Turjanmaa, T. Reunala

    
  • ·557 Cross-reactivity between latex and a medicinal plant: Marsdenia conduirango

    Page :322

    J.L. Justicia, M.A. Muñoz, E. Segurado, M. Barcelo, J.J. García, M. Blanca

    
  • ·558 Latex allergy in operating room nurses

    Page :322

    S. Mace, G. Sussman, D.F. Stark, R. Thompson, K. Kelly, D. Beezhold

    
  • ·559 Changes in pulmonary function after skin prick test with latex protein extracts

    Page :322

    B. Magera, K.J. Kelly, J.N. Fink, T. Sullivan, L.L. Gehring, R. Thompson, P. Havens, V. Kurup

    
  • ·560 Comparison of pharmacia CAP and whole blood leukocyte histamine release in the detection of sensitivity to latex

    Page :322

    L.M. Du Buske, A.A. Babakhin, G. Cieslewicz, H. Nolte, P. Skov, I. Zakirova, J. Boyce, K. Pearson, A.L. Sheffer

    
  • ·561 Latex allergy in office practice

    Page :323

    D.B.K. Golden, J. Matz

    
  • ·562 Latex allergy diagnosis: Standardization of a natural rubber latex (NRL) extract

    Page :323

    H. Sicard, K. Turjanmaa, T. Palosuo, H. Alenius, F. Leynadier, J.E. Autegarden, C. Andre, M. Hrabina, T.X. Tran

    
  • ·563 Latex skin and serologic testing in operating room nurses

    Page :323

    K.J. Kelly, B. Magera, V.P. Kurup, J.N. Fink, T. Sullivan, L.L. Gehring, J.Q. Xia, P. Havens, R. Thompson

    
  • ·564 Latex allergy: Comparison of IgE immune responses to latex proteins in latex-allergic patients from 7 hospitals in Europe, US and Canada

    Page :323

    T. Reunala, K. Turjanmaa, V. Kurup, J.W. Yunginger, F. Storrs, G.L. Sussman, M. Gold, T. Fuchs, D. Vervloet, T. Palosuo

    
  • ·565 IgE antibodies to 3 purified latex proteins measured by ELISA

    Page :324

    T. Palosuo, H. Alenius, N. Kalkkinen, K. Turjanmaa, S. Mäkinen-Kiljunen

    
  • ·566 Prevalence of latex sensitivity among health care workers in an allergy clinic

    Page :324

    J.R. Eades, J.J. Murray

    
  • ·567 Latex antibody in asthmatics and blood donors and latex allergens in paved road dust and airborne particles in Los Angeles

    Page :324

    B. LeBerthon, M.M. Glovsky, A. Miguel, J. Weiss, G. Cass

    
  • ·568 A questionnaire survey of latex allergy in the staff of an Australian dental school

    Page :324

    C.H. Katelaris, R.P. Widmer, R. Lazarus

    
  • ·569 Reduction in airborne latex protein exposure by use of low protein, powder-free gloves

    Page :325

    S.R. Siu, G.J. Smith, G.L. Sussman, M.C. Swanson, J. Yunginger, M.P. Cividino, S.A. Brown, D. Beezhold

    
  • ·570 In vivo and in vitro evaluation of allergenicity of natural rubber latex (NRL) gloves used in health care: A nation-wide study

    Page :325

    K. Turjanmaa, S. Mäkinen-Kiljunen, H. Alenius, T. Reunala, T. Palosuo

    
  • ·571 Characterization of latex allergens by capillary electrophoresis

    Page :325

    H.D. Chen, C.L. Chen, S.W. Huang

    
  • ·572 Electrophoretic characterization of latex allergens by two-dimensional electrophoresis

    Page :325

    A. Posch, Z. Chen, M. Raulf-Heimsoth, X. Baur

    
  • ·573 Latex allergen levels in disposable medical gloves

    Page :326

    G.L. Sussman, Bradley Pugh, D.H. Beezhold

    
  • ·574 A multicenter, longitudinal study of natural rubber latex (NRL) allergy in nursing students (NS)

    Page :326

    P. Steinberg, A.M. Pheley, C.M. O'Hara

    
  • ·575 The relationship between latex allergies, hydration and compromised barriers in surgical gloves

    Page :326

    R. Thompson, D. Korniewicz, J. Bennett, K. Kelly, P.S. Murali, V. Kurup, J. Fink

    
  • ·576 HLA immunogenetics and the specific IgE response to Hevea latex antigens

    Page :326

    H.P. Rihs, Z. Chen, R. Cremer, H. Allmers, X. Baur

    
  • ·577 Intravenous catheter hypersensitivity

    Page :327

    A. Alvarado, S.L. Abramson, H.M. Rosenblatt, M.W. Kline, W.T. Shearer

    
  • ·578 Latex hypersensitivity in emergency medical service providers

    Page :327

    G.S. Safadi, E.C. Corey, J.S. Taylor, L.C. Pien, W.O. Wagner, A.L. Melton

    
  • ·579 Latex sensitivity and latex allergy in atopic and non-atopic children

    Page :327

    C. Liebke, B. Niggemann, U. Wahn

    
  • ·580 Impact of a restrictive latex glove policy on identification of latex allergic health care workers at a tertiary care hospital

    Page :327

    J.L. Cohn, A. McTier, P. Pesaros, M. Crook, R.R. Woodard, J.D. Band, C.B. Lauter

    
  • ·581 Specific IgE response in mice immunized with a recombinant latex protein

    Page :328

    R.J. Cahaly, L.C. Granady, J.E. Slater

    
  • ·582 Identification of unique antigenic fractions of soy and peanut

    Page :328

    P.A. Eigenmann, A.W. Burks, G.A. Bannon, H.A. Sampson

    
  • ·583 Antihistamine prophylaxis for low grade exposure in severe peanut anaphylaxis

    Page :328

    W.A. Spiegel, R. Anolik, M.A. Posner

    
  • ·584 PBMC proliferative and cytokine responses to peanut

    Page :328

    J.O.'B. Hourihane, M.C.A. Clarke, J.O. Warner, T.P. Dean

    
  • ·585 Peanut anaphylaxis: An allergist-immunologist's personal experience with food cross-contamination

    Page :329

    S.F. Kemp, R.F. Lockey

    
  • ·586 A sandwich enzyme-linked immunosorbent assay (ELISA) for the quantitation of peanut in foods

    Page :329

    S.L. Taylor, J.A. Nordlee, S.L. Hefle

    
  • ·587 Amino acid sequence analysis and cloning of the major peanut allergen, Ara h II

    Page :329

    J.S. Stanley, A.W. Burks, G. Cockrell, R.M. Helm, G.A. Bannon

    
  • ·588 IgE-binding epitopes on Ara h I, a legume vicilin protein and a major peanut allergen

    Page :329

    A.W. Burks, J.S. Stanley, G. Cockrell, T. Blake, R.M. Helm, G.A. Bannon

    
  • ·589 Characterization of the major peanut allergen Ara h 1 on protein level

    Page :330

    W.-M. Becker, L. Buschmann, M. Schlaak

    
  • ·590 Peanut allergen Ara h I: Identifying the clinically relevant epitopes

    Page :330

    G.A. Bannon, J.S. Stanley, G. Cockrell, R.M. Helm, H.A. Sampson, A.W. Burks

    
  • ·591 Two-dimensional SDS-polyacrylamide (SDS-PAGE) gel analysis of a 14 kD peanut allergen

    Page :330

    E. Vanness, B. Paradeis, S. Hefle, R.K. Bush

    
  • ·592 Anaphylaxis to casein in an adult patient

    Page :330

    M.T. Guinnepain, H. Bernard, E. Bloch-Morot, J. Laurent, B. David, G. Peltre, J.M. Wal

    
  • ·593 Evaluation of cow's milk formula allergenicity and tolerogenicity by intestinal mast cell protease release in the rat model

    Page :331

    R. Fritsché, C. Schwarz, C. Martin

    
  • ·594 Release of inflammatory mediators after cow's milk intake in a new born with idiopathic pulmonary hemosiderosis (IPH)

    Page :331

    M.J. Torres, M. Blanca, M. Girón, J.L. Corzo, F. Rodriguez, F. Moreno, E. Perez, A. Martinez-Valverde

    
  • ·595 Allergenic properties of ovomucoid, the dominant egg protein

    Page :331

    S.K. Cooke, J.J. Rowe, P.A. Eigenmann, S.K. Huang, H.A. Sampson

    
  • ·596 Wheat alpha amylase inhibitor, a 15 Kd protein, is an allergen in wheat-allergic patients

    Page :331

    J.P. Sixbey, J.M. James, R.M. Helm, G.A. Bannon, A.W. Burks

    
  • ·597 An indirect enzyme-linked immunosorbent assay (ELISA) for the quantitation of whey in foods

    Page :332

    S.L. Hefle, K. Shimakura, S.L. Taylor

    
  • ·598 Breast milk fatty acid composition following maternal exclusion diet

    Page :332

    A.N. Hunt, C. Pollard, J.O.'B. Hourihane, S. Bevin, S.A. Little, J.O. Warner, T.P. Dean

    
  • ·599 IgE response to bovine colostral IgG and to their F(ab)′2 fragments in milk allergic patients

    Page :332

    D. Vercaigne-Marko, J.M. Wal, C. Lefranc-Millot, A. Lepretre, G. Peltre, P. Dhulster, D. Guillochon

    
  • ·600 Effect of bioactive plant compounds on the small intestine transmucosal passage of milk allergens in normal and sensitized rat

    Page :332

    J.M. Wal, J. Gee, H. Atkinson, F. Grigoriadou, G.M. Wortley, M.V. Wijnands, A.H. Penninks, K. Miller, I.T. Johnson

    
  • ·601 TNFα secretion in cow's milk allergy with intestinal or skin symptoms

    Page :333

    M. Heyman, N. Benloumes, J.F. Desjeux, C. Candalh, M.A. Blaton, N. Darmon, C. Dupont

    
  • ·602 Effect of lactoferrin on GM-CSF release from human nasal polyp cells

    Page :333

    C. Vergnes, B. Lebel, J. Bousquet, A.M. Campbell

    
  • ·603 Cross-reactivity of Pen a 1, the major shrimp allergen and mouse tropomyosin?

    Page :333

    G. Reese, B.-J. Jeoung, C.B. Daul, S.B. Lehrer

    
  • ·604 A monoclonal antibody-based sandwich ELISA to quantify the major shrimp allergen Pen a 1

    Page :333

    B.-J. Jeoung, G. Reese, C.B. Daul, S.B. Lehrer

    
  • ·605 Monospefici allergy to swordfish

    Page :334

    J.M. Kelso, R.T. Jones, J.W. Yunginger

    
  • ·606 Asthma after consumption of snails in housedust mite allergic patients: a case of IgE crossreactivity

    Page :334

    R. van Ree, J.H. Akkerdaas, G.B. Pajno, L. Corbetta, G. Ferro, M. Zambito, M.S. Garritani, F. Bonifazi, R.C. Aalberse, L. Antonicelli

    
  • ·607 Eggplant anaphylaxis: Isolation of the major allergens and demonstration of cross-reactivity with other solanaceae

    Page :334

    R. Muthiah, A. Zondlo, J. Zondlo, S. Kagen

    
  • ·608 Peach allergy with no pollen sensitization in children

    Page :334

    M. Morais Almeida, C. Santa Marta, S. Prates, J.M. Abreu Nogueira, J.E. Rosado Pinto

    
  • ·609 Study of allergenicity of peel and pulp from Rosaceae fruits

    Page :335

    M. Fernández-Rivas, A. Martínez, M. Cuevas

    
  • ·610 IgE antibodies cross-reaction between Der p1, the major allergen of Dermatophagoides pteronyssinus and Ananain, a cysteine proteinase from Ananas comosus, the pineapple plant

    Page :335

    T. Musu, J. Rabillon, B. David, J.P. Dandeu, M.T. Guinnepain, Y. Looze

    
  • ·611 Immunological cross-reactivity of apple 18 kD allergen and constituents of common vegetables

    Page :335

    L.-S. Hsieh, B. Martin, L. Hadswiger

    
  • ·612 Allergy to chicory (Witloof)

    Page :335

    A. Helbling, A. Reimers, M. Wälti, R. Borgts

    
  • ·613 Wine histamine content does not influence the tolerance of wine in normal subjects

    Page :336

    G. Kanny, Th. Bauza, S. Frémont, M. Dauça, G. Grignon, J.C. Cabanis, J.P. Nicolas, D.A. Moneret-Vautrin

    
  • ·614 Food allergy in human immunodeficiency virus (HIV) infection

    Page :336

    V.T. Tubiolo, L.A. Vazzo, G.N. Beall

    
  • ·615 Is multiple food protein intolerance (MFPI) the cause of “reflux oesophagitis” in distressed infants

    Page :336

    D.J. Hill, A.C.S. Catto-Smith, D.J.S. Cameron, C.W. Chow, D.M. Francis, C.S. Hosking

    
  • ·616 Diagnostic value of ALCAT test in intolerance to food additives compared with double-blind placebo-controlled (DBPC) oral challanges

    Page :336

    L. Høj

    

• Abstract Saturday, March 16, 1996

  • ·617 The incidence and principal foods of food allergy in Korean children with asthma

    Page :337

    Kyu-Earn Kim, Byung Ju Jeoung, Ki Young Lee

    
  • ·618 The effects of oral disodium cromoglycate [DSCG] on the basic types of nasal response (NR) to food ingestion challenge (FICH) and accompanying cellular changes in nasal secretions (NS)

    Page :337

    I. Knottnerus, D.M.V. Pelikan, Z. Pelikan

    
  • ·619 Screening of soybean germplasm for binding to IgE by immunoelectroblotting

    Page :337

    J.A. Nordlee, S.L. Taylor

    
  • ·620 Immunoblot analysis of salivary gland antigens in 10 mosquito species

    Page :337

    H. Li, F.E.R. Simons, Z. Peng

    
  • ·621 IgE and IgG4 saliva-specific antibodies in mosquito hypersensitive patients from Finland, Canada and USA

    Page :338

    K. Palosuo, Z. Peng, F.E.R. Simons, R.J.M. Engler, T. Reunala, H. Brummer-Korvenkontio

    
  • ·622 Routine testing of mosquito bite allergic patients

    Page :338

    G. Greinecker, W. Hemmer, M. Focke, M. Götz, R. Jarisch

    
  • ·623 Anaphylactic shock to tick (Ixodes Ricinus)

    Page :338

    D.A. Moneret-Vautrin, E. Beaudouin, G. Kanny, J.F. Roche, L. Guérin

    
  • ·624 Rush venom immunotheraphy in patient with previous anaphylaxis during venom immunotherapy

    Page :338

    D.A. Fischer, K.B. Payton, J.R.K. Butchey

    
  • ·625 Prevalence of systemic adverse reactions to hymenoptera sting in a general population in Uruguay

    Page :339

    J.C. Baluga, W. Fierro, J.F. Schuhl

    
  • ·626 Compartment syndrome: An unusual manifestation of hymenoptera hypersensitivity

    Page :339

    F.G. Peralta, H.B. Richerson

    
  • ·627 Neutralization of Africanized bee venom by antitoxic antibodies

    Page :339

    M.J. Schumacher, N.B. Egen, D. Tanner

    
  • ·628 Development of a specific instrument to measure Health Related Quality of Life (HRQL) in hymenoptera allergic patients

    Page :339

    J.N.G. Oude Elberink, A.E.J. Dubois, G.H. Guyatt, J.G.R. de Monchy

    
  • ·629 Cross reactivity between bee and snake venoms

    Page :340

    R.J. Rodriguez, J. Hershey, L.J. Smith, J. Vick, R.G. Hamilton, R.J.M. Engler

    
  • ·630 Fire ant induced skin tissue loss and infection in a nine month old child

    Page :340

    R.L. Swank, R.F. Lockey, L.S. Hernandez, J.P. Coughlin

    
  • ·631 Enzymatic, antigenic and physico-chemical properties of recombinant hyaluronidase

    Page :340

    L.N. Soldatova, R. Crameri, G. Kreil, D.M. Kemeny, U.R. Müller

    
  • ·632 Skin-tests (ST) and histamine-release (HR) assays using histamine-free venom extracts: a one-year follow-up in ten patients with wasp venom immunotherapy

    Page :340

    D.A. Vuitton, J.M. Didier, B. Adessi, R. Gibey, R. Laurent, J.P. Kantelip

    
  • ·633 Adverse reaction to porcine heparin

    Page :341

    V.M. Bommanna, R. Polasani, M. Ballow

    
  • ·634 Increased prevalence of angiotensin-converting enzyme inhibitor (ACE-I) drug induced angioedema in cardiac transplant and renal transplant patients (pts)

    Page :341

    J.A. Anderson, J.M. Abbosh, A.B. Levine, W.L. Kupin

    
  • ·635 Continued treatment with flourouracil for colon cancer despite severe phototoxic dermatitis

    Page :341

    D.B. Moyer

    
  • ·636 Creatine phosphokinase elevation secondary to metered dose inhaler Albuterol therapy

    Page :341

    T.J. Craig, R.F. Singh, W.H. Baker

    
  • ·637 Atrial fibrillation induced by an interaction of salmeterol (S), albuterol & clarithromycin (C)

    Page :342

    R.M. Young, S. Kosuri, D. Silbert, E. Jonas, E. Meadow

    
  • ·638 Antihistamines and risk of cardiac events

    Page :342

    J. Verspeelt, W. Amery, J. Jones, J. Staffa, C.B. Gable

    
  • ·639 Effect of non-sedating vs sedating antihistamine therapy in the elderly

    Page :342

    D.L. McNeil, Pam Detillio

    
  • ·640 A randomized, placebo-controlled study to evaluate the electrocardiographic effects of cetirizine in children aged 6 to 11

    Page :342

    J. Winder, M.J. Noonan

    
  • ·641 Astemizole is not carcinogenic in mice and rats

    Page :343

    J. Benze, L. Gypen, A. Lampo, J. Vandenberghe, R. De Coster, C. Bowden, H. Van Cauteren

    
  • ·642 Necrotizing cutaneous lesions as a complication of subcutaenous interferon beta-1b

    Page :343

    P. Benincasa, L. Bielory

    
  • ·643 Food additives as a cause for bullous drug eruption

    Page :343

    I. Traenckner, A. Langrock, W. Weyers, W.B. Schill

    
  • ·644 Vancomycin-induced Stevens-Johnson syndrome

    Page :343

    I.I. Alexander, P.A. Greenberger

    
  • ·645 Allergic reactions during general anesthesia (GA)

    Page :344

    S.R. Knowles, E. Weber, N.H. Shear

    
  • ·646 Anaphylaxis to mivacurium in a 65 year old female

    Page :344

    R.T. Hatch, T.R. Holman

    
  • ·647 The diagnosis of anaphylactic reactions to muscle relaxants by flow cytometry

    Page :344

    F. Leynadier, B. Rajoely, E. Ghazouani, H. Firat, C. Pecquet, N. Abuaf

    
  • ·648 Histamine and sulfidoleukotriene (SL) release from peripheral blood leukocytes (PBL) of patients with anapylactoid reactions provoked by acetylsalicylic acid (ASA)

    Page :344

    B. Brunner, B. Eberlein-König, B. Przybilla

    
  • ·649 Challenge with nimesulide, a new NSAID, in patients with reactions to aspirin and other NSAIDS

    Page :345

    M. Bernstein, C. Rodriguez

    
  • ·650 Copolymer-1 (Copaxone®) induces in non-immunologic activation of connective tissue type mast cells

    Page :345

    M. Shalit, Z. Meiner, F. Levi-Schaffer

    
  • ·651 Interferon beta-1b (IFβ) hypersensitivity and desensitization

    Page :345

    M.C. Young, J. Otis

    
  • ·652 Acute IgE-mediated generalized urticaria-angioedema after topical application of povidone-iodine

    Page :345

    M.P. López Sáez, A. Prieto, S. Olalde, L. Armentia, M.L. Baeza, A. Montoro, M. Barrio de

    
  • ·653 Allergic reactions to methyl prednisolone hemisuccinate: One case

    Page :346

    M. Murrieta-Aggutes, C. Duarte-Risselin, F. Leynadier

    
  • ·654 Positive intracutaneous and oral provocation test in a child with an anaphylactoid reaction to paracetamol

    Page :346

    D. Vieluf, I. Vieluf, K. Brockow, D. Abeck

    
  • ·655 Murine model of sulfamethoxazole-protein substitution

    Page :346

    R.D. Pesenko, R.S. Gruchalla

    
  • ·656 Sulfamethoxazole-specific antibodies in patients with AIDS: a prospective study

    Page :346

    Claire Coeshott, Cheryl Cook, Christie Ohnemus, William Burman, Patty Caraway, David Cohn, Catherine McCall

    
  • ·657 Oral desensitization to trimethoprim sulfamethoxazole in patients with HIV

    Page :347

    M.F. Lee-Wong, D. Resnick, M. Waldron

    
  • ·658 Antibiotic allergy in HIV-infected children

    Page :347

    S.J. Schuval, V.R. Bonagura

    
  • ·659 Can oral penicillin challenge replace minor determinant skin testing?

    Page :347

    J.M. DeMasi

    
  • ·660 The effect of penicillin skin testing on antibiotic usage in a large HMO

    Page :347

    E.M. Macy

    
  • ·661 Immediate allergic reactions to penicillins: Relationship between drug use pattern and reaction specificity

    Page :348

    A. Romano, M. Blanca, D. Quarantino, C. Mayorga, M. Di Fonso, A. Venuti, G.B. Gasbarrini

    
  • ·662 Recurrent pustular eruption induced by amoxycillin

    Page :348

    A. Prieto, P. Lopez-Saez, S. Olalde, A. Montoro, M. Lecona, V. Zazo, M. de Barrio

    
  • ·663 Selective immediate allergic response to penicillin V

    Page :348

    M.J. Carmona, M. Blanca, F. Moreno, J. Garcia, J.M. Vega, E. Segurado, J. Justicia

    
  • ·664 IgE antibodies to the benzylpenicilloyl (BPO). Comparisson of a RAST assay with three different carriers

    Page :348

    M. Blanca, F. Moreno, J. Garcia, J.M. Vega, J. Fernandez, S. Terrados, A. Miranda, M.J. Carmona

    
  • ·665 Cefazolin specific side chain hypersensitivity

    Page :349

    E.A. Weber

    
  • ·666 Anaphylaxis in Olmsted county

    Page :349

    M.W. Yocum, M.D. Silverstein, J.S. Klein

    
  • ·667 Idiopathic anaphylaxis: Long term follow-up, cost and outlook

    Page :349

    J. Krasnick, R. Patterson, K.E. Harris

    
  • ·668 Human seminal plasma (HSP) anaphylaxis

    Page :349

    D.G. Ebo, W.J. Stevens, C.H. Bridts, L.S. De Clerck

    
  • ·669 Anaphylactic response to thiamine (Vitamin B1)

    Page :350

    M. Fernandez, M. Blanca, M. Torrecillas, C. Muños, J. Garcia

    
  • ·670 Anaphylaxis and flushing after the administration of intranasal fluticasone propionate

    Page :350

    J. Melamed, B. Stone, W. Beaucher

    
  • ·671 Exercise-induced anaphylaxis associated with apple juice ingestion

    Page :350

    R.W. Hickey, M. Ballow

    
  • ·672 Risk factors (RF) of systemic reactions (SR) to immunotherapy (IT)

    Page :350

    M.T. Nguyen

    

• Abstract Monday, March 18, 1996

  • ·673 A case study of an allpyral prolonged anaphylactic reaction

    Page :351

    A.E. Livingston, J.A. Ford, G.B. Hamlin

    
  • ·674 Anaphylaxis in the allergy office

    Page :351

    D.B.K. Golden, H.J. Schwartz

    
  • ·675 IgE mediated urticaria to tetanus toxoid antigen

    Page :351

    M.A. Muñoz, E. Segurado, J.L. Justicia, C. Mayorga, M.J. Carmona, J. Garcia, M. Blanca

    
  • ·676 Latent period of tryptase serum peak levels in allergic drug reactions

    Page :351

    E. Ordoqui, A. Aranzábal, J.M. Zubeldia, M. de Barrio, M.P. López-Sáez, A. Prieto, V.M. Rodríguez, M.L. Baeza

    
  • ·677 Community-based education of anaphylaxis

    Page :352

    M.S. Dubravec, N. Battafarano, H. Spaulding

    
  • ·678 Effect of 6h exposure to 50ppb ozone (O₃) on release of IL-8 and RANTES from nasal epithelial cells (NEC) from atopic rhinitics and the influence of fluticasone propionate (FP), in vitro

    Page :352

    M.A. Calderón, J.L. Devalia, A.J. Prior, R.J. Davies

    
  • ·679 Increased levels of IL-13 and MCP-1 in nasal secretions following allergen challenge

    Page :352

    L.M. Reece, R. Alam, T.C. Sim

    
  • ·680 Comparison of environmental challenge to cat with bronchial and nasal allergen challenge

    Page :352

    S.H. Sicherer, R.A. Wood, P.A. Eggleston

    
  • ·681 The influence of loratadine (LO) on bronchial histamine challenge, early (EAR) and late (LAR) asthmatic reactions and the development of bronchial reactivity after single allergen challenge

    Page :353

    G. Cieslewicz, I. Grzelewska-Rzymowska, L.M. DuBuske, K. Gondorowicz, B. Wojciechowska, J. Rozniecki, M. Krol, G. Juszczyk

    
  • ·682 Effect of ICAM-1 blockade on inflammation and airway dysfunction during acute sendai viral illness in rats

    Page :353

    R. Sorkness, H. Mehta, M. Kaplan, S. Hefle, S. Haase, M. Miyasaka, R.F. Lemanske

    
  • ·683 Detection of Rhinovirus 16 (RV16) RNA in the lower airway of experimentally-infected subjects

    Page :353

    J.E. Gern, D.M. Galagan, N.N. Jarjour, E.A.B. Kelly, W.W. Busse

    
  • ·684 Rhinovirus infection increases ICAM-1 expression in pulmonary epithelium

    Page :353

    A. Papi, S.L. Johnston

    
  • ·685 Effect of inhaled mometasone furoate on inflammatory cell influx and cytokine levels in the lungs of allergic mice

    Page :354

    R.W. Chapman, S.A. Sehring, C.G. Garlisi, A. Falcone, T.T. Kung, D. Stelts, M. Minnicozzi, H. Jones, S.P. Umland, W. Kreutner

    
  • ·686 Serum osteocalcin (SO) and procollagen (PICP) as markers for osteoporotic fracture risk in steroid dependent asthmatics

    Page :354

    J.H. Toogood, L.J. Fraher, S. Cheng, J. Baskerville

    
  • ·687 Misoprostol, a PGE1 analog, improves the physiologic and inflammatory changes of nocturnal asthma

    Page :354

    D.C. Feldsien, S.I. Sloan, S.E. Wenzel

    
  • ·688 Intravenous immune globulin (IVIG) enhances glucocorticoid (GC) sensitivity

    Page :354

    J.D. Spahn, S.J. Szefler, S.R. Nimmagadda, E.W. Gelfand, D.Y.M. Leung

    
  • ·689 Pathological markers of airway inflammation in childhood asthma

    Page :355

    I.B. Resnick, A.J. Shcherbina, G.I. Kovalev, J.V. Kulak, V. Naszimov, A. Mysin, A.P. Prodeus, A.A. Bologov

    
  • ·690 Immunocytochemical study of inflammation in airways of surgically resected lungs from asthmatic and non-asthmatic subjects

    Page :355

    Q.A. Hamid, S. Ying Lee, E. Minshall, M. Elliott, J.C. Hogg

    
  • ·691 Comparison of two methods of obtaining induced sputum (IS) samples in asthmatic subjects

    Page :355

    N.H. Gershman, J.T. Liu, H.H. Wong, M.J. Mahlmeister, J.V. Fahy

    
  • ·692 The safety of asthma and allergy medications during pregnancy

    Page :355

    M. Schatz, R. Zeiger, K. Harden, C. Hoffman, D. Petitti

    
  • ·693 Variability in asthma claims by geographic regions

    Page :356

    D.A. Stempel, A.M. Carlson, D.A. Buchner

    
  • ·694 Cord blood IgE concentrations predict methacholine and skin test responses in six year old children

    Page :356

    D.R. Ownby, C.C. Johnson, E.L. Peterson

    
  • ·695 Refining factors which predict the complex trait asthma

    Page :356

    L. Freidhoff, K. Barnes, N. Maestri, P. Ferbert-Harris, A. Togias, R. Rosenthal, F. Malveaux, D. Marsh

    
  • ·696 Predictive value of skin tests and RASTs in the diagnosis of cat allergy

    Page :356

    Robert A. Wood, Elizabeth Flanagan, Peyton A. Eggleston

    
  • ·697 Fluticasone propionate 50MCG BID and 100MCG BID improves functional status and decreases sleep disturbances in children with asthma

    Page :357

    P. Mahajan, L. Okamoto, T. Bosh, D. Kellerman, K. Baker, E. Bronsky

    
  • ·698 The crystal structure of human Charcot-Leyden crystal protein, eosinophil lysophospholipase, identifies it as a new member of the carbohydrate binding family of animal galectins

    Page :357

    S.J. Ackerman, D.D. Leonidas, B.L. Elbert, Z.-O. Zhou, H. Leffler, K.R. Acharya

    
  • ·699 Apoptosis of neutrophils (Neu) and eosinophils (Eos) and their ingestion by macrophages is associated with the resolution of allergen-induced cutaneous late phase response (LPR)

    Page :357

    A.B. Kay, Q. Meng, L. Taborda-Barata, Sun Ying

    
  • ·700 Eosinophils express and produce IL-4, IL-8, and IL-10 — Evidence for stored and newly synthesized cytokine

    Page :357

    H. Nakajima, G.J. Gleich, H. Kita

    
  • ·701 Expression of high affinity IgE receptors (FcεRI) on peripheral blood basophils, monocytes and eosinophils in atopic subjects

    Page :358

    O.M. Kon, B.S. Sihra, J.A. Grant, A.B. Kay

    
  • ·702 The effect of treatment with a monoclonal antibody directed against IgE on allergic airway responses in asthmatic subjects

    Page :358

    J.V. Fahy, H.E. Fleming, H.H. Wong, J.T. Liu, J.O. Su, J. Reimann, R.B. Fick, H.A. Boushey

    
  • ·703 Human recombinant IgE-dependent histamine releasing factor (HrHRF) enhances IL-4 secretion by human basophils

    Page :358

    J.T. Schroeder, L.M. Lichtenstein, A. Kagey-Sobotka, S.M. MacDonald

    
  • ·704 Interleukin-13 production by human basophils

    Page :358

    T.C. Sim, H. Li, L.M. Reece, R. Alam

    
  • ·705 Cytokine production by highly-purified human cultured basophils

    Page :359

    H. Tachimoto, M. Ebisawa, M. Kimata, K. Fukagawa, K. Matsumoto, H. Saito, Y. Yanagihara, Y. Iikura

    
  • ·706 Cultured human mast cells are capable of producing multiple cytokines and chemokines

    Page :359

    M. Ebisawa, H. Tachimoto, H. Saito, Y. Iikura

    
  • ·707 Activated human lung fragments and human mast cells synthesize IL-13

    Page :359

    J.S. Jaffe, Y. Wang, T.J. Post, M.C. Glaum, D.G. Raible, J.G. Mohanty, J.H. Butterfield, D.M. Lang, E.S. Schulman

    
  • ·708 IL-5 secretion by allergen-specific CD4+ cells in short-term culture: dissociation from allergen-induced proliferation and dependence on B7-2 co-stimulation

    Page :359

    J. Bungre, S.J. Till, M. Larché, M. Humbert, D. Robinson, D. Huston, R. Dickason, A.B. Kay, C. Corrigan

    
  • ·709 Creation of a functional IL-5 monomer targets a single helical bundle for the development of therapeutic analogues

    Page :360

    R.R. Dickason, D.P. Huston

    
  • ·710 IL-4-Induced immunoglobulin class switching involves protein tyrosine phosphatase activity

    Page :360

    F. Imani, K.J. Rager, D.G. Marsh

    
  • ·711 Prostaglandin E₂(PGE₂) causes inhibition of CD40 ligand (CD40L) expression on activated human T-cells which is reversible with IL-2 or IL-4

    Page :360

    A.A. Horner, L.G. Beck, H. Spiegelberg

    
  • ·712 Transcriptional regulation of the human IL-4 gene in asthma

    Page :360

    H. Inamura, D. Klemm, J. Dresback, L.J. Rosenwasser

    
  • ·713 Transcriptional correlations of cytokine gene promoter polymorphisms in asthma

    Page :361

    J. Dresback, D. Klemm, H. Inamura, J. Mascali, L. Borish, L.J. Rosenwasser

    
  • ·714 Contribution of interleukin (IL)-10 promoter polymorphism to allergic inflammation

    Page :361

    K. Hobbs, J. Mascali, D. Klemm, L. Borish

    
  • ·715 NF-κB as a mediator of differential gene expression in T helper cell subsets

    Page :361

    V. Casolaro, S.N. Georas, J.Y. Chiu, Z. Song, D. Thanos, L.M. Lichtenstein, S.J. Ono

    
  • ·716 Alterations in glucocorticoid(GC) receptor(R) binding to DNA contributes to steroid resistant (SR) asthma

    Page :361

    D.J. Klemm, W. Surs, J.D. Spahn, S.J. Szefler, D.Y.M. Leung

    
  • ·717 Inhibition of specific IgE antibody formation by naked plasmid DNA immunization

    Page :362

    E. Raz, H. Tighe, Y. Sato, M. Roman, S. Swain, D. Carson, H. Spiegelberg

    
  • ·718 Protamine hypersensitivity complicating desensitization to insulin

    Page :362

    M.E. Bollinger, R.A. Wood

    
  • ·719 In vitro demonstration of IgE to folate-albumin in anaphylaxis from folate

    Page :362

    W. Sun, N.A. Orfan, M.S. Dykewicz

    
  • ·720 Vancomycin anaphylaxis associated with IgE and IgG antibodies

    Page :362

    M.H. Goldman, R.G. Hamilton, C. Stellato, A. Kagey-Sobotka, N.F. Adkinson

    
  • ·721 Anaphylaxis after ingestion of wheat flour contaminated with dust mites

    Page :363

    C. Blanco, T. Carrillo, R. Castillo, J. Quiralte, J. Delgado

    
  • ·722 Postmortem diagnosis of an anaphylactoid reaction due to non-ionic radiocontrast media by serum tryptase analysis: A case report

    Page :363

    K. Brockow, D. Vieluf, J. Ring

    
  • ·723 α- and β-tryptase levels in near-miss sudden infant death syndrome (SIDS) patients

    Page :363

    A.D. Hogan, M.A. Dolan, C.K. Abernathy, A.M. Irani, L.B. Schwartz

    
  • ·724 Use of nimesulide in aspirin sensitive patients: A long term evaluation

    Page :363

    L. Andri, G.E. Senna, G. Andri, A.R. Dama

    

• Abstract Tuesday, March 19, 1996

  • ·725 Assessment of human seminal plasma hypersensitivity prevalence in North America using a validated questionnaire

    Page :364

    J.A. Bernstein, R. Sugumaran, D.I. Bernstein, I.L. Bernstein

    
  • ·726 IgE-mediated systemic reactions to gelatin included in vaccines

    Page :364

    S. Inouye, M. Sakaguchi, H. Ogura

    
  • ·727 Correlation of skin bite reactions and serum mosquito-specific IgE among three mosquito species with world-wide distribution

    Page :364

    Z. Peng, J. Yang, F.E.R. Simons

    
  • ·728 Cutaneous responses to VIP and SOM in healthy adults(HA), delayed pressure(DPU) and chronic idiopathic(CIU) urticaria: The effect of cetirizine and dimethindene

    Page :364

    R. Borici-Mazi, S. Kouridakis, K. Kontou-Fili

    
  • ·729 Hypodermic epinephrine (EPI) spray and uvular angioedema revisited

    Page :365

    H. Bateman, S. Peltz, R. Reyes, J. Oppenheimer, L. Bielory

    
  • ·730 Hydroxychloroquine (HCQ) in corticosteroid-dependent chronic urticaria (CDCU)

    Page :365

    J.K. Lammert, D.M. Robinson

    
  • ·731 Predictive relationship between the severity of cold urticaria and the area of the ice-cube test

    Page :365

    P. Mathelier-Fusade, N. Abbas, M.H. Chabane, F. Leynadier

    
  • ·732 Autologous serum skin testing of patients with CIU can produce a cutaneous late phase response

    Page :365

    R. Joks, S.A. McClain, A.S. Josephson

    
  • ·733 Angiodema—Unusual causes

    Page :366

    A. Varner, A. Kumar, R. Bush

    
  • ·734 Urticarial-like skin eruption as a prodrome to attacks of hereditary angiodema (HAE)

    Page :366

    D.N. Ruddell, C.T. Stafford

    
  • ·735 Chronic idiopathic urticaria associated with hypogammaglobulinemia

    Page :366

    K.R. Lee, R.J. Warrington

    
  • ·736 Investigation of chronic urticaria with autoimmune thyroid disease and RBL cell degranulation

    Page :366

    A. Finn, G. Balakrishan, S. Reddigari, A.P. Kaplan

    
  • ·737 Case report: Control of angioedema with danazol in a patient with normal C-1 esterase inhibitor levels

    Page :367

    R. Harris

    
  • ·738 Reversal of acquired C1 esterase inhibitor (C1 INH) deficiency with splenic irradiation

    Page :367

    G.B. Carpenter, T.A. Waytes

    
  • ·739 De-novo angioedema due to C₁-inhibitor deficiency

    Page :367

    D. Charpin, J. Birnbaum, J. Laurent, D. Vervloet, M. Tosi

    
  • ·740 Characterization of naturally occuring pseudoallergens causing chronic urticaria

    Page :367

    C. Pfrommer, R. Bastl, S. Vieths, I. Ehlers, B.M. Henz, T. Zuberbier

    
  • ·741 Dimephosphon in treatment of chronic urticaria

    Page :368

    V.N. Tsybulkina

    
  • ·742 Soluble HLA class I (sHLA-I) and food sensitivity in children with moderate to severe atopic dermatitis

    Page :368

    C. Moore, M. Ehlayel, J. Inostroza, P. Muñoz, L. Leiva, J. Hughes, R.U. Sorensen

    
  • ·743 Lymphocyte transformation test (LTT) with ovalbumine (OV) and house dust mite (HDM) in children with eczema

    Page :368

    H.P. Van Bever, I. Vereecke, C.M. De Gendt, C.H. Bridts, L.S. De Clerck, W.S. Stevens

    
  • ·744 Red cell fatty acid composition in atopic dermatitis and asthma

    Page :368

    J.F. Máspero, A. Yáñez, M. Kohan, S. Catz, P. Setton, M. Fernández, C. D'Antuono, M. Speziale

    
  • ·745 Skin reactivity to and in patients with atopic dermatitis in Puerto Rico

    Page :369

    F. Montealegre, C. Quiñones, W. Léon, K. Goth, J. Villa, M. García

    
  • ·746 The incidence of atopy in psoriasis

    Page :369

    H.B. Freye, C. Litwin

    
  • ·747 Human IgE response to scabies

    Page :369

    M.S. Morgan, L.G. Arlian, S.A. Estes

    
  • ·748 Topical application of a platelet activating factor (PAF-) antagonist in atopic eczema

    Page :369

    T. Schmidt, D. Abeck, E. Grosshans, S. Jablonska, K. Kragballe, A. Valquist, P. Dupuy, J. Ring

    
  • ·749 Lack of type I sensitization to laundry enzymes among consumers in the Philippines

    Page :370

    K. Sarlo, E. Cormier, D. MacKenzie, L. Scott

    
  • ·750 Evaluation of sensitization to laundry enzymes among consumers in the Philippines: Results of a six month clinical study

    Page :370

    E. Cormier, K. Sarlo, D. MacKenzie, L. Scott

    
  • ·751 Patch testing with unprocessed pollen of gramineae in patients with atopic eczema

    Page :370

    U. Darsow, H. Behrendt, J. Ring

    
  • ·752 Disturbance of epidermal barrier function in atopy patch test reactions in patients with atopic eczema

    Page :370

    M. Gfesser, J. Rakoski, J. Ring

    
  • ·753 Post-marketing survey results for TRUE test™, a new allergen patch test

    Page :371

    J.C. Prue

    
  • ·754 Group allergy to tri- and ortho-diphenols in a patient sensitized by propyl gallate

    Page :371

    W. Hemmer, M. Focke, R. Bracun, S. Wolf, F. Wantke, M. Götz, R. Jarisch

    
  • ·755 Contact dermatitis from budesonide nasal spray

    Page :371

    R.K. Jorgensen, C.E. Reed, G.J. Gleich, C. Wilson, A.L. Schroeter

    
  • ·756 Evaluation of cutaneous hypersensity to aluminium by routine patch testing with AlCl₃

    Page :371

    R. Jarisch, W. Hemmer, F. Wantke, M. Focke, M. Götz

    
  • ·757 Contact allergy to Euxyl K400®

    Page :372

    S. Wolf-Abdolvahab, R. Bracun, W. Hemmer, M. Focke, F. Wantke, M. Götz, R. Jarisch

    
  • ·758 Contact dermatitis to jojoba oil and myristal lactate/maleated soybean oil

    Page :372

    C. Botzi, F. Wantke, W. Hemmer, M. Focke, M. Götz, R. Jarisch

    
  • ·759 Occupational contact allergy to herbicide aminotrazol

    Page :372

    A. Rodríguez, M.J. Alvarez, S. Echechipía, A. Sanchez-Palacios, J.L. Sada

    
  • ·760 Comparison of the bifurcated needle with the dermaPIK® and duotip® for allergy skin testing

    Page :372

    W.T. Corder, N.W. Wilson

    
  • ·761 H₁-receptor antagonists: Systemic absorption and peripheral H₁-blockade following administration in topical liposome formulations

    Page :373

    K.J. Simons, S. Venkataram, Y. Zheng, F.E.R. Simons

    
  • ·762 Effect of cetirizine on the inflammatory cells in cutaneous mosquito-bite reactions

    Page :373

    A. Karppinen, I. Rantala, A. Vaalasti, B. Burtin, H. Brummer-Korvenkontio, T. Reunala

    
  • ·763 A double-masked study on the need for adjunctive steroid treatment in vernal keratoconjunctivitis patients treated with alomide 0.1% ophthalmic solution or Opticrom 2%

    Page :373

    L. Tomazzoli, L. Scullica, C. Cespedes, M. Iruzubieta, R. Sans, A. Secchi

    
  • ·764 A simplified method for human conjunctival allergen challenge

    Page :373

    M.H. Friedlaender, A. Martien, S. Friedlaender

    
  • ·765 Alomide 0.1% versus sodium cromoglycate 2% and 4% in patients with giant papillary conjunctivitis

    Page :374

    R.H. Stewart, J.P. McCulle, C.S. Ostrov, D.R. Caldwell

    
  • ·766 Should sesquiterpene lactone sensitive patients avoid consuming SL containing vegetables?

    Page :374

    S.B. Tjiook, R. de Haas, H.D. Oei

    
  • ·767 Trisomies 9 and 8 detected by fluorescence in situ hybridisation in patients with systemic mastocytosis

    Page :374

    R. Confino-Cohen, M. Lishner, A. Goldberg, M. Feigin, A. Amiel, Y.A. Mekori

    
  • ·768 Cloning and sequencing of the cDNA encoding the Pityrosporum orbiculare 37 kDa major allergen

    Page :374

    L. Lindblom, M. Schmidt, U. Hellman, A. Zargari, I. van der Ploeg, B. Härfast, A. Sheynius

    
  • ·769 Murine skin mast cells release histamine after stimulation with vanilloids In vitro

    Page :375

    M. Maurer, C. Pfrommer, R. Paus, S. Eichmüller, B.M. Henz, T. Zuberbier

    
  • ·770 Wheezing in non-hospitalized infants is neither predicted by atopic inheritance, nor does it predict atopic manifestation in the second year or life

    Page :375

    J. Forster, U. Tacke, H. Krebs, H.J. Streckert, H. Werchau, U. Wahn

    
  • ·771 Is daycare a risk factor for exacerbation of bronchial asthma (BA)

    Page :375

    D.F. German, R. Watson

    
  • ·772 Increasing trend of asthma and allergic disease in Hong Kong schoolchildren

    Page :375

    R. Leung, S.S. Ho, J. Chan, G. Wong, J. Lau, C.K.W. Lai

    
  • ·773 Factors associated with asthma in a birth cohort of children followed to six years of age

    Page :376

    C.C. Johnson, E.L. Peterson, D.R. Ownby

    
  • ·774 The impact of eczema in Seattle School Children

    Page :376

    C.K. Cook, G.J. Redding, B.H. Morray, H.M. Arrighi

    
  • ·775 Asthma deaths in Chicago

    Page :376

    T. Levenson, P.A. Greenberger, B. Lifschultz

    
  • ·776 Asthma mortality in Israel 1971–1990

    Page :376

    Y. Katz, M. Livne

    
  • ·777 Socioeconomic status (SES) and risk factors for asthma in rural appalachian children

    Page :377

    N.W. Wilson, W.T. Corder

    
  • ·778 St. Louis asthma database

    Page :377

    J.W. Knutson, L.K. Sussman, R.G. Slavin, M. Castro

    
  • ·779 Comparing the demographics of inpatients and outpatients with asthma

    Page :377

    A.J. Apter, S.T. Reisine, R.L. Zu Wallack

    
  • ·780 Asthma mortality rate and the sales amount of MDI in Japan

    Page :377

    Takehiko Matsui, Makoto Onobori, Minoru Baba

    
  • ·781 Screening of high school athletes for exercise asthma by free running test

    Page :378

    C. Randolph, C. Mattasavage, B. Fraser

    
  • ·782 Asthma and air pollution: two major grass pollen allergens bind to diesel exhaust particles (DEPs)

    Page :378

    R.B. Knox, C. Suphioglu, P. Taylor, J.L. Peng, L.A. Bursill

    
  • ·783 Correlation of asthma exacerbations and environmental factors in Middle Tennessee: The importance of mold

    Page :378

    D.R. Sandidge, J.J. Murray, R.B. Leftwich

    
  • ·784 The atopic profile of adult asthmatics admitted to hospital in Wellington, New Zealand

    Page :378

    P. Fitzharris, L. Stone, G. Sawyer, S. Tohill, S. Lewis, J. Crane, J. Miles

    
  • ·785 The effect of exposure to animal dander in school dust in children with asthma and rhinits

    Page :379

    G. Hedlin, K. Lönnkvist, I. Enander, G. Hallden, M. van Hage-Hamsten

    
  • ·786 Allergy to the Blatella germanica (Bla g) cockroach (CR): A major risk factor for asthma severity in adolescents

    Page :379

    E. Horowitz, D. Joyner, L. Guydon, F. Malveaux, A. Togias

    
  • ·787 Correlation of asthma admissions with levels of environmental pollutants, pollen and viral outbreaks

    Page :379

    E.A. Quaidoo, D.W. Pulver

    
  • ·788 Aggressive household cleaning alone is as efficient as when combined with a new acaricide in improving house dust mite allergic asthmatic children

    Page :379

    A. Bahir, A. Goldberg, R. Confino-Cohen, Y.A. Mekori

    
  • ·789 The relationship of psychological functioning of the severe asthmatic child (SAC) and family to medical costs over four years after short term residential rehabilitation (Rhb)

    Page :380

    A.G. Weinstein, J. Stapleford, D. Faust

    
  • ·790 Asthma center treatment: Prospective data

    Page :380

    P.E. Korenblat, M. Korenblat Hanin, E.B. Fisher, S.J. Gaioni

    
  • ·791 A chart review of chest x-rays in pediatric asthmatic patients

    Page :380

    J. Tuck, M. Osborne, P. Dowling

    
  • ·792 Reduction in health care resource utilization associated with theophylline

    Page :380

    R.M. Schulz, W.N. Yates

    
  • ·793 Asthma management: A survey of emergency department (ED) visits for wheezing

    Page :381

    G.A. Friday, H. Khine, M.S. Lin, L.A. Caliguiri

    
  • ·794 Intravenous terbutaline and continuous albuterol nebulization therapy: A safe combination!

    Page :381

    J.M. Becker, S. Coffey, R. Amin, C. Smolij, D.P. Goldsmith

    
  • ·795 Identification of the high risk pediatric asthma patient

    Page :381

    B.I. Oyefara, L. Taylor, J. Louie, T. Brown, N.A. Pawlowski

    
  • ·796 Telemetry of field spirometry data to assist physician treatment and triage of asthmatic patients

    Page :381

    T. Aquino, L. Bielory, B. Tortella, B. Lavery

    
  • ·797 A new model of pediatric asthma care delivery

    Page :382

    J.A. Pongracic, C.Y. Zachary, R. Evans

    
  • ·798 Management of status asthmaticus by pediatric ER and ICU training program directors

    Page :382

    B.A. Becker, J.R. Leipzig, M.S. Dykewicz

    
  • ·799 Continuous inhalation of isoproterenol (L-type) in the treatment of children with severe asthmatic attacks

    Page :382

    Y. Iikura, H. Saito, M.C.T. Capulong, N. Sakaguchi, H. Inui, T. Obata, N. Koya, H. Uchiyama, A. Sasamoto

    
  • ·800 A multiple linear regression analysis of meteorologic factors (MF) and emergency department (ED) utilization by patients with asthma (PwA) in a rural setting

    Page :382

    J. Krishna, S. Huskey, T. Camp, R.E. Peterson, V. Mamlok, D. Hubbard, R.J. Mamlok

    
  • ·801 In-vitro assessment of a new efficient nebulizer system for continuous operation

    Page :383

    W. Gutmann, M. Knoch, E. Wunderlich

    
  • ·802 T-cell receptor Vβ gene usage in BAL T-cells in health and in asthma

    Page :383

    J. Dasmahapatra, E.A. Hodges, A.E. Redington, T. Krishna, A.W. Boylston, S.T. Holgate, J.L. Smith, A.J. Frew

    
  • ·803 Monozygotic twins as a model for study in asthma

    Page :383

    M.E. Miller, G. Leikauf, J.A. Bernstein

    
  • ·804 Prospective twin study of IgE immune responses in acute otitis media (AOM)

    Page :383

    L. Fireman, M. Casselbrant, B. Angelini, P. Fireman

    
  • ·805 Efficient transfer and expression of genetic material in vivo in rat lung using Starburst™ dendrimer synthetic vectors

    Page :384

    J. Kukowska-Latallo, M. Rymaszewski, A. Bielinska, D. Tomalia, J. Baker

    
  • ·806 HLA and respiratory allergy

    Page :384

    D. Aguilar, D. Delgado, F. Vidal

    
  • ·807 Serum IgE to hen's egg is a risk factor for consecutive sensitization to aeroallergens

    Page :384

    R. Nickel, M. Kulig, J. Forster, R. Bergmann, C.P. Bauer, S. Lau, I. Guggenmoos-Holzmann, U. Wahn

    
  • ·808 The correlation of allergy history & skin test results

    Page :384

    M.G. Ostro, S. Abi-Younes, K.J. Bloch

    
  • ·809 Evaluation of the AlaTOP® allergy screen

    Page :385

    J. McCullough, S. Blocki, D. Ownby

    
  • ·810 Comparison of a multiallergen in vitro screen to skin testing in a large HMO-based allergy clinic

    Page :385

    B.J. Goldberg, T. Pham, S. Cocke, M. Kaplan, A. Staveren, P.M. Lad

    
  • ·811 Performance of a fully automated enzyme immunoassay system for the determination of allergen-specific IgE in serum

    Page :385

    T.M. Li, N. Nayak, J. Tung

    
  • ·812 Evaluation of the recombinant aspergillus fumigatus allergen 1 (rAsp f 1) in the pharmacia CAP system

    Page :385

    R. Crameri, J. Lidholm, H. Grönlund, K. Blaser, C. Ismail, G. Menz

    
  • ·813 Total IgE determinations: Comparison of results obtained by immulite and CAP system

    Page :386

    J.M. Abreu Nogueira, Virginia Loureiro, M. Morais de Almeida, J.E. Rosado Pinto

    
  • ·814 House dust mites and alternaria in allergicrhintis: Role of allergen immunotherapy

    Page :386

    Hisham Tarraf, Anissa El-Hefny, Esmat Ekaldius

    
  • ·815 Intravenous administration of a potential T cell toleragenic peptide to cat sensitive patients

    Page :386

    P.S. Norman, A.M.G. Pasatiempo, P.S. Creticos, C.F. Nicodemus, N.H. Jones, L.M. Lichtenstein, M.L. Gefter

    
  • ·816 Efficacy of dust mite allergen reduction by ePTFE-encasings and clinical response in combination with specific immunotherapy

    Page :386

    K.P. Paul, U. Klettke, U. Wahn

    
  • ·817 The cat room model for associating allergen levels with asthma symptoms and evaluating treatment effects of peptide therapy

    Page :387

    J.L. Ohman, D.V. Bennett, M.P. Happ, M.R. Settles, N.H. Jones, S. Hirani, A.A. Long

    
  • ·818 Aeroallergen avoidance in offspring of allergic patients

    Page :387

    B. Deuell, J. Frazer, A. Alblowich, G. Rakes, J.M. Ingram, M. Chang, T.A.E. PlattsMills, P. Heymann

    
  • ·819 Skin test reactivity in infants and young children

    Page :387

    M. El-Falaki, A. El-Hefny, A. El-Beleidy

    
  • ·820 House dust mite hypersensitivity in a group of asthmatic children

    Page :387

    L. Prieto, J. Sienra, B. Del Río, V. Mercado, J. Martínez

    
  • ·821 Survey of skin tests in a central FL practice

    Page :388

    G.W. Price, L.V. Bonini, A.P. Spoto, W.C. Tabb

    
  • ·822 California house dust antibodies in the sera of allergic patients in Tabuk, Saudi Arabia: Preliminary report

    Page :388

    A.O. Somorin, S.N. Al-Dusari, A.U. Zaman

    
  • ·823 Long-term oral corticotherapy does not alter skin test reactivity

    Page :388

    L. Paradis, A. Des Roches, Y.H. Bougeard, Ph. Godard, J. Bousquet, P. Chanez

    
  • ·824 False positive skin prick tests with commercially available dog dander extracts caused by contamination with house dust mite allergens

    Page :388

    M.J. van der Veen, M. Mulder, A.M. Witteman, R. van Ree, R.C. Aalberse, H.M. Jansen, J.S. van der Zee

    
  • ·825 Evaluation of the reproducibility of skin test measurements by a computer imaging technique

    Page :389

    D. Khayamy, J. Moy, R. Mariano, B. Yu

    
  • ·826 Cutaneous prick testing with duotip-test

    Page :389

    K.J. Liddle, G.G. Gilmet, J.L. Baldwin

    
  • ·827 A variation in potency of two standardized dust mite extracts

    Page :389

    J. Hill, T. Crawford, A. Howard, B.C. Kang

    
  • ·828 Deficiency of janus kinase 3 (Jak3) protein in severe combined immunodeficiency (SCID)

    Page :389

    J.L. Roberts, J.J. O'Shea, J.M. Puck, R.H. Buckley

    
  • ·829 Elevated TNF-α associated with neutropenia in combined immunodeficiency (CID)

    Page :390

    T.O. Harville, S.S. Winter, G.A. Hanissian, J.E. Gern, R.E. Ware

    
  • ·830 A 3-year-old boy with ZAP-70 deficiency, thrombocytopenia and ulcerative colitis

    Page :390

    D.E. Parry, J. Blumenthal, R.H. Tomar, S.D. Horowitz, M.E. Elder, J.E. Gern

    
  • ·831 Oral ribavirin for gastrointestinal adenovirus in severe combined immunodeficiency

    Page :390

    S.E. Miller, M.L. Tang, A.M. Garcia-Turner, J.L. Gitch, T.O. Harville

    
  • ·832 Gastroesophageal reflux and severe combined immunodeficiency

    Page :390

    A. Boeck, R.I. Schiff, R.H. Buckley

    
  • ·833 Cytokine production and IgE in Wiskott-Aldrich syndrome (WAS) patients

    Page :391

    H.G. Herrod, R.B. Raby, W.R. Valenski, S.R. Hutchinson, K.J. Nastasi, M.E. Conley

    
  • ·834 Analysis of In vitro and serum IgM production in Wiskott-Aldrich syndrome (WAS) patients

    Page :391

    K.J. Nastasi, R.B. Raby, W.R. Valenski, M.E. Conley, H.G. Herrod

    
  • ·835 Carcinoma in Wiskott-Aldrich syndrome/variant (WAS)

    Page :391

    M.B. Hogan, J. Krasnick, N.W. Wilson

    
  • ·836 Development of normal T-cell function and TCR repertoire after post-natal thymic transplantation for DiGeorge syndrome

    Page :391

    M.L. Markert, C.M. Davis, F.E. Ward, D.D. Kostyu, R.H. Buckley, S.E. Schiff, T.J. Watson, T.M. McLaughlin, L.P. Hale, B.F. Hanes

    
  • ·837 Clinical analysis of patients with DiGeorge anomaly

    Page :392

    B.S. Zeffren, N.K. Day, R.A. Good, S.J. Kornfeld

    
  • ·838 Cellular immunodeficiency with elevated IgE and a new anomaly of chromosome

    Page :392

    R.S. Kagan, V.M. Der Kaloustian, P. Eydoux, B.D. Mazer

    
  • ·839 Familial congenital CD4 T cell deficiency: A new syndrome of immune deficiency

    Page :392

    Z. Dranitzki, R. Ulmansky, F. Szafer, E. Kerem, Z. Freier, C. Brautbar, R. Rabinowitz, Y. Naparstek

    
  • ·840 Idiopathic CD4+ T-lymphocytopenia (ICL) with systemic nocardiosis and a large population of CD3+ CD4⁻CD8⁻ T cell receptor (TCR) α/β⁺ lymphocytes

    Page :392

    J. Venzor, Q. Hua, C.H. Miranda, D.P. Huston, R.B. Bressler

    
  • ·841 Hyper-IgM syndrome (HIgMs): A B-cell defect

    Page :393

    S.J. Weiss, F.-F. Zeng, V.R. Bonagura

    
  • ·842 Expression of CD 40 ligand in immunodeficiency with hyper IgM due to congenital rubella

    Page :393

    J. Beausoleil, R. Schwarz, S.J. McGeady

    
  • ·843 Disseminated in a 5-year old girl with hyper-IgM syndrom (HIMS) with exceedingly high serum IgM

    Page :393

    L. Oftadeh, M. Keller, N. Sun, D.C. Heiner, C. Oh, C. Song

    
  • ·844 Atypical presentation of ataxia-telangiectasia (AT) with features of non-X-linked hyperIgM (HIGM)

    Page :393

    L.M. Noroski, H.M. Rosenblatt, I.C. Hanson, S.L. Abramson, M.E. Paul, W.T. Shearer

    
  • ·845 Parainfluenza type 3 in a patient with hyper IGM (HIM)

    Page :394

    M.N. Nashed, A.H. Assa'ad, M.B. Lierl

    
  • ·846 Pneumocystis carinii pneumonia (PCP) as presenting infection in patients with hyper IgM syndrome

    Page :394

    B. Gonzales, A. King, L. Leiva, R.U. Sorensen

    
  • ·847 Cellular and cytokine abnormalities in common variable immunodeficiency

    Page :394

    E.N. Grant, A.L. Landay, J.N. Siegel, M.S. Kaufman, V.L. Mosiman, G.W. Richmond

    
  • ·848 Monocytes from patients with CVI provide optimal co-stimulation for cytokine secretion

    Page :394

    L. Mayer, G. Stadtmauer

    
  • ·849 Granulomatous disease in common variable immunodeficiency — Not sarcoidosis

    Page :395

    L.J. Mechanic, S. Dikman, C. Cunningham-Rundles

    
  • ·850 Absence of recurrent bacterial infections in common variable immunodeficiency (CVID): Retention of functional antibody responses despite severe panhypogammaglobulinemia

    Page :395

    M. Kalenian, A.I. Levinson

    
  • ·851 Antibody deficiency with normal immunoglobuline presenting in adult life

    Page :395

    A. Alshaar, H. Al-Assaly, S.J. McGeady

    
  • ·852 Agammaglobulinemia associated to chromosome 2 deletion

    Page :395

    J. Wheba, A. Richieri-Costa, B.T. Costa-Carvalho, M.M.S. Carneiro-Sampaio, D. Solé, C.K. Naspitz

    
  • ·853 Saldino-Mainzer-like syndrome with persistent panhypogammaglobulinemia and T cell dysfunction

    Page :396

    D. Fuentes, I.C. Hanson, S.L. Abramson, H.M Rosenblatt, W.T. Shearer

    
  • ·854 Polyarthritis responsive to methotrexate (MTX) in x-linked agammaglobulinemia (XLA)

    Page :396

    P.R. LoGalbo, N.T. Ilowhite

    
  • ·855 In vitro immunoglobulin production in patients with partial IgA deficiency (pIgAd)

    Page :396

    R.B. Raby, K.A. Barsness, S.R. Hutchinson, W.R. Valenski, R.L. Trouy, H.G. Herrod

    
  • ·856 IgG & IgA subclasses and anti-IgA antibodies in 34 IgA deficient patients

    Page :396

    M. Kirschfink, A.C. Pastorino, C.M.A. Jacob, A.S. Grumach

    
  • ·857 Prevalence of humoral immunodeficiency in the African-American and hispanic populations of East Harlem

    Page :397

    M. Lewis, M. Mujashiro, J. Hunton, L. Miller, K. Sperber

    
  • ·858 Transient hypogammaglobulinemia of infancy: Long term follow-up

    Page :397

    S.J. McGeady, J.L. Beausoleil

    
  • ·859 Severe asthma, difficult infections, and mild hypogammaglobulinemia

    Page :397

    S.R. Lane, S.J. Bigelsen

    
  • ·860 Panhypogammaglobulinemia after anticonvulsant therapy

    Page :397

    C.K. Chung, L.G. Billips, H.W. Schroeder

    
  • ·861 Characterization of an immunodeficiency manifest by severe viral skin infections, eczema, and asthma

    Page :398

    R.L. Rabin, I. Fuss, C. Prussin, J. McDyer, O. Garraud, T.B. Nutman, T.A. Fleisher, R. Seder, W. Strober, S.M. Holland

    
  • ·862 Transplacental transmission of serotype-specific pneumococcal antibodies in a Brazilian population

    Page :398

    B.T. Costa Calvalho, M.M.S. Carneiro Sampaio, D. Solé, C.K. Naspitz, L. Leiva, R.U. Sorensen

    
  • ·863 An algorithm for clinical and laboratory testing in suspected primary immunodeficiency disease in infants and children

    Page :398

    C. Cunningham-Rundles, M.A. Davis-Lorton, G. Stadmauer, L. Mayer

    
  • ·864 Immunogenicty of hemophilus influenzae type B polysaccharide vaccine for the evaluation of patients with suspected immunodeficiency

    Page :398

    R.O. Go, L.C. Schneider

    
  • ·865 Pneumococcal immunization in pateints with recurrent infections and in patients with primary immunodeficiency (ID) syndromes

    Page :399

    D. Solé, B.T. Costa Carvalho, M.M.S. Carneiro Sampaio, L. Leiva, C.K. Naspitz, R.U. Sorensen

    
  • ·866 Characterization of specific antibody responses to diphtheria/tetanus booster vaccination in pediatric patients evaluated for immune deficiency

    Page :399

    C. McCusker, W. Somerville, V. Grey, B. Mazer

    
  • ·867 Delayed type hypersensitivity (DTH) skin testing (SKT) for the evaluation of cellular immunity: Normal responses for adult men and women

    Page :399

    A. Heisser, R. DeGuzman, J. Brooks, N. Veltri, V. Carregal, L.S. Smith, G.B. Carpenter, R.J.M. Engler

    
  • ·868 Measurement of CD69 by flow cytometry is a rapid and efficient substitiute for ³H-thymidine incorporation in the assessment of mitogen or anti-CD2/Cd2R induced T cell proliferative capacity in normal individuals

    Page :399

    M. Mardiney, T.A. Fleisher

    
  • ·869 Cytokine production in the hyper-IgE syndrome

    Page :400

    L.A. Esswein, S.A. Bader, T.A. Chatila

    
  • ·870 Development of Candida endocarditis in a patient with hyper IgE syndrome (HIE)

    Page :400

    Anne B. Yates, Deepak Mehrotra, John E. Moffitt

    
  • ·871 Clinical & immunopathological aspects of hyper-IgE syndrome (HIE)

    Page :400

    M. Moin, A. Farhoudi

    
  • ·872 Thymic regrowth in a patient with chronic granulomatous disease on IFNγ

    Page :400

    L.J. Kobrynski

    
  • ·873 Trichosporon inkin pulmonary abscesses presenting as a perforating chest wall mass in a child with chronic granulomatous disease (CGD)

    Page :401

    G.J. Stadtmauer, J. Piwoz, E. Bottone, I. Weitzman, C. Cunningham-Rundels

    
  • ·874 Multifocal osteomyelitis due to Pseudomonas gladioli in a patient with autosomal recessive chronic granulomatous disease

    Page :401

    C.A. Smith, K. Sullivan, N.A. Pawlowski, J.M. Greene, T. Brown, A.G. Yip, J. Rae, J. Curnutte, S.D. Douglas

    
  • ·875 Obstructive hydrocephalus caused by basilar meningitis in a patient with chronic granulomatous disease (CGD)

    Page :401

    F.H. Zaitoun, B.B. Wray, F.E. Cox, R.E. Figueroa, M.A. Flannery

    
  • ·876 Differential expression of CD18/Cd11a/b/c on lymphocytes and neutrophils in leukocyte adhesion deficiency type-1 (LAD-1)

    Page :401

    C.M. Watkins, T.O. Harville, S.E. Schiff, R.I. Schiff

    
  • ·877 Complement deficiencies in patients affected by meningitis caused by N. meningitidis

    Page :402

    A.S. Grumach, A. Campeas, C.L. Diogo, M.C. Raymundo, L.C. Oliveira, M.S.S. Carneiro, M. Kirschfink

    
  • ·878 A novel familial C2 abnormality

    Page :402

    J.S. Seggev, P. Giclas

    
  • ·879 Properdin deficiency: Rare presentation with meningococcal osteomyelitis and arthritis

    Page :402

    M. Rottem, E. Shiloach, M. Schlezinger

    
  • ·880 Immunomodulatory effects of levamisole in chronic fatigue syndrome

    Page :402

    R. Polasani, S.A. Schwartz

    
  • ·881 Upregulation of HIV replication by CD4 crosslinking

    Page :403

    H. Dalal, N. Oyaizu, Than Soe, M. Paul, S. Bakshi, S. Pahwa

    
  • ·882 Dioxin increases HIV-1 replication by activating NF-kB and HIV-1 long terminal repeat (LTR)

    Page :403

    S. Gupta, C.H. Kim, S. Gollapudi

    
  • ·883 Objective measures of allergic disease in children with HIV infection

    Page :403

    B.K. Bacot, M. Navarro, S.L. Abramson, I.C. Hanson, M.W. Kline, H.M. Rosenblatt, W.T. Shearer

    
  • ·884 Morbidity of respiratory virus infections in HIV-exposed and HIV-infected children

    Page :403

    J.T. Love, M.W. Kline, G. Demmler, B. Bohannon, W.T. Shearer

    
  • ·885 Differential expression of Tat associated protein

    Page :404

    Ketan Desai

    
  • ·886 The stress hormone, cortisol, synergizes with HIV-1 Gp-120 to induce apoptosis of normal human peripheral blood monuclear cells (PBMC)

    Page :404

    M.P.N. Nair, J. Hou, A. Sweet, S.A. Schwartz

    
  • ·887 HIV-1 Nef protein induces interleukin-10 production in peripheral blood mononuclear cells and H9 cell line

    Page :404

    E. Brigino, S. Haraguchi, A. Koutsonikolis, U. Owens, R.A. Good, N.K. Day

    
  • ·888 Positive direct antiglobulin test (DAT) and auto-immune hemolytic anemia (AIHA) in children with vertically acquired HIV infection

    Page :404

    J.P. Sinclair, H.M. Rosenblatt, I.C. Hanson, M.W. Kline, S. Rossmann, M. Paul, S.L. Abramson, W.T. Shearer

    
  • ·889 CD45RO and CD45RA peripheral lymphocyte subsets in HIV-1+ patients

    Page :405

    G.S. Del Giacco, V. Arangino, S. Lombardini, E. Manca, B. Ambrosini, L. Di Martino, S. Del Giacco, P.E. Manconi

    
  • ·890 Nasal epithelial alterations are associated with chronic nasal symptoms in HIV infection

    Page :405

    E. Clarin, M. Lee, R.Y. Lin

    
  • ·891 EBV associated leiomyosarcoma metastasizing to bone

    Page :405

    B. Goodman, M.E. Paul, I.C. Hanson, H.M. Rosenblatt, S.L. Abramson, W.T. Shearer

    
  • ·892 Effect of exercise on Th1- and Th2-type cytokine production in HIV-1 infected subjects

    Page :405

    J.K. Smith, G. Krishnaswamy, D. Chi, R. Dykes, S. Reynolds, S. Berk

    
  • ·893 Modulation of activated B and T cell tyrosine phosphorylation by IVIG

    Page :406

    I. Melamed, E.W. Gelfand

    
  • ·894 Sumatriptan succinate is effective treatment for headache induced by intravenous gammaglobulin (IGIV)

    Page :406

    R.L. Wasserman

    
  • ·895 Transmission of hepatitis C virus via intravenous immunoglobulin infusions in patients with common variable immunodefficiency

    Page :406

    M.A. Davis-Lorton, C. Cunningham-Rundles

    
  • ·896 Hepatitis C Virus (HCV) infection in common variable immunodeficiency (CVID) associated with IVIG

    Page :406

    M.B. Fasano, J. Gilliam, R. Peters, H. Prabhakara

    
  • ·897 The four year experience with intravenous gamma globulin at a tertiary medical center

    Page :407

    R. DeGuzman, R. Rodriguez, E. Bernton, D. Auth, D. Green, L. Smith, R.J.M. Engler

    
  • ·898 Metabolic and hematologic changes after different IVIG infusion rates

    Page :407

    M.M.S. Carnciro Sampaio, B.T. Costa Carvalho, D. Solé, R.U. Sorensen, C.K. Naspitz

    
  • ·899 Benign eczematous eruption following high dose intravenous immunoglobulin therapy

    Page :407

    R.S. Pence, J.S. Beard, R.J.M. Engler, P.M. Benson, W.S. Davis, V.A. Carregal

    
  • ·900 Hyperthyroidism and elevated immune thyroid stimulating globulin (ITSG) following high dose intravenous immunoglobulin therapy

    Page :407

    C.E. Buckley, G.J. Ellis

    
  • ·901 Hemiplegia following IVIG infusion in a 4-year-old girl with combined immunodeficiency (ID)

    Page :408

    E. Sarinho, B.T. Costa, M.M.S. Carneiro Sampaio, D. Solé, R.U. Sorensen

    
  • ·902 Interferon alpha modulates proliferation and production of eosinophilopoietic cytokines by peripheral blood mononuclear cells and T-cell clones

    Page :408

    G. Krishnaswamy, S. Srikanth, S.K. Huang, J. Kalbfleisch, J.K. Smith, D.S. Chi

    
  • ·903 Distint cytokine profiles among subjects with immediate and delayed hypersensitivity to Trichophyton tonsurans

    Page :408

    J.B. Slunt, E.A. Taketomi, J.A. Woodfolk, T.A.E. Platts-Mills

    
  • ·904 CD8⁺ T cells from allergic patients produce IL-4 and enhance IgE synthesis in vitro

    Page :408

    N. Meissner, F. Kussebi, J. Coutelle, C. Baumgarten, Ratti H., Ch. Heuser, H. Renz

    
  • ·905 Adenovirus E1A-p300 binding blocks interferon-stimulated gene expression

    Page :409

    J. Routes, H. Li, S. Bayley, S. Ryan, D. Klemm

    
  • ·906 CD40 mediated transcriptional activation of the human lymphotoxin gene depends on NF-kB activation

    Page :409

    M. Worm, R.S. Geha

    
  • ·907 In vitro production of IFN-r, IL-4, IL-10, IL-12, IL-13 and IGE in asthmatic children

    Page :409

    K.H. Hsieh, C.C. Chou, B.L. Chiang

    
  • ·908 Downregulation of lymphocyte proliferation and IL-4 production by caseins hydrolysed with intestinal bacterial enzymes

    Page :409

    Y. Sütas, M. Hurme, E. Isolauri

    
  • ·909 Mucosal cytokines in allergic airway disease may be moved into the lumen through a plasma exudation

    Page :410

    M. Linden, E. Andersson, M. Andersson, L. Greiff, C. Svensson, U. Alkner, C.G.A. Persson

    
  • ·910 Culture conditions modify the Th1-Th2 cytokine pattern of human T cell clones

    Page :410

    B. Lagier, G. Mautino, H. Rabesandratana, J. Bousquet, J. Pène

    
  • ·911 Allergen driven interleukin-4 production by human T cell lines

    Page :410

    M.H. Hermanoff, G. Khare, S. Tilles, L.J. Rosenwasser

    
  • ·912 Dexamethasone inhibits gene expression and production of both T_H1 and T_H2 cytokines from peripheral blood mononuclear cells

    Page :410

    D.S. Chi, S. Srikanth, K. Hall, J.K. Smith, G. Krishnaswamy

    
  • ·913 VLA-4 expression on allergen, tetanus, and Candida

    Page :411

    M. Tarkowski, K. Pacheco, M. Katlan, L.J. Rosenwasser

    
  • ·914 Cytokine expression in mice tolerized to house dust mite using cholera toxin B subunit

    Page :411

    J. Clark, T. Shen, M. Suzuki, K.C. Cheng, T.J. Yoo

    
  • ·915 Clonal diversity of IL-4 and IL-13 expression in human allergen-specific T lymphocytes

    Page :411

    J. Kleine-Tebbe, D.M. Essayan, W.F. Han, X.M. Li, H.O. Xiao, S.K. Huang

    
  • ·916 IL-1b appears to have a predominant role in the regulation of IL-8-expression in hyaline membrane disease (HMD)

    Page :411

    K.Y. Kwong, R. Cayabyab, I. Randhawa, C. Lecart, C.L. Stotts, P. Minoo, R.A. deLemos, C.A. Jones

    
  • ·917 The inhibitory effects of the flavonoid quercetin on endotoxin (LPS)-stimulated production of tumor necrosis factor-α (TNF-α) by normal human peripheral blood mononuclear cells (PBMC)

    Page :412

    E. Middleton, M.P.N. Nair, C. Kandaswami, S.A. Schwartz

    
  • ·918 Regulation of IgE production by anti-IL-4 in mouse asthma model

    Page :412

    C.Y. Zhou, G.A. Koenig, I.C. Crocker, F.A. Romero, A.K. Bewtra, R.G. Townley

    
  • ·919 Preliminary competition studies on interactions of plasma macroglobulins and specific autoantibodies to cytokines with TNFα and IFNα₂

    Page :412

    I.V. Makrushina, N.A. Zorin, S.G. Zhabin, N.M. Pustoshilova, A.I. Zakabunin, V.P. Gur'ev, V.S. Gorin, M.I. Musatov

    
  • ·920 Serum concentrations of autoantibodies (AAT) against TNFα in normal adults and patients with exsudative pleurisy

    Page :412

    S.G. Zhabin, N.C. Zorin, I.V. Makrushina, N.M. Pustoshilova, A.I. Zakabunin, A.L. Khanin, A.A. Varin, M.I. Mustatov

    
  • ·921 Circadian rhythm in serum interleukin-6 soluble receptor (IL6sR): Temporal and functional relationship to IL6

    Page :413

    B. Roitman-Johnson, R.B. Sothern, E.L. Kanabrocki, J.G. Yager, K. Corcoran, R.K. Fuerstenberg, J.A. Weatherbee, B.M. Nemchausky, L.E. Scheving

    
  • ·922 Immunohistochemical study of cytokin producing cells in Peyer's patch and intestinal lamina propria of ovalbumin (OVA)— Sensitized BALB/c mouse

    Page :413

    M.A. Vinuesa, Y. Tanaka, T. Matsushita, J. Kakugawa, H. Yoshida, J. Galimany

    
  • ·923 Relationship between interleukin-8 (IL-8) and neutrophil adhesion molecules in rheumatoid arthritis (RA)

    Page :413

    C.M. De Gendt, L.S. De Clerck, C.H. Bridts, N. Van Osselaer, W.J. Stevens

    
  • ·924 The effect of recombinant interferon gamma on IgE synthesis in adult asthmatic patients

    Page :413

    A. Blaziene, M. Mauricas

    
  • ·925 T cell-myocyte interactions in airway inflammation

    Page :414

    E. Puré, H. Reitz, S.P. Peters, S.M. Albelda, R.A. Panettieri, A.L. Lazaar

    
  • ·926 Recognition of individual human cytomegalovirus (HCMV) proteins by HCMV-specific class I MHC restricted cytotoxic T cells (CTL)

    Page :414

    S.B. Boppana, W.J. Britt

    
  • ·927 Class I MHC and TAp-1 down-expression in HPV infected papillomas: Mechanism for evasion of CTC recognition

    Page :414

    A. Vambutis, B.M. Steinberg, V.R. Bonagura

    
  • ·928 Restricted TCR V_α and V_β usage in HDM induced allergic sensitivity in mice

    Page :414

    K.C. Cheng, M. Suzuki, M.S. Krug, J. Clark, T.J. Yoo

    
  • ·929 Atopic and non-atopic individuals show a different T-cell proliferative response to grass pollen allergens

    Page :415

    P.A. Würtzen, J. Arnved, H. Ipsen, S.H. Sparholt

    
  • ·930 Histamine dependent regulation of T- and B-lymphocytes in patients with atopic diseases

    Page :415

    N. Bereznaya, S. Kotova

    
  • ·931 Differential of stapylococcal toxic shock syndrome toxin-1 (TSST-1) on B cell apoptosis versus activation

    Page :415

    M.F. Hofer, K. Newell, D.Y.M. Leung

    
  • ·932 Previous oral feeding of latex allergens down regulates IgE and eosinophil responses in mice

    Page :415

    J.Q. Xia, K.J. Kelly, V.P. Kurup, H. Choi, J.N. Fink

    
  • ·933 Oral tolerance can prevent Th2 cell-mediated allergic inflammation on mice

    Page :416

    A. Nakao, M. Kasai, H. Nakajima, K. Kurasawa, I. Iwamoto

    
  • ·934 Familial patterns of allergen sensitivity

    Page :416

    M.N. Blumenthal, D. Drury, J.E. Blumenthal, S.S. Rich

    
  • ·935 Familial aggregation of IgE and correlation with allergen sensitivity

    Page :416

    S.S. Rich, H.N. Nguyen, D. Drury, M.N. Blumenthal

    
  • ·936 Analysis of multiplex families containing asthma using pooled DNA analysis

    Page :416

    M.J. Brott, D.J. Flanders, W.S. Oetting, R.A. King, M.N. Blumenthal

    
  • ·937 Familial aggregation of BHR

    Page :417

    R. Wahid, S.S. Rich, L. Hadaway, M.N. Blumenthal

    
  • ·938 Antigen-specific induction of airway inflammation and hyperreactivity in sensitized mice

    Page :417

    X.M. Li, M. Wills-Karp, S.K. Huang

    
  • ·939 Prevention of hearing loss in EAE mice using antibody therapy

    Page :417

    M. Suzuki, K.C. Cheng, M.S. Krug, T.J. Yoo

    
  • ·940 Effect of sulfated polysaccharides on L-selectin (Leu-8) and CD11b/Cd18 (leu-15) expression on polymorphonuclear leukocytes (PMNs)

    Page :417

    N. Van Osselaer, L.S. De Clerck, C.H. Bridts, A.G. Herman, W.J. Stevens

    
  • ·941 A chimeric IgE antibody against a tumour associated antigen mediates activation of basophils and platelets in vitro

    Page :418

    B.E. Daniel, L.R. Coney, P.J. Marsh, C. Chan, J. Shi, G.A. Mackay, M. Hide, M. Joseph, M. Capron, H.J. Gould

    
  • ·942 Inter-relationship between CD30 positive lymphocytosis, hypereosinophilia, and elevated IgE, in systemic parasitosis

    Page :418

    M.R. Murali, B.K. Thakur, D. Volkman

    
  • ·943 A major Blatella cockroach allergen has significant tandem repeated structures that bind IgE

    Page :418

    R.M. Helm, G. Cockrell, S. Stanley, A.W. Burks, R. Brenner, G. Bannon

    
  • ·944 Molecular and immunologic studies of a major German cockroach allergen: Blattella germanica glutathione-S-transferase (Bla g 5)

    Page :418

    L.K. Arruda, L.D. Vailes, M.D. Chapman

    
  • ·945 Cockroach allergen (Bla g 1) in school dust

    Page :419

    S.B. Sarpong, Wood R.A., P.A. Eggleston

    
  • ·946 Molecular cloning of a 41 kD Alternaria allergen

    Page :419

    H. Sanzhez, R.K. Bush

    
  • ·947 Characterization of recombinant Alternaria alternata major allergen Alt a 1 expressed in Pichia pastoris

    Page :419

    M.W. De Vouge, M. Burton, H.M. Vijay

    
  • ·948 Is dust sampling a good surrogate for exposure to airborne fungi?

    Page :419

    G. Chew, M. Muilenberg, D. Gold, H.A. Burge

    
  • ·949 Assaying inhalable allergen exposures using a mini-cascade impactor

    Page :420

    R. Gandhi, R. Lewis, A. Dixit, R. Slavin, H.J. Wedner

    
  • ·950 Sequence and IgE-binding of a new recombinant allergen from Blomia tropicalis

    Page :420

    L. Caraballo, L. Puerta, S. Jiménez, B. Martínez, A. Avjiouglu, D. Marsh

    
  • ·951 In vivo cross reactivity between IgE ab to Blomia and Dermatophagoides spp and to the recombinant group 5 allergen among mite allergic patients living in the UK

    Page :420

    A. Smith, R. Green, A. Custovic, A. Woodcock, K. Arruda, M. Chapman

    
  • ·952 Immunological activity of recombinant Der p 2 and Der f 2

    Page :420

    Y. Lapalme, J.P. Valet, J. Boulanger, Y. Boutin, C. Brunet, A. Lavoie, P.M. Bédard, J. Hébert

    
  • ·953 Determining compliance with environmental controls

    Page :421

    E.A. Leyvas, C.R. Bartz, R.A. Simon

    
  • ·954 Role of the mattress-bases in dwelling mite infestation

    Page :421

    G. Pauli, F. de Blay, J.C. Bessot, M. Ott, P. Gries

    
  • ·955 Assessment of airborne Fel d I concentrations using an amplified ELISA

    Page :421

    P.H. Larsson, P. Malmberg, M. Wickman

    
  • ·956 Concentrations of airborne Fel d I in special daycare centres for atopic children

    Page :421

    A.C. Egmar, G. Emenius, P.H. Larsson, P. Malmberg, M. Wickman

    
  • ·957 Fel d I levels in Wellington primary schools and on children's clothing

    Page :422

    K.L. Patchett, S. Lewis, K. Wickens, J. Crane

    
  • ·958 Cloning and analysis of different isogenes encoding Bet v 1 isolated from pollen of North American birch

    Page :422

    Y. Boutin, R. Labourdette, J. Boulanger, J. Hébert

    
  • ·959 Overexpression of recombinant Phl p 5 isoallergens in Escherichia coli

    Page :422

    M. Wissenbach, S. Klysner, M. Spangfort, H. Ipsen

    
  • ·960 Identification of snow-crab antigens in air sampling of a production plant

    Page :422

    P. Chrétien, R. Brassard, C. Chiquette, J.-L. Malo, A. Cartier, M. McCants, S. Lehrer

    
  • ·961 Recovery of peanut allergens from ventilation filters of commercial airliners

    Page :423

    R.T. Jones, D.F. Stark, G.L. Sussman, J.W. Yunginger

    
  • ·962 Ten minutes in a clothes dryer kills all mites in blankets

    Page :423

    J.D. Miller, A. Miller

    
  • ·963 In vivo expression of interleukin-12 and interleukin-13 in atopic dermatitis

    Page :423

    T. Naseer, Q.A. Hamid, E.M. Minshall, Y.L. Song, M. Boguniewicz, D.Y.M. Leung

    
  • ·964 Dichotomy of blood and skin derived interleukin-4 producing nickel specific T-cells and restricted Vβ repertoire in allergic contact dermatitis

    Page :423

    T. Werfel, M. Hentschel, A. Kapp, H. Renz

    
  • ·965 Eosinophil cationic protein in atopic dermatitis and urticaria

    Page :424

    A. Montoro, T. Chivato, R. Laguna, M. Baeza, J. Zubeldia, M. Rubio

    
  • ·966 Assessment of autoimmunity in chronic urticaria patients

    Page :424

    L. Tong, G. Balakrishanan, J. Kochan, A.P. Kaplan

    
  • ·967 Association of reduced NF-ATp binding at the IL-4 promoter element CLE0 and high IgE levels in severe atopic eczema

    Page :424

    M. Walchner, E.A. Wierengal, M. Meurer, P. Kind, G. Plewig, G. Messer

    
  • ·968 Ovomucoid-specific CD8⁺ TH2-like cell lines in atopic dermatitis patients [AD] with egg allergy

    Page :424

    H.A. Sampson, J. Rowe, P.A. Eigenmann, D.Y.M. Leung, S.K. Huang

    
  • ·969 Cutaneous injection of RANTES causes eosinophil (EOS) recruitment: Comparison of nonallergic (NA) and allergic (A) human subjects

    Page :425

    L. Beck, C. Stellato, S. Dalke, K. Leiferman, C. Bickel, R. Hamilton, H. Rosen, B. Bochner, R. Schleimer

    
  • ·970 Role of food hypersensitivity in mild to severe atopic dermatitis

    Page :425

    A. Hiegel, J.M. James, G. Wilson, A.W. Burks

    
  • ·971 Modulation of the histamine releasing activity (HRA) present in the serum of patients with chronic idiopathic urticaria (CIU)

    Page :425

    M. Valenzano, B. Zweiman, P.C. Atkins

    
  • ·972 Recruitment of high affinity IgE receptor (FcεRI)-bearing cells in allergen-induced skin late phase reactions

    Page :425

    L. Taborda-Barata, J.A. Grant, M. Humbert, J. Barkans, S. Ying, A.B. Kay

    
  • ·973 Anergy induction in cloned phospholipase A2-specific T cells of Th2 functional phenotype

    Page :426

    A. Faith, A.C. Akdis, K. Blaser

    
  • ·974 Succesful immunotherapy with T-cell epitopes of bee venom phospholipase A₂ (PLA) in patients with bee venom (BV) allergy

    Page :426

    U. Müller, M. Fricker, A.C. Akdis, J. Carballido, K. Blaser

    
  • ·975 Constitutive cytokine mRNA production in human post-natal thymus: RT-PCR analysis of cellular subsets

    Page :426

    J.S. Sundy, D.D. Patel, L.P. Whichard, P.J. Lager, B.F. Haynes

    
  • ·976 Formation of germinal centers (GC) is absolutely dependent on lymphotoxin-α (LTα) and type I TNF receptors

    Page :426

    D.D. Chaplin, M. Matsumoto

    
  • ·977 Expression of unique cell surface proteins of B cells of patients with severe combined immunodeficiency (SCID)

    Page :427

    S.E. Schiff, R.H. Buckley

    
  • ·978 Platelet-activating factor blocks apoptosis and the inhibition of immunoglobulin synthesis induced by crosslinking of the surface IgM receptor in a human B lymphoblastoid cell line

    Page :427

    B. Toledano, F. Noya, Y. Bastien, B. Mazer

    
  • ·979 Down-regulation of human B-cell antigen receptor signaling by Fc receptor cross-linking

    Page :427

    N. Rabinovitch, H.R. Patel, D. D'Ambrosio, J.C. Cambier, E.W. Gelfand

    
  • ·980 bcl-x rather than bcl-2 promotes cell survival during centrocyte selection in the germinal center

    Page :427

    K.M. Druey, J.M. Tuscano, A. Riva, J. Pena, C.B. Thompson, J.H. Kehrl

    
  • ·981 Epitope analysis of a major latex allergen, hevein preprotein

    Page :428

    D.H. Beezhold, D.A. Kostyal, G.L. Sussman

    
  • ·982 Isolation and identification of hevein as a major IgE-binding polypeptide in latex from Hevea brasiliensis

    Page :428

    Z. Chen, A. Posch, M. Raulf-Heimsoth, X. Baur

    
  • ·983 Characterization and standardization of a latex extract

    Page :428

    T. Wikborg, N. Johansen

    
  • ·984 Latex and cow's milk casein allergens in 31 latex gloves

    Page :428

    Soili Mäkinen-Kiljunen, Kristiina Turjanmaa, Harii Alenius, Timo Reunala, Timo Palosuo

    
  • ·985 Quantitation of airborne latex allergens produced by bursting and snapping latex gloves

    Page :429

    J. Abbosh, D. Ownby, J. McCullough

    
  • ·986 Resolving discordant clinical history and latex IgE antibody test results by a latex glove provocation

    Page :429

    R.G. Hamilton, N.F. Adkinson

    
  • ·987 The effect of avoidance of the natural history of latex rubber allergy

    Page :429

    R.K. Zeldin, R.G. Hamilton, N.F. Adkinson

    
  • ·988 Latex contamination in penicillin determinants for skin testing may induce false positive results

    Page :429

    S. Terrados, M. Blanca, J. Fernandez, J.M. Vega

    
  • ·989 Allergy impairment questionnaires: Validation studies

    Page :430

    M.C. Reilly, L.A. Tanner, E.O. Meltzer

    
  • ·990 The prevalence and impact of allergic rhinitis among teenagers

    Page :430

    H.M. Arrighi, C.K. Cook, G.J. Redding

    
  • ·991 The relationships between nasal hyperreactivity, quality of life (QOL) and nasal symptoms in perennial allergic rhinitis

    Page :430

    R. Gerth van Wijk, C. de Graaf-in 't Veld, S. Koenders, I.M. Garrelds

    
  • ·992 Leukocyte influx after capsaicin (CAPS) nasal challenge is a dose dependent phenomenon

    Page :430

    A.M. Sanico, S. Atsuta, A. Togias

    
  • ·993 The nasal response to hyperosmolar saline (HS) is inhibited by capsaicin treatment

    Page :431

    G. Lai, G. Philip, A. Togias

    
  • ·994 Comparison of natural and induced cold models for the study of nasal congestion, rhinorrhea, and secretion

    Page :431

    D.K. Riker, T.J. Witek, R.B. Turner

    
  • ·995 Seasonal variations in mediator levels in nasal lavage fluid of rhinitic patients

    Page :431

    B. Mainprice, A.M. Campbell, B. Lebel, J. Bousquet

    
  • ·996 Objective assessment of the allergic reaction in seasonal rhinitis

    Page :431

    L.P. Nielsen, T. Bierke, B. Pedersen, M.B. Christensen, T.R. Rasmussen, R. Dahl

    
  • ·997 Nasal epithelial and leukocyte patterns in allergic disease: a study of mucosal cytology specimens obtained by 2 different methods

    Page :432

    R.Y. Lin, E. Clarin, M. Lee, H. Menikoff

    
  • ·998 The interaction of lysozyme with proteoglycans; Implications for its antibacterial activity and its allergenic potential

    Page :432

    A.S. Josephson, H. Drew

    
  • ·999 Prophylactic use of topical triamcinolone acetonide nasal inhaler in patients with seasonal allergic rhinitis

    Page :432

    W. Storms, D. Bernstein, C. LaForce, D. Pearlman, D. Proud, A. Kagey-Sobotka, J. Lim, P. Creticos

    
  • ·1000 Triamcinolone acetonide nasal spray (T) vs loratadine tablets (L) vs T+L in patients with spring pollen allergic rhinoconjunctivitis(RC)

    Page :432

    M. Gold, P. Small, P. Patel, P.A. Houle, W. Yang, J. Schulz, W. Arkinstall, A. Lavoie, J. Hébert, M. Drouin, D. Lee, R. Phillips, J. Spénard

    
  • ·101 Patient satisfaction with seasonal allergic rhinitis therapy in a clinical trial comparing fluticasone with loratidine

    Page :433

    E. Schenkel, F. Cox, B. Goodwin, F. Picone, D. Aaronson, K. Reed, C. Cook, P. Rogenes, G. Anschuetz

    
  • ·1002 Comparison of once-daily triamcinolone acetonide aqueous nasal spray and twice-daily beconase AQ® for the treatment of seasonal allergic rhinitis due to ragweed

    Page :433

    C. LaForce, F. Hampel, F. Kiechel, W. Lumry, J.J. Murray, J.A. Furst, B. Simpson, J.S. Smith

    
  • ·1003 Triamcinolone acetonide nasal spray (T) vs fluticasone propionate aqueous nasal spray (F) in patients with seasonal allergic rhinitis

    Page :433

    P. Small, P.A. Houle, J. Day, M. Briscoe, M. Gold, A.J. Ham, M.A.J. Mandl, I. Brodarec, J. Spénard, R. Phillips

    
  • ·1004 Once daily mometasone furoate aqueous nasal spray in seasonal allergic rhinitis: An active and placebo-controlled study

    Page :433

    J. Hebert, K.B. Nolop, B.N. Lutsky, I92-200 Study Group

    
  • ·1005 Evaluation of safety and efficacy of dexacort™ turbinaire® (DEX) nasal spray in patients with perennial allergic rhinitis

    Page :434

    Gary Rachelefsky, Jeffrey Adelglass, Jonathan Corren, Sheldon Spector, Howard Schanker, Linda Kiely, Sheldon Siegel

    
  • ·1006 Comparative CNS depressant effects of cetirizine and classical antihistamines in an experimental animal model

    Page :434

    M. del Prado, J. Sherwood, J.A. Hey

    
  • ·1007 Onset of action, efficacy and safety of a single dose of 60 mg and 120 mg fexofenadine HCl for ragweed (RW) allergy using controlled antigen exposure in an environmental exposure unit (EEU)

    Page :434

    J.H. Day, M.O.P. Briscoe, A. Welsh, J. Smith, J. Mason

    
  • ·1008 A placebo-controlled trial of cetirizine in seasonal allergic rhinitis in children aged 6 to 11

    Page :434

    W.R. Lumry, D.S. Pearlman

    
  • ·1009 Efficacy and safety of fexofenadine HCl in fall seasonal allergic rhinitis

    Page :435

    D. Tinkelman, C. Falliers, E. Bronsky, H. Kaiser, J. Mason

    
  • ·1010 Fexofenadine: A new nonsedating antihistamine is effective in the treatment of seasonal allergic rhinitis

    Page :435

    D. Bernstein, W. Schoenwetter, R. Nathan, W. Storms, J. Mason

    
  • ·1011 Acute and subchronic effects of cetirizine terfenadine, diphenhydramine & placebo on cognition in the elderly

    Page :435

    F. Gengo, P. Kinkel

    
  • ·1012 Early nasal effect of cetirizine and loratadine in allergic rhinitis

    Page :435

    N. Frossard, J. Lacronique, M. Mélac, O. Benabdesselam, N. Glasser, G. Pauli

    
  • ·1013 Intranasal doxepin HCl in the treatment of allergic rhinitis

    Page :436

    J. Fink, I. Lawrence, W. Palo, J. Podpora

    
  • ·1014 A comparison of third generation antihistamines with a first generation antihistamine in the treatment of perennial allergic rhinitis

    Page :436

    W.W. Crawford, P.H. Lee, I.M. Placik, W.B. Klaustermeyer

    
  • ·1015 Evaluation of efficacy and duration of action of levocabastine (LEVO) nasal spray under nasal challenge conditions

    Page :436

    Sheldon Spector, Jonathan Corren, Gary Rachelefsky, Howard Schanker, Sheldon Siegel

    
  • ·1016 Ketoconazole enhances the QTc interval prolongation effects of the nonsedating antihistamines terfenadine and ebastine in an experimental animal model

    Page :436

    J.A. Hey, M. del Prado, W. Kreutner, R.W. Egan

    
  • ·1017 The electrocardiographic effects of loratadine syrup in pediatric patients

    Page :437

    J.E. Harrison, M.R. Danzig, R.R. Lorber

    
  • ·1018 Clemastine (CLEM) (0.5 Mg) partially inhibits the early nasal allergic reaction when given 4 and 6 hours (hrs) before nasal challenge with allergen

    Page :437

    F.M. Baroody, J. Chung, M. DeTineo, J. Sorrentino, C.M. Winslow, R.M. Naclerio

    
  • ·1019 Topical azelastine and levocabastine protection on histamine nasal provocation test

    Page :437

    A. Roger, J. Simon, C. Lucas, E. Martí

    
  • ·1020 Levocabastine versus cetirizine in children with perennial allergic rhinitis (PAR)

    Page :437

    L. Arrequín, R. Cerino, A. Meza, R. García

    
  • ·1021 A multicenter study of the taste of the once-daily antihistamine cetirizine in children with perennial allergic rhinitis

    Page :438

    J.M. Adelglass

    
  • ·1022 Allergies are not a cause of chronic fatigue syndrome (CFS): IgE concentrations and prevalence of allergic rhinitis in atopic, CFS, and negative control populations

    Page :438

    A.L. MacDowell-Carneiro, P. Pandiri, S. Foong, M. Ali, J. Bellanti, D. Clauw, J.N. Baraniuk

    
  • ·1023 Chronic nonallergic rhinitis complants identified in chronic fatigue syndrome (CFS)

    Page :438

    E. Gaumond, D. Radulovic, S. Wethington, B. Wilson, D. Clauw, J.N. Baraniuk

    
  • ·1024 pollinosis in southern Brazil

    Page :438

    F. Vieira

    
  • ·1025 Relevant pollens in the etiology of seasonal allergic rhinitis in the city of Bahía Blanca (Argentina) and its surrounding area

    Page :439

    G.D. Ramón, S. Bronfen, C.B. Villamil, N. Ferrer Lic, S. Apphatie, S. Barzón

    
  • ·1026 Mold allergy is a risk factor for persistent cold-like symptoms in children in winter

    Page :439

    S.W. Huang, J. Kimbrough